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Abstract 
a.-FLUOROAMIDES IN 
BIOTRANSFORMA TIONS 
By John W. Banks 
Classically hydrolytic enzymes, such as lipases, are considered to exhibit selectivity at 
a stereogenic centre, based on the steric nature of the adjacent substituent. In this 
study we report on the selectivity of hydrolytic enzymes (acylase's and protease's) on 
compounds containing both hydrogen and fluorine atoms at the stereogenic centre. A 
selectivity of 96% de is reported for the hydrolysis of an a.-fluoroamide using 
Aspergillus mel/eus acylase. The Km and V max values are reported for each 
diastereomer, which demonstrate a ten-fold preference for the (S, S)-isomer over the 
(S, R)-isomer. A similar phenomenon is established for the analogous a.-chloroamide 
and a comparison of reaction rates for non-halogenated amides is made. This effect 
has been rationalised by; a) the fluorine substituent controlling ofthe conformation of 
the amide bond and b) the stabilisation of the enzyme I amide intermediate. 
Furthermore a selection of racemic a.-fluoroamides were prepared and their solid state 
conformations determined by X-ray crystallography. The C-F and the amide bonds are 
found to orientate in a very specific manner with respect to each other, consistent with 
a very specific stereoelectronic alignment. 
Attempts at preparing the elusive dipeptide with a fluorine atom alpha to the amide 
bond proved unsuccessful, however, one attempt led to the formation of a dimeric 
compound for which X-ray crystal analysis secured the structure. 19F variable 
temperature NMR was used to examine the barrier to rotation that existed for this 
dimeric compound. 
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Chapter 1 - Introduction to fluorine substitution and its 
application in biomedicinal chemistry 
1 
Fluorine1, mainly as the mineral fluorspar (CaF2), is the thirteenth most abundant 
element in the Earth's crust. In 1529, Georigius Agricola reported the use of fluorspar 
as a flux and later Schwandhard, in 1670, discovered hydrofluoric acid when he found 
that the vapours produced when fluorspar was treated with acid etched glass. 
Elemental fluorine (F2) was finally isolated in 1886 by Moisson by electrolysis of 
potassium hydrogen fluoride in the presence of hydrofluoric acid. Commercial 
applications, using F2, were rare until the start of the Second World War when the 
emerging nuclear industry made it necessary to produce large quantities of elemental 
fluorine for separating uranium isotopes via. the hexafluoride. Other commercial 
applications include chlorofluorocarbon (CFC) solvents for refrigeration, fluorinated 
high temperature plastics (polytetrafluoroethene, PTFE) and hydrogen fluoride, which 
is extensively used in glass etching processes. 
In recent times a major increase in organofluorine research has been seen in the 
pharmaceutical industry. Fluorine substitution has become a popular strategy among 
medicinal chemists in their attempts to improve the efficacy of active 
pharmaceuticals. 
~ .2 fhJJorine in 1111atural compounds 
Natural products containing fluorine are extremely rare, considering the relative 
abundance of fluorine, with only thirteen metabolites containing fluorine having been 
identified2'3 . The first natural compound containing fluorine to be identified was 
fluoroacetate 1, which was isolated from the South American plant Dichapetalum 
cymosum and the latest metabolite to be identified was 4-fluorothreonine from the 
bacterium Streptomyces cattleya. The remaining compounds identified so far are eo-
fatty acids, fluoroacetone, nucleocidin and 5' -fluoro-5' -deoxyadenosine (5-FDA). 
2 
F 
1 
Marais first achieved the isolation of tluoroacetate 1 in 19444 from the South African 
plant D. cymosum, where potassium monotluoroacetate has been found at levels up to 
8000 ppm. Fluoroacetate is highly toxic to most species but certain animals have 
developed resistance to its effects. For example, the caterpillar Sindris albimaculatus 
can feed on the fruits and leaves of D. cymosum and accumulate tluoroacetate as a 
defence against predators. In addition grazing animals and humans that live where D. 
cymosum grows show higher resistance to the toxin. Fluoroacetate is converted in vivo 
to (2R, 3R)-tluorocitrate, 3, as shown in Scheme 1.1, via. tluoroacetyl-CoA, 2. 
Acetyl CoA! 
Synthase 
~~~~~se 1 Oxaloacetate 
Aconitase ! 
§cllueme 1.1: "Lethal synthesis" of tluoroacetate 
3 
Acetyl CoA! 
Synthase 
CSitrathte ! Oxaloacetate yn ase 
H02C .OH H02C~C02H 
3 F 
t 
The conversion of fluoroacetate to fluorocitrate has been termed the lethal synthesis, 
as (2R, 3R)-fluorocitrate is an effective inhibitor of the aconitase enzyme, so blocking 
the normal citrate metabolism, which in turn leads to inhibition of respiration. 
Interestingly, only the (2R, 3R)-fluorocitrate stereoisomer is produced by citrate 
synthase and this is the only stereoisomer that is able to inhibit aconitase. 
Figure 1.1 shows the naturally occurring ro-fluorofatty acids, which are found in the 
seeds of Dichapetalum toxicarium, a plant that can metabolise fluoroacetate. 
OH 
F OH 
4 
n = 6, 12, 14, 16 and 18 
5 
n(a) = n(b) = 6 and 7 
n(a) = 7, n(b) = 9 
n(a) = 9, n(b) = 7 
0 
OH 
Figure 1.1: Natural ro-fluorofatty acids from D. toxicarium 
6 
Saturated ro-fluorofatty acids (e. g. ro-fluorocapric acid) have the general structures 
shown in 4 and to date five different types have been isolated from the seeds of D. 
toxicarium. The most abundant ro-fluorofatty acid is ro-fluorooleic acid, which is a 
C18 (i. e. n(a) = n(b) = 7) unsaturated acid of the type shown in 5. For the C20 
unsaturated acid two isomers are seen with the double bond being at either the 9 or 11 
positions. One further type of ro-fluorofatty acid has been identified, 9, 10-
dihydroxystearic acid, 6. It is assumed that this arises from the metabolism of ro-
fluorooleic acid via. the 9, 10-epoxide. ro-Fluorofatty acids are found in the same 
chain lengths and unsaturation patterns as their non-fluorinated counterparts and this 
leads to the conclusion that they are manufactured by the same biosynthetic pathway, 
which presumably starts fi·om fluoroacetyl~CoA. ro-Fluorofatty acids are extremely 
4 
toxic as a consequence of J3-oxidation, as they are readily converted to fluoroacetyl-
CoA and then to fluorocitrate. 
Two bacteria have been found to elaborate fluorinated metabolites. Nucleocidin, 7, 
has been identified as a metabolite of the soil bacteria Streptomyces calvus5 when it is 
grown in a fluoride ion medium. 
(-{H: 
({, 0 N~) 
H,N'Sb ~N 
OH OH 
7 
The structure of nucleocidin was elucidated in 19696 . This metabolite is 
fundamentally different from those found in plants, as its formation cannot easily be 
rationalised from fluoroacetate. 4-Fluorothreonine, 8, is the second fluorine containing 
metabolite from a bacterium. It has been isolated from Streptomyces cattleya. 
OH 0 
F-J?OH 
NH2 
8 
S. cattleya eo-produces fluoroacetate and 4-fluorothreonine7. These metabolites have 
been the subject of biosynthetic investigations in S. cattleya. 13C and 2H labelling 
studies have revealed that the C-3 and C-4 atoms of fluorothreonine have the same 
biosynthetic origin and that there is a single fluorination enzyme. Fluoroacetaldehyde, 
9, has also been identified as the precursor to both metabolites as shown in Scheme 
1.2. 
Initially it was suggested that 4-fluorothreonine was a product ofthe condensation of 
fluoroacetaldehyde and glycine but it has now been shown that L-threonine is the 
amino acid that condenses with fluoroacetaldehyde in S. cattleya. The pyridinal 
phosphate dependant transaldolase responsible for the biosynthesis has been isolated 
5 
and studies have shown that in the absence of L-threonine or fluoroacetaldehyde no 
fluorothreonine is produced. 
OH 0 FJ00H 
NH2 
8 
Scheme 1.2: Biosynthesis of fluoroacetate and fluorothreonine 
Cell free studies have revealed the nature ofbiological fluorination inS. cattleya8 . 
NH 2 ~Nn F0 N 
OH OH 
10 
It has been demonstrated that 5' -fluoro-5' -deoxyadenosine 10 (5-FDA), is the product 
of a fluorinase enzyme, which mediates a reaction between fluoride ion with S-
adenosylmethionine 11 (SAM), as shown in Scheme 1.3. 
6 
OH OH 
SAM, 11 
F 
Fluorinase 
NH2 
tD F~ N 
OH OH 
10 
Scheme 1.3: The fluorinase reaction inS. cattleya 
+ methionine 
1.3 Fluorine's influence on physico-chemical properties 
In spite of nature largely ignoring a role for fluorine, in medicinal chemistry 
replacement of a hydrogen atom with fluorine is a common tool used to improve the 
efficacy of a drug target. This approach has been successful due to the changes in the 
physico-chemical properties of the target molecule caused by the introduction of the 
fluorine atom. 
1.3.1 Steric influence of fluorine 
When hydrogen is substituted with fluorine it has long been recognised that the steric 
impact of this change is very smalL The precise size of a fluorine atom in relation to 
other substituents is a controversial issue and various tables of comparative data exist. 
For instance, Schlosser and Michel9 report the following data for comparison between 
hydrogen, fluorine and other substituents. 
Table 1.1: Comparison ofVan der Waals radii 
X H F 0 N 
Van der Waals Radii, 1.29 1.47 1.52 1.55 
AIO 
Table 1.1 shows that while fluorine is the smallest substituent after hydrogen, its steric 
influence is expected to be closer to that of oxygen at first glance, as they have very 
similar Van der Waals radii. However, measurement of Van der Waals radii is not the 
only factor when considering steric crowding in a molecule as this may also be 
influenced by interatomic attraction and repulsion. 
7 
The steric parameter devised by Charton11 aims to link the Van der Waals radii to 
kinetic data obtained from rates of ester hydrolysis. 
X X 
~0~ k ~OH 
0 0 
Table 1.2: Comparison of steric parameters 
X H F 
u 0.00 0.27 0.52 0.91 
Table 1.2 shows that for the groups studied the steric influence of fluorine is again 
closer to the hydrogen atom than the other substituents. 
A generally appreciated method for measuring steric effects of substituents is to 
measure the energy required for conformational transformations to occur. This has 
been studied for various substituents on the cyclohexane moiety for the transitions 
between the equatorial and axial conformers, generally termed "A values". 
9 ;::::::;r-X 
X 
Table 1.3: Comparison of AGo for conformational transformations 
X H F OCH3 CH3 CH(CH3)2 CF3 
AG0 ax!eq 
0.15 12 0.65 13 1.78 2.1 8 2.414 (kcal mol"1) 0.00 
It is clear from Table 1.3 that fluorine and hydrogen have the closest steric match. 
Another demonstration of the steric similarity between hydrogen and fluorine has 
been illustrated using scanning tunnelling microscopy (STM)15 to investigate the two-
dimensional packing of mono-fluorinated stearic acids deposited on graphite. STM 
analysis indicates that very little packing disorder is observed when fluorine replaces 
8 
hydrogen, which confirms that hydrogen and fluorine can be considered closely 
isosteric. 
1.3.2 Electronic effects of fluorine 
While the steric requirements of fluorine and hydrogen have been demonstrated to be 
similar the electronic nature of the two atoms is very different. The higher 
electronegativity of fluorine over hydrogen renders them very different in this regard 
and hence the subsequent reactivity of a molecule can change dramatically on 
replacing hydrogen for fluorine. 
1.3.2.1 Anomeric effect 
The anomeric effect16, which has been widely discussed in carbohydrate chemistry, 
can be rationalised by the donation of electron density arising from oxygen non-
bonding electrons into a C-0 anti bonding cr* orbital. This stereoelectronic effect 
preferentially stabilises the axial conformer. 
~ - ~OH 
OH 
•• 0'-P 
t. 
(J 
Figure 1.2: Anomeric effect 
This effect is also observed for fluorine. For example the preferred conformation of 
fluoropyran has the C-F bond axial 17 as illustrated in Figure 1.3. 
~ - ~F 
F 
Figure 1.3: Anomeric effect in fluoropyran 
In fluoropyran the C-F bond prefers the axial conformation, rather than the perhaps 
more sterically favoured equatorial conformation. The axial conformation positions 
the lone pair on the oxygen antiperiplanar to the C-F bond and this allows donation of 
electron density into the cr* C-F anti bonding orbital. 
9 
1.3.2.2 Anh - Eisenstein effect 
Anh and Eisenstein18 originally undertook investigations into the electronic factors 
involved in nucleophilic attack on carbonyl of an a.-chlorocarbonyl compounds. This 
was extended by Paddon- Row to include the a.-fluorine analogues19. The latter study 
investigated the trajectory of nucleophilic attack (CN) on the carbonyl of 2-
fluoropropanal as shown in Figure 1.4. 
o = H 
• =C 
O=N 
0 =0 
0 =F 
Figure 1.4: Paddon- Row study on nucleophilic attack to a a.-fluorocarbonyl 
Of the six possible conformations for the intermediate in the above reaction, Paddon-
Row found that the orientation depicted in Figure 1.4 was the most stable. They 
proposed that stabilisation of the transition state during nucleophilic attack involves a 
number of re-inforcing influences. Two of the most significant influences are 
stabilisation, via donation of electron density from the incoming nucleophile into the 
C-F cr* orbital, and electrostatic repulsion between the nucleophile and the fluorine 
atom. 
Based on these considerations two diastereomeric transition states can be envisaged 
for the following reaction where the fluorine and hydrogen atoms are interchanged 
(Figure 1.5). 
A 
Figure 1.5: C-F cr* in transition states 
Me 0 NU~~H 
FR 
8 
Transition state A indicates stabilisation by donation of the nucleophile electron 
density into the C-F cr* orbital. This can only be achieved if the nucleophile 
approaches anti to the fluorine substituent. This trajectory in turn also reduces the 
electrostatic repulsion between the incoming nucleophile and the fluorine atom. The 
10 
transition state arising from conformation A has been calculated to be 7.2 kJmor1 
lower in energy than the transition state that arises from conformation B. 
An ongoing discussion in fluorine chemistry is whether organic bound fluorine can 
take part in hydrogen bonding. In hydrogen bonding, acceptor and donor constituents 
are required. 
--..._ x-· H 'a-· H ... X 
I 
R 
donor acceptor 
Figure JL.6: Hydrogen bonding interactions showing donors and acceptors 
Figure 1. 6 shows an alcohol as both an acceptor and a donor. Obviously in the case of 
fluorine only the acceptor role can be considered, as no acidic hydrogen is available 
for donation as shown in Figure 1. 7. 
""x 
donor 
not 
possible 
F .. H ... X 
I 
R 
acceptor 
Figure JL. 7: Fluorine as a hydrogen bond acceptor 
Theoretical calculations20 have estimated the strength of C-F---H-X interaction to be 
between 2. 0 - 3.2 kcal mor1, which is about half that of a hydrogen bond to an oxygen 
atom. This is consistent with the electrostatic influence of fluorine being 
approximately half that of oxygen21 and is a reflection of the greater electronegativity 
and poorer polarisability of fluorine compared to oxygen. 
A wide ranging review of X-ray crystal structures in the Cambridge Structural 
Database System (CSDS) of molecules containing CF, CF2 and CF3 groups22 has 
revealed F---H interactions up to 3 A, with mean values being in the range 2.5 to 2.6 
A. This is close to the sum of the van der Waals radii reported in section 1.2.1 and in 
case where fluorine is argued to be a hydrogen bond acceptor, F---H interactions in 
the range of2.00 to 2.30 A should exist. 
A review23 of the CSDS for F---H contacts of less than 2.35 A has revealed that short 
contacts between fluorine and hydrogen do occur but they are infrequent, with only 40 
examples being found, and where they do exist they always involve interaction with 
the hydrogen of hydroxyl or amino compounds. From this information it can be 
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concluded that organic bound fluorine forms hydrogen bonds to acidic hydrogens but 
that this interaction is weak and is usually overridden by other intermolecular packing 
forces in the solid state. 
1.4 Pharmaceutical development of fluorinated compounds 
Recently there have been many examples of fluorine containing compounds being 
developed as new chemical entities in the pharmaceutical industry. Reviews24 have 
highlighted several important therapeutic areas and modes of action of fluorine 
containing compounds. Some of the most important compounds are shown in Figure 
1.8 
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Figure 1.8: Fluorinated pharmaceuticals 
Perhaps the best-known fluorine containing pharmaceutical is the anticancer agent 5-
fluorouracil, 12. This molecule is successful as it incorporates a deceptor fluorine. 
This leads to enzyme inhibition, which blocks thymidylate synthase, the enzyme 
involved in converting uracil to thiamine in DNA biosynthesis. Thymidylate synthase 
is extremely active in tumour growth and many variations have been developed to 
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inhibit this enzyme, leading to molecules with higher efficacy or ones that have been 
specifically tuned for certain types of tumour. 
Fluorine substitution has opened up many opportunities for compounds with antiviral, 
antibacterial and antifungal properties. Examples are 3-fluorothymidine ll.3, which has 
been studied for its ability to inhibit human immunosuppressive virus-1 (HIV -1) 
replication. In the field of antibacterials, the fluorinated quinolones have become an 
important addition to the arsenal of physicians, particularly in light of the recent 
development of resistant bacteria. Temafloxacin 14, is a typical example of a 
fluoroquinolone and many variations ofthis type of molecule exist. Fluconazole 15, is 
a major antifungal agent which is effective in the treatment of a broad range of fungal 
infections and again other examples of fluoro-substituted azoles exist which exhibit 
similar properties. 
The field of anaesthetics was transformed by the introduction of halothane 13. It was 
one of the first anaesthetics developed with minimal side effects and has the key 
advantage that it is non-flammable. 
In the search for drugs that correct central nervous system (CNS) disorders, perhaps 
one of the best known is haloperidol 17, which is used in the treatment of severely 
psychotic patients. Without the 4-fluorophenyl group all therapeutic activity is lost. It 
is postulated that the group increases the lipid solubility, which increases the rate at 
which the drug is transferred across the blood brain barrier. 
The final compound, atorvastatin calcium 18, is a member of the statio class of drugs, 
which are used to reduce cholesterol levels. This compound functions by inhibition of 
the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This enzyme 
catalyses the conversion of HMG-CoA to mevalonate, which is an early step in the 
biosynthesis of cholesterol. 
Inspection of the top 100 pharmaceuticals by virtue of number of prescriptions reveals 
that the most prescribed medicine, atorvastatin calcium, has annual sales in excess of 
$8B. A further 13 compounds from the top 1 00 contain at least one fluorine 
substituent, which supports the fact that fluorine substitution is an important method 
of improving pharmacological activity of compounds. 
1.5 Hydrolytic enzymes 
Hydrolytic enzymes are used as catalysts in the hydrolysis of esters and amides to 
give a carboxylic acid and either the alcohol or amine. The general pathway for the 
reaction is shown in Scheme 1.4 below. 
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Scheme 1.4: Catalytic hydrolysis of an amide with a hydrolytic enzyme 
The first stage in the process is the binding of the substrate to the enzyme. At this time 
the substrate is forming one or more hydrogen bonds with the enzyme and, depending 
on the active site, this step can introduce varying degrees of selectivity. The next stage 
is nucleophilic attack of the serine oxygen on the carbonyl carbon of the substrate. A 
proton transfer to histidine assists this. The amide bond is then cleaved, again with 
assisted proton transfer from histidine, to eliminate the first product. Nucleophilic 
attack on the remaining substrate by water produces the second carboxylate product, 
while at the same time restoring the enzyme to its initial state. 
Enzymes are naturally occurring catalysts, with the most common sources being from 
animal organs (e.g. pig liver esterase) and bacteria (eg Aspergillus melleus and 
Pseudomonasjluorescens). It has long been known that the way the substrate interacts 
with the enzyme is controlled by the steric arrangement of the molecule. An active 
site model for Pig Liver Esterase (PLEi5 has been developed which has helped 
rationalise the outcome of reactions involving this enzyme. The model shown in 
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Figure 1.9 displays the four binding regions of the enzyme. Two are hydrophobic and 
these interact with the aliphatic or aromatic part of the substrate. They are depicted HL 
and Hs and can accommodate different sized substituents. The remaining binding 
regions interact with polar groups present in the substrate and they are denoted as PF 
(Front) and P8 (Back). 
""' 
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Figure 1.9: PLE active site model 
The above model can be used to rationalise the enantiomeric selectivity exhibited in 
the hydrolysis of esters. The ester carbonyl must locate next to the serine residue 
while the other substituents will locate based on their size and electronic 
compatibility. It can clearly be seen that certain orientations of substrates will be 
favoured over others. 
The reaction becomes particularly useful if a chiral or prochiral centre exists in the 
ester or amide starting material. If this is the case then the reaction may proceed in a 
stereoselective manner yielding optically pure products. Examples of this approach 
include the production of a.-aryl-a.-hydroxyacetates in high enantiomeric excess using 
pig liver acetone powder (Scheme 1.5), a crude form of pig liver esterase (PLE?6, and 
the production of optically pure amino acids from their N-acyl derivatives27 using 
acylase I (Scheme 1.6). 
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Scheme 1.5: Production of a.-aryl-a.-hydroxyacetates using PLE 
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§chem.e 1.6: Production of stereochemically pure amino acids using acylase I 
There are numerous examples of similar enzymatic resolutions28 . The experiments 
described in this thesis were particularly focussed on how the substitution of fluorine 
would influence the outcome ofthese hydrolytic reactions. 
1.6 Effect of fluorine 0111 enzyme hydll"olysis reactions 
1.6.1 Electronic effects of fluorine on enzyme hydrolysis reactions 
Despite their similar sizes, it has been shown that lipase enzymes can distinguish 
between fluorine and hydrogen atoms when substituted a to a carboxylate group of an 
ester. For example, the MY lipase can preferentially hydrolyse one enantiomer of 
diethyl fluoromalonate29 at a much greater rate than the other and the resultant 
product, (R)-2-fluoromalonic acid monoethylester, 20, has been isolated with a 99% 
ee, as shown in Scheme 1. 7. 
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Scheme 1. 7: Preferential hydrolysis of one enantiomer of diethyl fluoromalonate 
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Another example of a similar resolution30 is the hydrolysis of ethyl (RS)-2-
fluorohexanoate, 21, which liberates the residual ester, ethyl (R)-2-fluorohexanoate, 
22, with a 99.9% ee and generates the (S)-2-fluorohexanoic acid, 23, with a 68.5% ee 
after 60% conversion as shown in Scheme 1.8. 
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Scheme 1.8: Hydrolysis of ethyl (RS)-2-fluorohexanoate 
It is difficult to attribute the stereoselectivity observed here to the steric differences 
between hydrogen and fluorine and the electronic influence of fluorine must be 
dominating the outcome of the reaction. As discussed in section 1.3 there are two 
possible transition states. These have the nucleophile approaching either anti, A or 
gauche, B to the fluorine atom. The Anh - Eisenstein effect predicts that the 
nucleophile approaching anti to the fluorine will result in the more stable transition 
state. For the lipase reaction where the fluorine and hydrogen are interchanged the 
possible transition states for each enantiomer is shown in Figure 1.10 
~ Me 0 Enz-o-~~F 
~ H OR 
~ Me 0 Enz-0-~~H 
~ F OR 
Figure 1.10: Enzyme I a-fluoroester transition states 
It can clearly be seen that stabilisation of the intermediate by donation of electron 
density into the C-F a* can only be achieved if the nucleophile approaches anti to the 
fluorine substituent, this in turn will also reduce the electrostatic repulsion between 
the incoming nucleophile and the fluorine atom. 
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Ab initio calculations 31 confirm that the anti transition state of the a-fluoroester I 
enzyme transition state is more stable than the gauche transition state by 2.8 kcal 
mor1. This energy difference in transition states is sufficient to account for the 
enantiomeric excess observed. The effects described above for the a-fluoroester case 
could clearly apply to the hydrolysis of a a-fluoroamide by an acylase, and this aspect 
is explored in this thesis. 
1.6.2 Molecular modelling of a.~fluoroamides 
Clearly transition state energies are important in determining the stereochemical 
outcome (relative rates) of a reaction. Another important factor in enzyme reactions is 
the initial conformation of the substrate, as this will also influence the binding of the 
substrate to the enzyme. It has recently been shown by O'Hagan and Rzepa that a-
fluoroamides, such as N-methyl-2-(S)-fluoropropionamide 24, adopt a very definite 
conformation. 
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This study showed that ~ 5.0 kcal mor1 stabilisation was evident for a single lowest 
energy conformation32. This conformation was found to have the fluorine atom anti to 
the oxygen and syn to the hydrogen as shown in Figure 1.13. 
It is proposed that the lowest energy conformation is stabilised by stereoelectronic 
effects in a similar manner to the Anomeric effect discussed for fluoropyran in section 
1.3, i.e. donation of electron density from the carbonyl oxygen into the C-F a* orbital, 
as shown in Figure 1. 11. 
Figure 1.11: Stabilisation of conformation with fluorine anti to oxygen 
Furthermore it was noticed that the preferred conformation positioned the fluorine and 
hydrogen in close proximity and this could potentially lead to the formation of a 
hydrogen bond. Finally, the amide and the C-F dipoles oppose each other and reduce 
the overall dipole of the amide in this conformation as shown in Figure-1.12. -
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Figure 1.12: Dipoles in a-fluoroamides 
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Figure 1.13: Relative conformation energies of24 
Figure 1.13 indicates that a-fluoroamides fall into a deep energy well with a clear 
preferred conformation. This energy difference also indicates that 24 will have a very 
high barrier to rotation and if this substrate were to react with an enzyme it would be 
this lowest energy conformation that would present itself to the enzyme. The barrier to 
rotation will have a significant effect on the substrates ability to bind with the acylase 
as shown in Figure 1.14. 
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Figure 1.14: Steric requirements for different conformations 
Depending on the active site model for the acylase a large, sterically demanding 
substituent may only be accommodated in one position. If this orientation does not 
correspond to the lowest energy conformation then the restricted rotation will severely 
impact on the substrates ability to bind with the acylase. 
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1.7 Aims and objectives 
1.7.1 Effect of fluorine on enzymatic hydrolysis of a~fluoroamides 
In this study we were interested in expanding on the lipase hydrolysis of esters to 
determine if enzymatic hydrolysis of a-fluoroamides could be achieved in an 
enantioselective manner. This has not been previously explored. It was anticipated 
that a combination of the Anh - Eisenstein effect (Figure 1.15) and the restricted 
conformational mobility of a-fluoroamides (Figure 1.16) would contribute to the 
outcome of the a-fluoroamide hydrolysis reaction and lead to significant kinetic 
resolutions with acylases. 
~ Me 0 Enz-0-~~F 
~ H NH 
~ Me 0 Enz-0-~~H 
~ F NH ~ R' ~ R' 
Figure 1.15: Enzyme I a-fluoroamide transition states 
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Figure 1.16: Barrier to rotation leading to stereoselectivity 
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Accordingly the aims and objectives were to: 
• Prepare suitable a-fluoroamide substrates. 
• Develop an analytical method to monitor enzymatic hydrolysis. 
• Screen and identify an enzyme that will mediate a stereoselective hydrolysis. 
• Prepare a range of a-fluoroamides and study how the substrate affects the 
outcome of the hydrolysis. 
• Prepare optically pure a-fluoroamides and use these to identify the maximum rate 
of reaction, Vmax, and the binding affinity, Km. 
1. 7.2 Effect on peptide conformations 
Another challenge was to try to prepare an a-fluoropeptide. a-Fluoroamides 
experience restricted conformational flexibility as discussed above. Thus it was 
attractive to try to prepare a peptide, such as that shown in Figure 1. 17 containing an 
a-fluoroamino acid residue. Such a-fluoroamino acids or peptides have never been 
prepared. 
Figure 1.17: a-Fluoropeptide 
However, inclusion of a fluorine substituent in a peptide molecule is not trivial as a-
fluoroamino acids, such as 25, are unknown and, for non-fluorinated peptides, amino 
acids are the standard building blocks. 
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a-Fluoroamino acids are unstable due to the lone pair on the nitrogen promoting the 
elimination of F. Alternative methods for the preparation of a-fluoropeptides will be 
investigated, where the nitrogen lone pair is conjugated in such a manner that it is not 
free to eliminate fluoride in this way. At the outset two synthetic routes were 
envisaged which seemed to satisfy the above criteria. 
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The first route involved fluorination of an oxazolone, 26. Oxazolone '1.7 holds 
prospects for further elaboration to a-fluoropeptides. 
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Scheme L9: a-Fluoropeptide preparation using oxazolone intermediate 
An alternate approach is shown in Scheme 1.1 0, whereby an a-fluoropeptide ts 
prepared via. 32, following the methodology ofHeimgartner. 
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Scheme 1.10: a-Fluoropeptide preparation using aziridine intermediate 
These results are discussed in chapter 4. 
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It has been discussed in Chapter 1 that an a-fluoroester can be hydrolysed by a lipase 
in high enantiomeric purity. In this programme we have extended this to explore the 
resolution of a-fluoroamides with acylase enzymes. 
The initial aim was to identify and synthesise a suitable racemic substrate and a 
suitable acylase that would stereoselectively catalyse the amide hydrolysis. At the 
outset N-((RS)-2-fluoropropanoyi)-(S)-phenylalanine, 36, was chosen as a candidate 
substrate for acylase studies. 
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The acylated phenylalanine 36 was selected as it provided a challenge to an acylase 
enzyme to distinguish between diastereoisomers, which differed only by 
interchanging a hydrogen and a fluorine substituent. 
However, it was predicted that the introduction of a fluorine substituent would restrict 
the rotation of the propionyl moiety, as the lowest energy conformation will have the 
fluorine anti to the carbonyl. Restricting the rotation in this way will then introduce 
differential binding constants between the diastereoisomers, which may lead to 
stereoselectivity during hydrolysis. 
It was also predicted that having fluorine anti to the approaching serine hydroxyl will 
lead to the most stable transition state and, for reasons explained in the previous 
chapter, this will be possible for only one of the diastereoisomers due to binding 
interactions with the enzyme. 
N-Acylphenylalanines are expected to be good substrates for a range of acylase 
enzymes. Also the fluorine atom allows direct observation of the diastereoisomers by 
19F NMR, and this provides an excellent analytical basis on which to monitor the 
diastereoisomer ratio throughout the course of the reaction. 
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§cheme 2.1: Hydrolysis of 36 with an acylase 
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Any stereoselectivity exhibited during the hydrolytic reaction will have to be 
monitored in the residual substrate, as the products of the reaction are phenylalanine 
37 and 2-tluoropropionoic acid 38, both of which only have one stereogenic centre, 
and so the ability to distinguish stereochemical purity by 19F NMR is lost. 
N-((RS)-2-Fluoropropionyl)-(S)-phenylalanine was also selected as it is derived from 
the amino acid alanine. This has the advantage of being readily available in either 
enantiomeric series or in its racemic form. The availability of these stereoisomers 
provided an excellent basis for establishing the absolute stereochemistry of residual 
substrates and products as synthetic standards I references could be prepared. 
phenylalanine 
Various methods for the preparation of 36 were considered but Scheme 2.2, shown 
below, appeared to offer the most promising route at the outset.33 
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Scheme 2.2: Proposed Synthetic Route to 36 
2.2.1 Diazotisation I fluorination of alanine 
The first step in the synthetic sequence involved a diazotisation of the amino acid 
alanine. Olah34 has shown that diazotisation reactions of a-amino acids to generate a-
hydroxy acids proceed predominantly with retention of stereochemistry, as shown in 
Scheme 2.3. 
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Scheme 2.3: Diazotisation I hydrolysis of a-amino acids 
This retention of stereochemistry, which is perhaps counter intuitive, is afforded by 
the anchiomeric assistance of the carboxylate group as shown in Scheme 2.4. 
Essentially there are two sequential reactions. The first generates an a-lactone after 
carboxylate displacement of nitrogen (N2). The second involves ring opening ofthe a-
lactone by water. Each involves an SN2 inversion, which leads to overall retention of 
stereochemistry in this substitution reaction. 
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§cheme 2.41: Anchiomeric assistance by carboxylate explains retention of 
stereochemistry 
Although there is a clear dominance of product with retained stereochemistry, Retey 
has indicated that there can be a significant level of stereochemical scrambling in 
these reactions34· Diazotisation reactions involve the formation of an R-N2 + group, 
which is an excellent leaving group for any subsequent nucleophilic attack. The 
reactive species is N20 3, which is generated as shown in Scheme 2.5. 
HF 
---<> 
§cheme 2.5: Formation ofN203 from NaN02 and HF 
N20 3 then reacts with the amine moiety of the amino acid to generate the diazonium 
species as shown in Scheme 2.6. 
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Scheme 2.6: Diazonium salt formation during diazotisation 
The final stage of the reaction is a nucleophilic substitution by fluoride ion to generate 
the desired product, 38. At this stage there are two possible reaction pathways, one of 
which leads to an overall inversion of configuration and the second, by means of a 
double inversion, leading to an overall retention of configuration, as shown in Scheme 
2.7. 
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Scheme 2. 7: Nucleophilic Substitution by p-
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At this stage little was known about the stereochemical integrity of the fluorination 
reaction with alanine but this has been explored later in this study using 
enantiomerically pure starting materials. 
2.2. L lL Other synthetic issues 
Initially the conditions suggested by Olah et al (1.5 equivalents of sodium nitrite to 
amino acid, for 4 hours at room temperature)34a were used, however the yields were 
found to be low and variable. Also a side reaction, which generated an 
a,p-unsaturated product, was evident in the 1H NMR spectrum. This was possibly 
caused by the elimination of HF from the desired product, giving rise to acrylic acid, 
40. 
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After several unsuccessful attempts to reproduce the results achieved by Olah, an 
alternative method34b was tried. This was found to give adequate yields, with no trace 
of the side reaction. The main difference between the two procedures was the 
quantities of reagents and the reaction time. Using 3.5 equivalents of sodium nitrite 
and approximately a 50% reduction in the amount of pyridinium hydrogen fluoride 
was found to be optimal. Also the reaction time was extended to 16 hours at room 
temperature. 
The anhydride 41 was evident, when monitoring the reaction directly by 19F NMR, as 
an intermediate in the optimised procedure. Scheme 2.8 shows the likely mechanism 
for the formation of the anhydride, presumably from activation of the carboxylic acid 
group by N20 3, leading to attack by a second molecule of2-fluoropropionic acid. 
Scheme 2.8: Proposed mechanism for anhydride formation 
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19F NMR clearly shows this anhydride as a pair of diastereoisomers resulting from the 
RS I SR and RR I SS stereoisomers. In optimised experiments the typical ratio of 
carboxylic acid to anhydride was 8 : 1 as shown in Figure 2.1. 
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Figure 2.1: 19F NMR of2-fluoropropionic acid 37 and anhydride 41 in an 8 : 1 ratio 
The expected NMR spectrum for 2-fluoropropanoic acid, 37, is a doublet of quartets 
but due to overlapping signals only six peaks are seen. The anhydride, 41, has a more 
complex 19F NMR spectrum as this is a mixture of diastereoisomers. Each 
diastereoisomer should exhibit a doublet of quartets and therefore sixteen peaks would 
be expected, but again due to overlapping signals only twelve peaks are evident. 
Impurity 41 was not a cause for concern as the following step was to generate the acid 
chloride by reaction with thionyl chloride, and the anhydride was anticipated to 
undergo reaction to the desired acid chloride. 
The resultant crude product was purified by vacuum distillation (B. Pt. 66°C@ 13mm 
Hg), following Olah's method34a. - - - -
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Acid chlorides are classically prepared directly from carboxylic acids by their reaction 
with thionyl chloride, 35 generating sulphur dioxide as a gaseous by-product, so 
leaving the desired product. Scheme 2. 9 shows a possible mechanism for the 
production of the acid chloride by this method. 
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Initial investigations of this reaction were carried out on a small scale in deuterated 
chloroform (2 mL). A stoichiometric quantity ofthionyl chloride was added to the 2-
fluoropropanoic acid, 38, and the mixture was heated under reflux for 30 minutes and 
monitored directly by 19F NMR. Further aliquots ofthionyl chloride were added until 
the starting material was no longer evident (i. e. dq at -186 ppm). For this experiment 
a three-fold excess ofthionyl chloride was required to consume all ofthe acid 38. At 
this point a new 19F NMR signal became apparent at -171 ppm (dq), which was 
subsequently shown to correspond to the desired acid chloride as shown in Figure 2.2. 
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Figure 2.2: The reaction of2-fluoropropanoic acid, 38 with thionyl chloride 
As the level of water present in the acid 38 was variable, different amounts of thionyl 
chloride was required for each reaction. The method for controlling the addition of 
thionyl chloride involved dropwise addition at ambient temperature until the vigorous 
reaction had ceased. Then a stoichiometric amount of thionyl chloride was added and 
heated to reflux to react with acid 38. Finally, distillation at atmospheric pressure was 
carried out to remove any residual acid 38, to give the desired acid chloride, 39. 
2.2.3 Preparation of N-((R, S)-2-fluoropropanoyi)-(S)-phenylalanine 
Scheme 2.10 shows the preparation ofN-((RS)-2-fluoropropanoyl)-(S)-phenylalanine, 
36 from (S)-phenylalanine and 2-fluoropropionyl chloride, 39. 
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§cllneme 2.10: Preparation ofN-((RS)-2-fluoropropanoyl)-(S)-phenylalanine, 36 
Zabicky and Chenault et al have discussed the direct coupling of acid chlorides to 
phenylalanine. 36 The reaction was initially investigated using propionyl chloride and 
this proceeded in a straightforward manner producing a colourless oil. When the oil 
was triturated with hexane it generated the amide as a white crystalline material 412. 
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§cheme 2.11: Preparation ofN-propanoyl-(S)-phenylalanine, 42 
When acid chloride 39, was used the reaction with (S)-phenylalanine generated a 
mixture of products. This included the desired diastereoisomeric mixture N-(RS)-2-
fluoropropanoyl-(S)-phenylalanine 36 but the major product was (RS)-2-
fluoropropanoic acid 38. Attempts to reduce the level of 38 involved carrying out the 
reaction with reduced solvent volumes. This proved successful and suppressed the 
formation of 38, yielding the amide, 36 as a colourless oil. This material was 
essentially pure, as judged by 1H and 19F NMR analysis. A white solid was obtained 
and recrystallised from ethyl acetate I hexane but unfortunately an X-ray crystal 
structure of 36 could not be obtained as the product was not sufficiently crystalline. 
2.3 Identification of a selective hydrolytic enzyme 
As already described in chapter 1 there are many examples of enzymatic hydrolysis of 
amides. However, to date there have been no examples reported where the amide 
contains an a.-fluorine. The steric impact of substituting fluorine for a hydrogen atom 
has been demoristrafed-~to be- minimal -making this~ a challenging substrate for the-
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enzyme. It is unknown if an enzyme can distinguish between hydrogen and fluorine in 
such a system. 
Before any reactions with enzymes could be carried out, the N-acylphenylalanine 36, 
had to be converted to a water-soluble form. This was achieved by converting the 
carboxylic acid to its sodium salt, by taking an aqueous suspension to pH = 7 with 
dilute NaOH. 
A number of acylases were selected for this study. These were hog kidney acylase 
(HKA), Aspergillus melleus acylase (AMA), Bacillus icheniformis protease (BIP) and 
the Streptomyces caespitrum protease (SCP). 
The selected acylases were prepared to varying concentrations in pH 7 phosphate 
buffer depending on the quoted activities for their reaction rates with N-acetyl-L-
methionine, i.e. the higher activity enzymes had the lower concentration solutions. 
The aim of adjusting the enzyme concentration was to obtain a reaction rate that could 
be followed readily by 19F NMR analysis. In this regard reaction times of a few hours 
are more desirable than a few minutes to give sufficient time to run the analysis. It 
was important that the composition in the NMR tube would not change significantly 
over the course of the data collection. 
The various enzyme solutions were stored under nitrogen at 0°C until they were 
required. In this form it was found acceptable to store the solutions over several days 
without significant loss of activity. 
An initial experiment to test the feasibility of using 19F NMR to follow these reactions 
was carried out using HKA and AMA, both supplied by the Sigma Chemical 
Company. 
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The results are shown in Table 2.1 and Table 2.2 below. 
Table 2.:n.: Reaction ofHKA with amide 36 
Time (h) 
0 
1 
2 
Conversion, % * 
4.6 
34.4 
59.9 
Table 2.2: Reaction of AMA with amide 36 
Run 1 
Time (h) *Conversion, % d.e.% Time (h) 
0 5.7 4 0 
0.5 21.2 22 0.5 
0.75 24.9 28 1 
1.75 39.0 64 3 
2.25 45.4 72 5 
2.75 45.4 84 7 
3.25 47.5 76 24 
18.33 57.4 96 168 
*Conversion as judged by 19F NMR 
d.e.% 
2 
6 
28 
Run2 
*Conversion, % 
4.2 
9.1 
13.3 
28.4 
33.6 
41.6 
49.4 
84.7 
d.e.% 
-2 
6 
18 
30 
36 
70 
78 
100 
In the above tables the values of the d.e. % is reported as measured in the residual 
substrate. The data revealed a low diastereoselectivity in the reaction with HKA, but 
in the case of AMA there was a very high differentiation by the acylase for each 
diastereoisomer. The absolute stereochemistry of the preferred diastereoisomer could 
not be identified at this stage until substrates of a known configuration were prepared. 
However, it emerged during this study that 19F NMR was a good analytical technique 
for following these reactions. The only problematical aspect was that at the lower 
concentrations, peak integrations were not so reliable. Below a concentration of 9 
mM, it was difficult to obtain good signal to noise in the time frame required to follow 
the reaction progress accurately. 
Two further protease enzymes, BIP and SCP were investigated for the hydrolysis of 
36. The results from these studies are tabulated below .. 
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Tablle 2.3: Reaction ofBIP and SCP with amide 36 
Time BIP SCP 
(h) Conversion, % d.e.% Conversion, % d.e.% 
0 4.7 0 4.1 0 
1 3.8 0 5.0 2 
3 4.4 2 5.6 0 
168 4.2 0 20.0 0 
Both BIP and SCP showed very slow rates of hydrolysis and virtually no selectivity in 
their reaction with the substrate and therefore no further studies were carried out using 
these enzymes. It emerged form this initial screen that all of the acylases were 
competent to hydrolyse amide 36, but only AMA showed a significant level of 
diastereoselectivity. This emerged as the most interesting enzyme of those screened 
and accordingly kinetic data using AMA as the catalyst was evaluated. This is 
discussed in section 2.5. 
As described above the hydrolysis of N-(RS)-2-fluoropropanoyl-(S)-phenylalanine, 
36, with Aspergillus melleus acylase (AMA) displayed a high degree of 
diastereoselectivity. It was desirable at this stage to prepare a sample of each of the 
diastereoisomers shown in Figure 2.3, to examine their rates of hydrolysis 
independently. This was judged necessary to quantify the influence that the different 
absolute configurations of the fluorine atom were having on the rate of the hydrolysis. 
00 
Jlti ~- yMe 
H F 
(S,R) 36 
Figure 2.3: The diastereoisomers of 36 
HO 0 O 
~~~ 
H F 
(S, S) 36 
Pure diastereoisomers of 36 were synthesised usmg the same methodology as 
previously described for 2-fluoropropionic acid, but this time toe stereochemically 
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pure D-(R)-alanine and L-(5)-alanine were used as the starting materials for the 
diazotisation reaction. 
Access to the stereochemically pure a-fluoroacids and amides also presented an 
opportunity to explore the stereoselectivity of the diazotisation I fluorination reaction 
to prepare the a-fluoroacids. With configurationally pure starting materials the extent 
of stereochemical scrambling could be assessed. 
2.4.1 Stereochemical study of the diazotisation I fluorination 
reaction 
Two approaches were used and these are described in the following sections. 
2.4.1.1 Enantiomeric analysis of 2-fluoropropionic acid by a chiral 
base method 
The chiral base used for this study was (5)-2-(diphenylmethyl)pyrrolidine, 43, a base 
previously developed in the research group for NMR analysis of chiral acids. This 
pyrrolidine when treated with racemic 2-fluoropropanoic acid 38, generated two 
diastereoisomeric salts, 44, which could be resolved by 19F NMR as shown in Scheme 
2.12. 
~Ph 
H Ph 
+ 
43 
(S, S) 44 
~Ph 
1:!2 Ph 
0 
o~·''F 
(S, R) 44 
Scheme 2.12: The diastereoisomeric salts of 44 for 19F NMR enantiomeric analysis 
The two diastereoisomers were detected as two resolved sets of signals in the 19F 
NMR spectrum as dq at -173.96 ppm and at -174.16 ppm respectively. 
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lFngu111re 2.41: 19F NMR analysis of a 10:1 mixture of the diastereoisomeric salts of 4141 
When 413 was reacted with (S)-2-fluoropropionic acid, prepared from L-(S)-alanine, 
the 19F NMR showed a major ( dq at -1 7 4 .16ppm) and a minor signal ( dq at -
174.06ppm). Integration demonstrated that the ratio ofthe two was 10: 1. This result 
confirmed that the diazotisation reaction was not completely stereospecific. There was 
a small, but significant (~ 10%) contribution arising presumably from direct 
substitution of the diazonium group by fluoride ion, leading to a product resulting 
from inversion of configuration. 
2A.1.2 IEmullntiomeric ~umaftysis olf 2~fnUllOII"OJPIIrOJPnmnnc add! by 
p1reparatimn olf a dlnaste~reoisomeric am.idle 
A second method was used to evaluate the stereospecificity of the diazotisation I 
fluorination reaction. This involved coupling the product of the diazotisation I 
fluorination reaction of (S)-alanine with (S)-phenylalanine. The 19F NMR spectrum of 
the resultant amide (S, S) 36 showed two signals, a ddq at -183.35 ppm and a ddq at-
183.45 ppm. The peaks were too close to obtain an integration but the ratio was 
estimated to be in agreement with previous results as shown in Figure 2. 5. 
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IFigunre 2.5: 19F NMR of an estimated 10:1 Mixture of (S, S) 36 and (S, R) 36 
The complimentary diastereoisomeric amide (S, R) 36 was also prepared, this time 
from a sample ofthe 2-fluoropropionic acid predominant in the (R) enantiomer (80% 
ee). The product again showed two sets of signals in the 19F NMR spectrum at the 
same chemical shift as discussed above. This time, of course, the ratio was 10 : 1 in 
favour of the high field signal. 
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Figure 2.6: 19F NMR of an estimated 10: 1 Mixture of (S, R) 36 and (S, S) 36 
These results agree well with the results obtained from the enantiomeric analysis 
using the chiral base, confirming that the diazotisation I fluorination reaction proceeds 
predominantly with retention of stereochemistry, however, there is a significant (:::::: 
10%) inversion component. 
2.4.2 Purification of the diastereoisomers of 36 
As both fluoropropionyl amides, (S, S) 36 and (S, R) 36, were contaminated with the 
corresponding minor diastereoisomer, purification was desirable prior to exploring 
these compounds as substrates in acylase reactions. For the slower reacting (S, R) 
diastereoisomer 36, this was achieved in a straightforward manner by using the AMA 
enzyme to remove the minor (S, S) diastereoisomer 36. 
However, for the faster reacttng dtastereoisomer (S, S) 36, removal of residual (S, R) 
was not readily achievable and it was decided to use this material in the kinetic study 
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without further purification as the AMA enzyme had already been shown to be almost 
totally selective in favour of substrate (S, S) 36 during the hydrolysis of the racemic 
substrate 36. 
2.5 Kinetic study on stereochemically pure substrates 
2.5.1 Enzyme kinetics 
In order to compare the two stereoisomers as enzyme substrates it became appropriate 
to measure their Vmax and Km values independently for their hydrolysis with AMA. A 
discussion of the factors affecting enzyme kinetics by Metzler37 has been useful in 
preparing the following summary. 
Vmax is the maximum rate of enzyme turnover, i.e. when the entire enzyme is present 
as an enzyme I substrate complex and this can only happen when the substrate is 
present at sufficient concentration to saturate the enzyme. At this substrate 
concentration 
Vmax = d[P] 
dt 
Km is a measure of binding affinity of the substrate by the enzyme and is the ratio of 
the sum of the rates of reaction of the enzyme I substrate complex divided by the rate 
of formation of the enzyme I substrate complex. 
This means that for the following reaction: 
E+S ES E+P 
In many cases k2 >> k3 therefore Km is related to the binding affinity of a substrate for 
the enzyme, with higher affinity substrates having the lower values of Km. Both V max 
and Km can be calculated by using the Michaelis- Menten equation which states that: 
Vo = Vmax = Vma..{S] 
1 + Kmi[S] Km+ [S] 
The Michaelis - Menten equation can be transformed into several linear forms e.g. 
Lineweaver - Burk or Eadic - Hoftsee. -The Lineweaver-- Burk_uses the equation: 
42 
1 1 Km 1 
-=--+----
Vo Vmax Vmax [S] 
so a plot of -
1
- against -
1
- would have an intercept of - 1- and a slope of Km . 
~ ~ ~ ~ 
The Eadie - Hoftsee uses the equation: 
Vo Vmax V 1 
-=--- o-
[S] Km Km 
I f Vo . V h I f -1 . . f V max d . so a p ot o - agamst o as a s ope o -, a y axis mtercept o --an an x axis [S] Km Km 
intercept of V max . 
From the above two equations it can be appreciated that if we know the initial 
concentration of the substrate and can monitor the reaction course by following either 
the decrease in the concentration of substrate or the increase in the concentration of 
the products we can calculate the Vmax and Km values for the AMA enzyme and a 
given substrate. 
2.5.2 Reaction Rate Measurement 
Initially, U.V. spectroscopy was explored as a method for following the reaction but, 
unfortunately, due to absorbance by the AMA enzyme, insufficient intensity of signal 
could be detected to follow the reaction progress. As 19F NMR had already been 
successful in monitoring the degree of diastereoselectivity of the AMA enzyme for the 
mixed substrate, it seemed appropriate to use 19F and 1H NMR to monitor the reaction 
progress. 
The minimum concentration that the reaction substrate could be observed in 64 scans 
was found to be around 8 mM, but for the slower reacting substrates the NMR 
acquisition time could be increased and therefore lower concentrations could be 
measured (4.9 mM was the lowest attempted). This appears to be an appropriate lower 
limit on which to proceed. 
The study was now carried out on both stereochemically pure diastereoisomers (S, S) 
36 and (S, R) 36, and the results are tabulated below: 
Table 2A: Reaction of AMA with Substrate (S, R) 36 
43 
Qo 
-o-('·~~ 
(S, R) 36 
AMA 
pH= 7 
Phosphate Buffer 
Run 1 
Initial cone. Initial velocity 
I 
'''NH2 + _0~ 
0 F 
Run2 
Initial cone. Initial velocity 
substrate (mM) (mMmin-1) substrate (mM) (mMmin- 1) 
10 0.038 4.9 0.022 
20 0.066 9.8 0.040 
30 0.078 14.6 0.052 
40 0.104 19.5 0.061 
52.3 0.097 24.4 0.077 
29.3 0.102 
34.2 0.105 
Raw data from kinetic study is attached in appendix I. 
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These results are presented in the following graphs. 
(S, R) 36 + AMA 
Run 1 Run2 
Graph 2.1 :Reaction velocity vs initial substrate concentration 
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Graph 2.2: Lineweaver-Burk plot 
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Graph 2.3: Eadie-Hofstee plot 
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The complimentary diastereoisomer (S, S) 36 was treated in similar manner to give the 
following results. 
Table 2.5: Reaction of AMA with (S, S) 36 
Initial cone. 
Run 1 
AMA 
pH= 7 
Phosphate Buffer 
Initial velocity Initial cone. 
Run2 
substrate (mM) (mMmin-1) substrate (mM) 
8.1 0.359 8.4 
15.3 0.493 16.7 
22.5 0.591 25.1 
30.6 0.704 33.4 
41.8 
50.2 
58.5 
66.9 
Raw data from kinetic study is attached in appendix I. 
46 
0 
+_o-Y 
F 
Initial velocity 
(mMmin-1) 
0.25 
0.40 
0.49 
0.46 
0.55 
0.54 
0.81 
0.72 
These results are presented in the following graphs. 
(S, S) 36 + AMA 
Run 1 Run2 
Graph 2.4:Reaction velocity vs initial substrate concentration 
c 0.8 • . 0.8 • :E 0.6 • c • ~ • :i 0.6 •• E 0.4 • ~ ••• E 0.4 
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Graph 2.5: Lineweaver-Burk plot 
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Graph 2.6: Eadie-Hofstee plot 
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From the above data the Km and Vmax values can be calculated for reaction of AMA 
with substrates (S, S) 36 and (S, R) 36 to give the following results. 
Table 2.6: Km and Vmax for the Reaction of AMA with (S, S) 36 and (S, R) 36 
Compound (S, R) 36 (S, S) 36 
Structure ~ ~ ''N~ '' N~ I I 0 H F 0 H F 
Run No. 1 2 1 2 
Lineweaver Ymax, mmol 0.18 0.22 0.99 0.86 
-Burk . -l mm 
Km, M 37.1 43.6 14.4 18.1 
Eadie- Ymax, mmol 0.19 0.22 1.04 0.86 
Hofstee min-1 
Km, M 39.5 48.9 16.1 23 .1 
Ymax /Km 0.0050 0.0566 
As Km is approximately a measure of the binding affinity of the substrate for the 
enzyme to form the enzyme I substrate (ES) complex it emerges that both substrates 
have high Kms and hence low affinities for the enzyme. The rate of decomposition of 
the ES complex being many times greater than the rate of formation of the ES 
complex. However the Km values do confirm that substrate (S, S) 36 has a 
substantially greater affinity for the enzyme than substrate (S, R) 36. The increased 
affinity of (S, S) 36 is probably due to the restricted rotation of both substrates 
positioning the fluorine anti to the carbonyl in the lowest energy conformation and 
therefore differentially orientating the bulky methyl group for each diastereoisomer. 
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(R, S) 36 (S, S) 36 
I 
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0 H F 
Figure 2.7: Possible reasons for restricted rotation 
Figure 2. 7 shows the different steric requirements of the two substrates if a barrier to 
rotation exists and this difference would be sufficient to explain the two-fold 
difference in the substrates affinity for the enzyme. 
V max is the rate at which the product is formed when the entire enzyme is present as 
ES complex, and from Table 2.6 it can be seen that substrate (S, S) 36 exhibits a four-
fold increase in the rate of de-acylation over substrate (R, S) 36. As this four-fold 
increase in V max cannot be attributed to the restricted rotation of the substrates giving 
diastereoisomers with differing affinities, then the fluorine substituent must be 
affecting the rate of hydrolysis also the hypothesis is that an Anh-Eisenstein type 
stabilisation of the transition state is increasing the hydrolysis rate of (S, S) 36 over (R, 
S) 36 as shown in Figure 2.8. 
~ H 0 Enz-o--=-~F I Me ~-H 
~ Me 0 Enz-o--=-~F I H ~-H 
(S, S) 36 (R, S) 36 
Figure 2.8: Anh-Eisenstein Transition State Stabilisation 
Additional stabilisation of the transition state will occur if the nucleophilic senne 
hydroxyl approaches anti to the fluorine as shown in Figure 2.8. For this to happen in 
both diastereoisomers, it requires the more sterically demanding methyl group to be 
accommodated in two different positions within the enzyme. From the difference in 
V max it would appear that the conformation shown for (S, S) 36 diastereoisomer is 
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more easily accommodated by the enzyme than that shown for the (S, R) J6 
diastereoisomer. 
A useful approximation of the overall enzyme efficiency for each substrate is to 
compare the V maxI Km values, which shows that the enzyme is an order of magnitude 
more efficient at de-acylating the (S, S) 36 diastereoisomer compared to the (S, R) 36 
diastereoisomer. This is consistent with the observed stereochemical outcome of 
greater than 90% d. e. 
At this stage it is not possible to be definitive about what is causing the enzyme to 
show greater efficiency for one substrate over the other, but it is thought to be a 
combination of conformational effects on binding and stereoelectronic effects during 
reaction, which are resulting in this highly stereoselective enzymatic resolution. 
50 
2.6.1 Dia&:otisation I fluorination reaction 
The diazotisation I fluorination of a-amino acids has been shown by two independent 
methods to proceed predominately with a retention of stereochemistry but there is a 
significant proportion ( ~ 10%) of inversion of stereochemistry under the conditions 
used as illustrated in Scheme 2.13. 
HF I Pyridine 
+ 
90% 10% 
Scheme 2.13: Stereochemistry of fluorination of alanine 
The major stereoisomer is formed via a double inversion reaction pathway involving 
anchiomeric assistance from the hydroxyl group on the carboxylic acid. This leads to 
the overall retention of stereochemistry. 
The minor stereoisomer is most probably derived by direct fluoride substitution ofthe 
diazonium intermediate leading to an inversion of the stereochemistry . 
.2.6.2 Aspergillus melleus acylase selectivity 
Of the four lipase I acylases examined only one showed good stereoselectivity. The 
Aspergillus melleus acylase, AMA selectively hydrolysed33 one diastereoisomer ofN-
(RS)-2-fluoropropanoyl-(S)-phenylalanine, 36, as shown in Scheme 2.14. 
0 
~OH 
u H:t 
36 
57.4% 
Conversion 
0 
~OH 
u H~:( 
F 
96%de 
Scheme 2.14: Diastereoselectivity of AMA hydrolysis 
51 
+ HO!O 
F'''~ 
By independent synthesis of the stereochemically pure substrates, it has been 
established that N-(S)-2-fluoropropanoyl-(S)-phenylalanine 36, is hydrolysed 
preferentially over the N-(R)-2-fluoropropanoyl-(S)-phenylalanine 36. 
2.6.3 fPlreparation of diastereoisomern, (S, S) 36 andl (S, R) 36 
The individual diastereoisomers, (S, R) 36 and (S, S) 36 were prepared for kinetic 
studies. Diastereoisomer (S, R) 36 was prepared as a single stereoisomer, while (S, S) 
36 was prepared to a de of80%, as determined by 19F NMR. 
2.6.4 IEnzymatic !hydrolysis !kinetic dahl 
V max and Km has been determined for both substrates and this shows that: 
o The binding affinity, Km, of AMA with diastereoisomer (S, S) 36 ts 
approximately twice that for diastereoisomer (S, R) 36. 
G> The maximum rate of hydrolysis of diastereoisomer (S, S) 36 is approximately 
five times the rate of diastereoisomer (R, S) 36 as demonstrated by their Vmax· 
G The overall enzyme efficiency, which is a function of the two parameters cited 
above, can be expressed as a V max I Km value and this demonstrates that the 
enzyme is an order of magnitude more efficient in the hydrolysis of the 
diastereoisomer (S, S) 36 compared to the diastereoisomer (R, S) 36. 
The difference in binding affinity, Km, is attributed to conformational effects. 
The difference in initial reactivity, Vmax, is attributed to electronic effects arising from 
the presence of the fluorine atom. Ab initio calculations have predicted that the most 
stable reaction intermediate will be formed when the nucleophile approaches anti to 
the fluorine. This can happen for both diastereoisomers but it means that the more 
sterically demanding methyl substituent will occupy a different location within the 
enzyme. From the results it appears that the location of the methyl group in the (S, S) 
36 case is more easily accommodated by the enzyme. 
The above two effects combined are contributing to the overall enzyme efficiency for 
the (S, S) 36 case being an order of magnitude greater than the (S, R) 36 case, resulting 
in a highly stereoselective biotransformation. Clearly such a reaction could have a 
synthetic utility in the preparation of homochiral organofluorine compounds. 
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Chapter 3 - Preparation and resolution of other am ides 
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3.1 Effect of fluorine on the rate of enzymatic hydrolysis 
The hydrolysis of N-(RS)-2-fluoropropanoyl-(S)-phenylalanine with the Aspergillus 
melleus acylase (AMA), and the determination of Km and Vmax data for the individual 
diastereoisomers described in chapter 2 indicates a high degree of diastereoselectivity 
in the acylase reaction. Further studies were now undertaken to investigate what 
effects other substituents would have on the outcome of these enzymatic hydrolysis 
reactions. 
Two optically pure substrates, N-propanoyl-(S)-phenylalanine 42 and N-fluoroacetyl-
(S)-phenylalanine 45, were now used to try to clarify the effect the fluorine atom is 
having on the rate of the enzyme hydrolysis. 
00 HO 0 O 
~A/Me ~~H 
"':: H H H F 
42 45 
It was envisaged that the evaluation of a non-fluorinated amide, 42, would provide a 
control for comparison with the fluorinated analogue 36. a-Fluoroamide 45 will 
clearly also exhibit the preferred a-fluoroamide conformation similar to 36, and the 
rate of hydrolysis for 45 would give a baseline rate for such an amide without any 
sterically demanding substituents. 
3.1.1 Synthesis of Amides 42 and 45 
Amide 42 was prepared by combining (S)-phenylalanine and propionyl chloride using 
similar conditions to those developed for the fluoropropionyl analogues described in 
Chapter 2. 
For the fluoroacetyl amide, 45, the starting material was sodium fluoroacetate, 46. 
This was reacted with phthaloyl dichloride, 47, and fluoroacetyl chloride, 48, was 
distilled from the reaction mixture. The fluoroacetyl chloride was then combined with 
(S)-phenylalanine to give the desired a-fluoroamide, 45 as shown in Scheme 3.1 
below. 
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00 
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-
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V H~IJ'F 
450 
§cllleme 3.1: Preparation ofN-fluoroacetyl-(S)-phenylalanine, 415 
3.1.2 Rate of AMA Hydrolysis of Amides 42 and 45 
The AMA hydrolyses were carried out as described previously on the sodium salt of 
the substrates 42 and 45 in a pH= 7 buffered system. The reactions for both substrates 
were followed once again using NMR spectroscopy. For substrate 45 19F-NMR was 
the most convenient. For 42 clearly 19F-NMR was not an option and the reaction was 
monitored by 1H-NMR. 
The results for the comparison of substrates 42 and 45 are included in Table 3. 1. 
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Table 3.1: Initial reaction rates for AMA with 42 and 45 
Substrates 
42 
0 
~YfMe 
H H 
[S], mM V0, mM/min [S], mM 
10 0.42 10 
20 0.68 20 
30 0.94 30 
40 1.08 40 
Raw data from kinetic study is attached in appendix I. 
45 
0 
~JlfH 
H F 
Vo, mM!min 
0.16 
0.19 
0.23 
0.27 
As before, the data was represented in both Lineweaver - Burk and Eadie - Hofstee 
plots and the Km and Vmax values could be calculated. 
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N-propionyl-(S)-phenylalanine, 42 
&HO ~Jy., H H _,;; 
N-fluoroacetyl-(S)-phenylalanine, 45 
HO 0 
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Graph 3.1 :Reaction velocity vs initial substrate concentration 
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Km and V max values for substrates 412 and 415 with the AMA enzyme derived from the 
Lineweaver - Burk treatment of the data are shown in Table 3.2. These results are 
compared with the data obtained in the previous chapter for the two stereochemically 
pure diastereoisomers of 36. 
Table 3.2: Comparison ofkinetics of acylase hydrolysis of(R, S) 36, (S, S) 36, 42 and 
415 
Substrate (R, S) 36 (S, S) 36 .:32 415 
&~Jy .. HO 0 &~Jy~ HO 0 0 0 Jlfe ~JlfH ~ H H F H F H H H F 
h h 
Structure 
Ymax, 0.20 0.93 2.25 0.31 
mM/m in 
40.3 16.3 43.8 9.7 
Ymaxf Km 0.005 0.057 0.051 0.032 
The binding affinity of the substrates for the AMA enzyme demonstrates that the three 
substrates with a methyl substituent have the higher Km values, and hence a lower 
binding affinity to the enzyme. This may be expected on steric grounds but the 
difference between the Km values for (S, S) 36 and 45 is small. It appears that the 
presence of a methyl substituent can be tolerated if it is in a certain orientation. The 
binding affinity for 42 is surprisingly poor but this may be due to the non-fluorinated 
amide having a less restricted rotation and only one of the possible conformations has 
the methyl substituent in a suitable orientation to bind with the acylase as shown in 
Figure 3.1. 
00 
Jl tJJe ~- IH 
H H 
High binding affinity 
conformation 
00 HO 0 O 
~JlfMe ~AfH 
H H H Me 
Low binding affinity conformations 
Figure 3.1: Relationship between conformation and binding affinity in 42 
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The V max values demonstrate that the fluorinated ami des have the slower rates of 
hydrolysis, but this is only significant if the entire enzyme is present as the enzyme 
substrate complex. The V max of substrate (S, S) 36, while not being as high as 42 is 
significantly higher than the other a-fluoroamides, which indicates that the methyl 
substituent in a certain location is beneficial to increasing the maximum rate of 
hydrolysis. A possible explanation could be that the presence of the methyl substituent 
in the correct location ensures the substrate is held with the C-F cr* orbital anti to the 
approaching nucleophile. For the cases of the other two fluorinated amides, (R, S) 36 
and 45 either the methyl is in the wrong location to support efficient hydrolysis or 
there is no methyl present at all and thus the substrate does not bind as efficiently and 
the C-F cr* orbital is not held anti to the approaching nucleophile at all times. 
The Vmax I Km value is a display of how selective the enzyme would be if it were 
added to a mixture of the four compounds. The comparative rates of hydrolysis of the 
four substrates is in the order: 
(S, S) 36 = 42 > 45 >> (R, S) 36. 
This shows that the acylase would not be able to differentiate between (S, S) 36 and 
42 when binding affinity and the maximum rate of hydrolysis are taken into account. 
It appears that with (S, S) 36 forming the greater proportion of enzyme I substrate 
complex and 42 having the higher maximum rate of hydrolysis, the two effects would 
cancel each other out. The next most efficient substrate is 45, which from Km data is 
the strongest binding, presumably due to the absence of a methyl substituent. 
Substrates (R, S) 36 and 45 have similar maximum rates of hydrolysis but as (R, S) 36 
shows poor binding affinity for the AMA enzyme the overall rate of hydrolysis for (R, 
S) 36 is the slowest. 
The fact that fluorine does not impact on the binding of the amide to the acylase and 
yet it has a large effect on the maximum rate of hydrolysis suggests that it suppresses 
the attainment of the optimal transition state. This perhaps merits a theoretical 
investigation. 
3.1.3 X-Ray crystal structures of substrate 45 
After synthesis ofthe a-fluoroamide 45 it was possible to obtain a suitable crystal for 
X-ray analysis. The resultant x-ray structure is shown in Figure 3.2. 
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Figure 3.2: X-Ray crystal structure ofN-fluoroacetyl-(S)-phenylalanine, 45 
Figure 3.3: Hydrogen Bonding in 45 
Figure 3.3 summarises the main findings from the X-ray crystal structure of 45 and 
reveals that the C-F bond and the N-H bond are almost eo-planar, while at the same 
time both are trans to the amide carbonyl. This finding is consistent with the ab initio 
calculation discussed in chapter 1 for the fluoropropionylamide case. 
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The X-ray structure also supports the presence of intramolecular hydrogen bonding. 
Two close contacts were identified. The first, unsurprisingly, between the acid 
carbonyl group and the N-H group, with a bond length of 2.29 A. The second, 
particularly relevant to this investigation, is the close contact between fluorine and 
hydrogen. The X-ray crystal structure reveals an interatomic distance of 2.27 A. This 
separation is much shorter than the sum of the hydrogen and fluorine atomic radii and 
is in line with the bond lengths reported for other cases where fluorine is thought to be 
acting as a hydrogen bond acceptor in a stabilising interaction. 
The conformation revealed in the X-ray crystal structure of the a-fluoroamide 45 
confirms the experimental predictions and supports the theory that rotation is 
restricted by the donation of electron density into the C-Fcr* antibonding orbital and 
the presence of this intramolecular hydrogen bonding. 
3.2 Comparison of chloro and methyl substituted amides 
At this stage the study was extended to a comparison of the effect of chlorine and 
methyl substitution on substrates for AMA hydrolysis. It was envisaged that the 
chlorine and methyl groups may be considered to be isosteric, and have similar 
controlling influences on the initial conformations and the direction of nucleophilic 
attack. This study therefore required the preparation of a further series of substrates. 
To this end N-(2-methylpropionyl)-(S)-phenylalanine 49, N-(S)-2-chloropropionyl-
(S)-phenylalanine (S, S) 50 and N-(R)-2-chloropropionyl-(S)-phenylalanine (R, S) 50 
were prepared. 
00 
Jl
1
Me ~- yMe 
H H 
49 (S, S) 50 
3.2.1 Synthesis of amides 49 and 50 
00 
~AfMe 
H Cl 
(R, S) 50 
The acid chlorides required to prepare substrates, 49 and 50, were all commercially 
available. These N-acylphenylalanines were therefore prepared in a one step synthesis 
using similar conditions to those developed for the fluoropropanoyl analogues. 
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Once again 1H NMR was used to follow the rates of hydrolysis of the sodium salts 
and the results are detailed in Table 3.3. 
Table 3.3: Reaction velocities for reaction of AMA with 4!9, (S, S) 50 and (R, S) 50 
Substrates 
4!9 (S, S) 50 (R, S) 50 
HO 0 HO 0 HO 0 
0 0 0 Jlfe ~ Me ~e ~ H ~At Me 
I'-': 
H H H Cl H Cl 
I'-': I'-': 
.,.-:;; .,.-:;; .,.-:;; 
[S], mM Vo, mM/min [S], mM Vo, mM/min [S], mM Vo, mM/min 
10 0.134 9.4 2.581 4.7 0.201 
20 0.203 18.8 2.978 9.4 0.426 
30 0.222 28.2 3.621 14.1 0.346 
40 0.257 37.5 4.232 18.8 0.540 
Raw data from kinetic study is attached in appendix I. 
The Lineweaver - Burke plots were used to determine the Km and V max values for the 
above substrates and the results are shown in Table 3.4 below. 
TaiDKe 3.4!: Comparison of kinetics of acylase hydrolysis of 419, (S, S) 50 and (R, S) 50 
Substrate 4!9 (S, S) 50 (R, S) 50 
0 0 0 
0 0 0 
Structure 
Jlfe ~ Me ~e ~ H ~AfMe 
H H H Cl H Cl 
V max, J.LM/min 0.36 4.71 0.97 
17.0 8.2 17.3 
V maxi Km 0.021 0.573 0.056 
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It needs to be emphasised that the reaction velocity data is reported in J...LM/min as 
opposed to mM/min for the fluorinated amides reported earlier. Therefore the rates of 
enzymatic hydrolysis are three orders of magnitude slower than those of the previous 
substrates. Clearly the extra steric bulk of these substrates is adversely affecting their 
reactivity with the acylase. Not withstanding this, the trends within this group of 
substrates follow a similar pattern to that with the a.-fluoroamides. 
Notably (S, S) 50 has the highest binding affinity for the enzyme. The higher binding 
affinity is attributed again to the enzyme being able to accommodate a methyl only if 
it is held in a certain orientation and it appears that chlorine is satisfying the same role 
as fluorine with regard to controlling the conformation of this substrate. The ratio for 
the binding affinity between (S, S) 50 and (R, S) 50 is approximately 2, which is 
similar to the fluorine case. The non-chlorinated amide 49 has a similar binding 
affinity to (R, S) 50, which again mirrors the experience of the fluorine case. 
The ratio of the V max values for (S, S) 50 and (R, S) 50 are again very close to the a.-
fluoroamide case, with (S, S) 50 having the higher value and about 5 times greater 
than that for (R, S) 50. Interestingly the slowest substrate of this group is the non-
chlorinated isobutyl substrate. This is probably because 49 contains two methyl 
substituents, which have to accommodated within the acylase and the second methyl 
has to be located in a region of the acylase incompatible with this role. 
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3.2.3 X-Ray crystal structure of amide (S, S) 50 
Two crystal structures were elucidated for (S, S) 50 depending on the presence of 
intermolecular hydrogen bonding, which produced conformational changes around the 
amide bond. 
Figure 3.4: X-Ray crystal structure ofN-(S)-2-chloropropionyl-(S)-phenylalanine, (S, 
S) 50 
Figure 3.4 shows the crystal structure for (S, S) 50 where no intermolecular hydrogen 
bonding is present. This demonstrates an approximately eo-planar relationship 
between theN-Hand C-Cl bonds, with both bonds being approximately trans to the 
carbonyl group. Presumably the increased steric influence of chlorine is mitigating 
against an eclipsing N-H interaction. This is consistent with the findings of the 
fluoroacetyl amide structures reported in the previous section, and presumably arises 
for similar reasons. 
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CIB 
Cl16Bl 
CIA 
FnguH"e 3.5: X-Ray crystal structure of (S, S) 50 with intermolecular hydrogen bonding 
Where this intermolecular hydrogen bonding is present the eo-planar relationship 
between the N-H and C-Cl bonds is lost as shown in Figure 3.5. This presumably 
arises because Cl---H bonding is not strong and the larger size of the chlorine 
mitigates against a eo-planar alignment with the N-H bond. 
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Again differing X-ray crystal structures of .g9 were elucidated depending on the 
presence of intermolecular hydrogen bonding. 
C(148) 
C(158) 
:!Figure 3.6: X-Ray crystal structure ofN-(2)-methylpropionyl-(S)-phenylalanine, 49 
Where no intermolecular hydrogen bonding was present the isopropyl group 
orientated with the N-H bond bisecting the C-C bonds to the methyl substituents and 
the C-H bond eclipsing and eo-planar to the carbonyl. All the evidence suggests that if 
the C-H bond was replaced by C-F, the isopropyl group would rotate by 180°. 
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Figure 3.7: X-Ray crystal structure of 49 with intermolecular hydrogen bonding 
Where intermolecular hydrogen bonding is present, between the carboxylate hydrogen 
and the amide carbonyl, the unit cell of substrate 49 revealed two conformers of 49 
within the structure. Interestingly the orientation of the isopropyl group was found to 
have rotated through 180° for one of the conformers. 
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3.3 Preparation of other a~fluoroamides 
The programme was now extended to the preparation of a range of a-fluoroamides. 
This was carried out to explore a wider range of substrates, to build up a database of 
their properties, and ultimately to determine if the acylase selectivity already 
demonstrated for the 2-fluoropropionamide case would extend to other amides. The 
target a-fluoroamides chosen were N-((RS)-2-fluoropropionyl)-aniline 51, N-((S)-2-
fluoropropionyl)-aniline (S) 51, N-((RS)-2-fluoropropionyl)-benzylamine 52, N-((S)-
2-fluoropropiony I )-benzy I amine (S) 52, N -( (RS)-2-fluoro-4-methy lpentanoy 1)-
benzylamine 53 and N-((RS)-2-fluoro-2-phenylacetyl)-benzylamine 54 as shown in 
Figure 3.8. 
u~f 
(S) 51 
Q~~ 
0 
53 
Q~~ 
~u 
54 
Figure 3.8: a-Fluoroamides screened as AMA substrates of interest 
It was desirable to record an X-ray crystal structure for a 2-fluoropropionamide 
system to again confirm the consistency of the expected C-F I N-H planar 
conformation. The preparation of (S) 51 and (S) 52 opened up this possibility. Also 
with the preparation of racemic a-fluoroamides 51, 52, 53 and 54 it may open up the 
possibility of examining the selectivity of AMA hydrolysis in other substrate systems. 
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3.3.1 Synthesis of a~fluoroamides 
3.3.1.1 N-2-Fiuoropropionamides 
a-Fluoroamides 51 and 52 were prepared m a similar manner to N-(R, S)-2-
fluoropropionyl-(S)-phenylalanine 36 as shown in Scheme 3.2. For the synthesis of 
(S) 51 and (S) 52 the optically pure amino acid (S)- alanine was used as the starting 
material in the diazotisation reaction. 
HF I Pyridine 
NaN02 
14% 
0 YoH 
F 
38 
83% 
Scheme 3.2: Preparation of2-fluoropropionamides 
0 Ycl 
F 39 l R-NH, 
51 R =Ph, 17% 
52 R = Bz, 21% 
3.3.1.2 N-(2-Fluoro-4-methylpentanoyl)-benzylamine 
a-Fluoroamide 53 was prepared in a similar manner to that described above, except 
that the starting material was racemic (RS)-leucine as shown in scheme 3.3. 
HF I Pyridine 
NaN02 36% 
SOCI2 
28% 
0 !Ycl 
56 
8% j Bz-NH, 
0 
~Y~u 
53 
Scheme 3.3: Preparation ofN-(2-fluoro-4-methylpentanoyl)benzylamine 53 
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3.3.1.3 N-(2-Fiuoro-2-phenylacetyl)-benzylamine 
a-Fluoroamide 54 was prepared according to Scheme 3.4. diOH HF I pyridine 
NaN02 88% 
57 
oxalyl 
chloride 
DMF cat 
F rrY!CI 
58 
80% Bz-NH2 
54 
Scheme 3.4: Preparation ofN-(2-fluoro-2-phenylacetyl)-benzylamine, 54 
The acid chloride, 58, could not be prepared by the same synthetic sequence described 
previously due to difficulties in obtaining the acid chloride from a thionyl chloride 
reaction. Distillation of the product required a higher temperature due to low 
volatility, which generated intractable polymerised products. The a-fluorocarboxylic 
acid 57 was instead reacted with oxalyl chloride in the presence of a catalytic amount 
of DMF, to liberate the acid chloride, in good yields. The presence of DMF was 
found to be important as only small conversions were observed in situ and the desired 
product could not be isolated when the reaction was carried out in the absence of 
DMF. 
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Scheme 3.5: Mechanism for DMF catalysed acid chloride formation 
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Obtaining suitable crystals of stereochemically pure a-fluoroamides proved difficult 
due to inhomogeneity of the crystals. However perseverance resulted in the crystal 
structure ofN-((S}-2-fluoropropionyl)-aniline 51 as shown in Figure 3.9. 
0(2) 
lFigure 3.9: X-Ray crystal structures ofN-((S)-2-fluoropropionyl)-aniline, 51 
There are two structures within the unit cell, which differed mainly by rotation of the 
phenyl ring. Importantly, the conformational arrangement of the amide and the C-F 
bond was found to be the same for both. Again the C-F bond was found to be eo-
planar with the N-H bond and both were trans to the carbonyl, consistent with 
previous observations and with the ab initio studies reported earlier. 
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Q~ly 
H----F 
2.17 or 2.22A 
Figure 3.10: Interatomic distance between fluorine and amide hydrogens 
The interatomic distances between F and H for the two conformations are shown in 
Figure 3.10, i.e. 2.17 A between N1(H) and F1 and 2.22A between N2(H) and F2. The 
interatomic distances are smaller here than that recorded previously for the 
fluoroacetyl case (2.27 A). This suggests an even greater barrier to rotation. 
3.3.3 Enzymatic resolutions of a-fluoroamides 
After completion of the synthesis of the four racemic a-fluoroamides 51, 52, 53 and 
54 it was now envisaged that they could be used as substrates in AMA hydrolysis. 
Initially the conditions employed for the previous AMA hydrolyses were used, i.e. 
reaction in water, buffered to pH =7. The rate of reaction, which is clearly dependent 
on the solubility of the substrate in water, was so slow that the highest conversion that 
was estimated by NMR was 0.7% even after an extended reaction period (1 week). 
This level of conversion was not sufficient to measure any stereoselectivity that may 
have occurred. Attempts were made to improve the substrate's solubility by the use of 
10% ethanol I water mixtures, but while solubility was improved, no improvement in 
the reaction rate was observed, possibly due to an adverse effect of ethanol on the 
acylase. 
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3.4 Conclusions 
A selection of amides have been prepared and characterised, of which five were novel 
a-fluoroamides. 
6(0 &00 ~~Me ~~H 
H H H F 
0 ~ 
42 45 
52 
Figure 3.11: Selection of ami des 
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Four of the amides, 45, 49, (S, S) 50 and 51, have had their X-ray crystal structures 
determined. In the case ofthe two a-fluoroamides, 45 and 51, and the a-chloroamide, 
(S, S)50, the C-X and N-H bonds have been found to be approximately eo-planar and 
anti to the carbonyl. 
The solid state structures indicate the presence of intramolecular hydrogen bonding as 
shown in figure 3. 12, with fluorine and chlorine acting as a hydrogen bond acceptor. 
Hydrogen I fluorine interatomic distances of <2.3A, which is considerably less than 
the sum of the Van der Waals radii, have been measured. 
0 
'R,~~R 
H- ---X 
Figure 3.12: Conformation of a-fluoroamides 
These observations support the developing hypothesis that restricted rotation ts 
present in all a-fluoroamides due to stereoelectronic effects and intramolecular 
hydrogen bonding. This conformation is disrupted when intermolecular hydrogen 
bonding is evident between molecules then theN-Hand C-Cl bonds are no longer eo-
planar. 
The rates of hydrolysis of five amides, 42, 45, 49, (S, S)50 and (R, S)50 have been 
evaluated in the AMA acylase system and the binding efficiencies, Km and maximum 
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rates of hydrolysis, Vmax have been determined. This has led to the following 
conclusions. 
> As the steric bulk increases a to the carbonyl the ability ofthe acylase to bind 
with the substrate decreases as revealed by higher Km values. 
> A methyl substituent can be tolerated and has little impact on Km only if it is 
held in one location within the acylase, i.e. that observed in (S, S) 50 
substrate. For all other methyl orientations a marked reduction in binding 
affinity is seen. 
0 ® R,~~ 
H X 
Binding affinity LOW HIGH 
> a-Fluoro and a-chloroamides behave remarkably similar towards the AMA 
acylase and the same relationship between rates of hydrolysis for (R, S) and 
(S, S) diastereoisomers exists. 
> Amides with an a-fluorine do not hydrolyse as fast as the equivalent amides 
where no fluorine is present. This suggests any stabilisation of the acylase 
hydrolysis transition state, by Anh Eisenstein effect, is far outweighed by the 
inherent ground state stability of these a-fluoroamides, relative to their non-
fluorinated counterparts. 
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Chapter 4 - Approaches to the synthesis of 
a-fluoropeptides 
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4.1 Introduction 
As discussed in previous chapters, a-fluoroamides have been shown to experience 
restricted conformational flexibility and thus it was attractive to try to prepare an a-
fluoro peptide, such as that shown in Figure 4.1. 
Figure 4.1: a-Fluoropeptide 
A peptide which exhibits this restricted conformational flexibility, would be expected 
to have significantly different biological properties than a non-fluorinated case. 
Classically peptides are prepared by N ~ C=O combinations of amino acids, however 
any synthetic approach to an a-fluoropeptide could not utilise this route as a-
fluoroamino acids, such as, 25, are unknown. 
0 
•• ) Jl 
H2N ~ 'OH 
F) 
25 
Unstable due to 
fluoride elimination 
a-Fluoroamino acids are unstable due to the lone pair on the nitrogen assisting the 
elimination of fluoride. In this project alternative methods for the preparation of a-
fluoropeptides were investigated, where the nitrogen lone pair is not free to eliminate 
fluoride in this manner. In our target peptide shown above, the a-fluorine is adjacent 
to an amide nitrogen. For our approach to be successful it was hoped that once the 
amide bond was in place, any instability due to fluoride being eliminated, would be 
removed due to conjugation of the nitrogen lone pair with the amide carbonyl. 
Other groups38 have recently tried to synthesise a-fluoropeptides without success, but 
they have been successful in preparing constrained cyclic pseudo peptides such as 59 
shown in Figure 4.2. 
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Figure 4.2: a.-Fluoro pseudo peptide prepared by Bailey38h 
At the outset two routes seemed to satisfy the above criteria. 
4.2 Oxazolone method 
Oxazolones have been used to prepare a.-substituted ammo acids39. The general 
approach has been to carry out the substitution on the oxazolone, which can then 
liberate the desired amino acid by treatment with acid as shown in Scheme 4.1. 
R1 H R1 R 0 
N)<( :__0 Base I R:Y( N)<( ~O H+ I AcOH 
1 
Jl \ r \ r H3+NX~ "'o-)Lo )Lo R1 R3 R2 R2 
Scheme 4.1: a.-Substituted amino acid preparation using oxazolone intermediate 
In the case of fluorine substitution, liberation of the amino acid is clearly undesirable 
as this would certainly lead to elimination of fluoride. However the potential for an 
oxazolone to provide the backbone of a peptide if the cleavage reaction is carried out 
in the presence of a protected amino acid offers an opportunity for a.-fluoroamide 
synthesis as shown in Scheme 4.2. 
00 H 0 d~~"~o/ 
28 29 
Scheme 4.2: a.-Fluoropeptide preparation using oxazolone intermediate 
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4.2.1 Oxazolone synthesis 
(RS)-4-Benzyl-2-phenyl-5( 4H)-oxazolone 26 was available in the research group. 
This compound was prepared by a two-step synthesis, involving formation of the 
amide bond followed by a dehydration as shown in Scheme 4.3. 
0 
~OH+ 0 (i'cl 2M NaOH I ooc 
74% Yield 
,,,H 0 
HN 
~OOH 60 
Ac20 I 1, 4 dioxane 
89% Yield 
N 0 ifo 
26 
Scheme 4.3: (RS)-4-benzyl-2-phenyl-5(4H)-oxazolone 26 synthesis 
4.2.2 Carbanion formation 61 
Treatment of oxazolone 26 with sodium hydride allowed generation of carbanion 61, 
as a consequence of deprotonation as shown in Scheme 4.4. 
0 NaH /THF I RT N 
uYO 
26 
Scheme 4.4: Carbanion synthesis 
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This reaction was carried out by adding a solution of the oxazolone 26 in THF to a 
slurry of sodium hydride again in THF at ooc. After 30 minutes at 0°C the reaction 
was warmed to ambient temperature for a further 60 minutes. The reaction proceeded 
smoothly with a gentle evolution of hydrogen gas, which subsided after 30 minutes, 
leaving a bright yellow solution. Due to the expected reactivity of the carbanion, no 
attempt was made to isolate this material and fluorination with Selectfluor was 
performed immediately. 
4.2.3 Electrophilic fluorination using Selectfluor 
Electrophilic fluorinating agents have been reviewed40, of which Selectfluor, 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo [2.2.2] octane his (tetrafluoroborate), 62 is 
the most widely used example. 
F 
CN)+D (BF4-) 2 N+ 
I 
CH2CI 
62 
Selectfluor is a member of the N-F class of electrophilic fluorinating agents and 
specific reviews41 pertaining to its use on a wide range of substrates have been 
published. Two mechanisms have been proposed for the mode of action of 
Selectfluor, both of which involve nucleophilic addition to the fluorine in either a one 
or two step process as shown in Scheme 4.5. 
NuF 
j 
Scheme 4.5: Selectfluor fluorination mechanisms 
Fluorination of a carbanion species was of interest in our research to achieve the 
desired substitution of the oxazolone 61. Examples42 of fluorinations of stabilised 
carbanions include a-sulphonylesters 63 and substituted malonates 64 as shown in 
Figure 4.3, which have been reported to proceed efficiently and in good yields. 
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Figure 4.3: Carbanions suitable for fluorination with Selectfluor 
In our case fluorination of carbanion, 61 offered access to 27 as shown in Scheme 4.6. 
F 
Na+ CND + (BF4-)2 
N 0 N 0 
~0 N+ ~0 I ~ CH2CI ~ 
// // 
61 62 27 
Scheme 4.6: Synthesis of (RS)-4-benzyl-4-fluoro-2-phenyl-5-oxazolone, 27 
The reaction was expected to be straightforward and a direct addition of 1 equivalent 
of Selectfluor to the carbanion solution was initially investigated. At this stage it was 
noticed that Selectfluor showed poor solubility in the reaction mixture. In an attempt 
to improve its solubility DMF was added to the reaction mixture prior to the 
Selectfluor addition. After stirring for 30 minutes a colourless solution remained and 
19F NMR analysis on this mixture shows add at -127.8 ppm, which is consistent with 
the formation of the C-F bond. The desired product was extracted into diethyl ether 
and washed with water until pH > 6. 19F NMR analysis of the recovered product is 
shown in Figure 4.4 and it corresponds to the desired compound 27. 
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Figure 4.4: 19F NMR of (RS)-4-benzyl-4-fluoro-2-phenyl-5-oxazolone, 27 
This would be the expected 19F NMR spectrum from a fluorinated oxazolone, 
showing coupling (J = 9 Hz and 11 Hz) with the two non-equivalent protons in the 
adjacent CH2 group. The reciprocal couplings were also evident in the 1H NMR 
spectrum. 
This material was found to be unstable even when stored in a fridge under nitrogen 
and for subsequent experiments it was used immediately. 
4.2.4 Attempted a-fluoro peptide preparation from 27 
At this stage a carboxylate protected amino acid was needed to react with the 
fluorinated oxazolone to prepare the desired a-fluoro peptide. It was decided that the 
methyl ester of (S)-alanine would be a suitable candidate. This was prepared by the 
liberation of the free base of (S)-alanine methyl ester hydrochloride using 
triethylamine. 
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Scheme 4. 7 Preparation of (S)-alanine methyl ester, 28 
This gave rise to a solution of (S)-alanine methyl ester 28 in DMF and this was used in 
the attempts to trap the fluorinated oxazolone to generate the a-fluoro peptide as 
shown in Scheme 4. 8. 
0 0 F H O 
N 0 + Yo/ er~ N~o/ -------~ ~0 0 "=:::: NH2 
_..-:::. 
27 28 29 
Scheme 4.8: Strategy for a-fluoro peptide synthesis 
The fluorinated oxazolone solution was added directly to a solution of 1 equivalent of 
amino ester 28. 19F NMR initially showed no change however after a 30-minute 
reaction time the organic fluorine signals were no longer evident in the NMR 
spectrum and only a broad peak at -160 ppm, which is consistent with an HF.DMF 
complex. It was postulated that the peptide was unstable and broke down via HF 
elimination as soon as any a-fluoropeptide was generated. 
4.2.5 Alternative oxazolone substituents 
Due to the unstable nature of the a-fluoropeptide, a strategy to further reduce the 
influence of the lone pair on nitrogen was sought. One approach that was investigated 
was to introduce electron withdrawing groups on the oxazolone as shown in Figure 
4.5 to reduce the potential for the lone pair to assist in the elimination of fluoride. 
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Fngunre 41.5: Proposed structure for a more stable a-tluoropeptide 
It was envisaged that a-fluoropeptide, 65 could be prepared by a similar route to that 
described above for a-fluoropeptide 29, starting from 2,6-difluorobenzoyl chloride, 
66, as shown in Scheme 4.9 below. 
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(S)-alanine methyl ester 
§cheme 4.9: Alternative a-fluoropeptide synthesis 
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Preparation ofthe initial amide 67, proceeded in a straightforward manner and in good 
yield. Conversion of 67 to oxazolone 68 required more aggressive conditions than 
those used previously (reflux for 60 minutes compared to ambient) to convert the last 
traces of the starting material. The resultant product also required chromatographic 
purification before it was suitable for use in the next stage of the synthesis. 
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The next stage in the synthesis was to generate a carbanion to enable fluorination with 
Selectfluor to be carried out. This again was achieved by reaction with sodium 
hydride in THF. This reaction produced a bright yellow slurry, which was reacted 
immediately with 1 equivalent of Selectfluor. The reaction solution was held for 15 
minutes at ambient temperature and TLC analysis confirmed that only 1 component 
was present and that it was different from the starting material. 19F NMR showed the 
presence of the aromatic CF group but no other organic fluorine substituents could be 
detected. The reaction was stirred overnight to allow the fluorination to progress, after 
which time NMR and TLC analysis showed no change. The reaction mixture was 
worked up in an attempt to identify this new compound by extracting into diethyl 
ether and washing with water. The solvents were removed and the colourless oil was 
recrystallised from ethyl acetate I hexane (20:80) to give a white solid. 
The white solid was analysed by NMR and MS and initially a tetramer was suggested 
as a possible structure for the new compound. However after further recrystallisation a 
crystal was obtained that was suitable for X-ray structure analysis confirming the 
formation of dimer product. This was 3,5-dibenzyl-1-(2,6-difluorobenzoyl)-3-(2,6-
difluorobenzoylamino)pyrrolidine-2,4-dione 70 as shown below in Figure 4.6. 
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Figure 4.6: X-ray structure of3,5-dibenzyl-l-(2,6-difluorobenzoyl)-3-(2,6-
difluorobenzoylamino )pyrrolidine-2,4-dione 70 
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The dimerisation of 5-oxazolones has previously been reported43 when treated with a 
strong base such as LDA. The dimer arises from the reaction between the carbanion 
and an unmodified oxazolone as shown in Figure 4.7. 
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Figure 4. 7: Mechanism for dim er formation 
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4.2.6 Barrier to rotation 
An interesting observation from analysis of70 was how different the two aromatic CF 
signals were in the 19F NMR spectrum as shown in Figure 4.8 . 
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Figure 4.8: 19F NMR spectrum of dimer, 70 
One of the signals was very sharp with the aromatic CH couplings being evident, 
while the other was a very broad peak with no coupling information visible. It was 
postulated that one of the ditluorophenyl substituents was experiencing restricted 
rotation as shown in Figure 4.9. 
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Figure 4.9: Restricted rotation of difluorophenyl substituent 
Rotation of the 2,6-difluorophenyl substituent at ambient temperature must be at such 
a rate as to allow the two fluorine nuclei to be detected in different environments by 
NMR. At higher temperatures the rate of rotation will of course increase and NMR 
should detect the two fluorine nuclei as one averaged signal. However, at lower than 
ambient temperatures the rate of rotation of the 2,6-difluorophenyl substituent is 
reduced so that NMR sees the two fluorine signals with different chemical shifts. In 
between these extremes will be the coalescence temperature, which has been 
described as the point where the two signals have neither a maxima or minima 
between them. 
Dynamic NMR can be an excellent tool44 for determining barriers to rotation if the 
rates of exchange between two signals are close to the NMR measurement time, 
which is typically in the millisecond range. In order to determine the energy barrier to 
rotation, the coalescence point and the chemical shift difference for the two signals 
needs to be determined. This can be determined by using variable temperature NMR 
and depending on the type of exchanging system that is present may require either a 
high or low VT experiment. 
With the example shown above m Figure 4.8 the signal of interest is already 
exchanging at a rate faster than the NMR experiment timescale and therefore a broad 
signal with a maxima is seen which averages the two individual signals. The 
temperature therefore needs to be reduced to identify the coalescence point and the 
chemical shifts of the individual signals. Accordingly 19F NMR spectra were collected 
in the temperature range -40 to 20°C and the spectra are shown in Figure 4.10. 
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Figure 4.10: 19F VT NMR on dimer 
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The 19F VT NMR spectra shown above are unusual and do not conform to what was 
expected from a simple barrier to rotation. As the temperature is reduced the broad 
signal begins to separate into two signals and the two signals would have expected to 
sharpen so the individual chemical shifts for the two fluorine signals could be 
determined. However in the VT NMR analysis of 70 a more complex relationship 
exists and two effects have been uncovered. 
The low field signal at ambient temperature behaves exactly as expected showing a 
gradual sharpening to reveal coupling with the adjacent aromatic protons. The high 
field signal at ambient temperature displays a very different response as the 
temperature is reduced. The chemical shift of this signal is dependant on the 
temperature at which it is measured, so much so that at temperatures below -30°C this 
signal has now become the low field signal of the pair. This can be explained by the 
movement of other substituents (e.g. aryl ring) in the molecule, which would affect 
the magnetic environment of one of the fluorine atoms. 
Secondly a barrier to rotation is evident and a coalescence temperature of 
approximately 20°C as shown in Figure 4.8 has been determined. 
Calculation of the energy barrier to rotation is possible from NMR data if the 
chemical shift difference and the coalescence temperature of the two signals are 
known. However in the VT NMR analysis of 70 the chemical shift difference for the 
two signals could not be determined and therefore the energy barrier to rotation could 
not be calculated. 
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4.3 Azirine method 
Our second approach to an a.-fluoropeptide is shown in Scheme 4.10 and involves 
reaction of a protected amino acid with azirine 71. 
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Scheme 4.10: a.-Fluoropeptide preparation using azirine intermediate 
At the outset this approach appeared desirable as it was already demonstrated for the 
preparation of non-fluorinated peptides45 . This approach has been demonstrated to be 
very successful in preparing a wide variety of a-substituted peptides with the only 
question being whether an a.-fluoropeptide could be prepared in this manner. The 
major difficulty with this approach at the outset was the preparation ofthe azirine 71 
as no examples of fluorinated azirines have been reported. 
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4.3.1.1 Attempted fluorinated azirine preparation 
Preparation of azirine 71 was attempted as shown below in Scheme 4.11. 
0 0 H YoH + c~r{ Ycl + /N'Q 
F F 
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76 
75 
71 
Scheme 4.11: Preparation of azirine 63 
4.3.1.1.1 Synthesis of amide 75 
N-(2-fluoropropionyl)-N-methyl aniline 75 was prepared in a straightforward manner 
using the methodology previously described for preparing the acid chloride 39, 
followed by reaction with N-methylaniline. The amide was produced in moderate 
yields ( 46%) as a colourless oil. A DCM solution of amide 75 was prepared (1 g I 10 
mL) for future use in the azirine synthesis. 
4.3.1.1.2 Synthesis of chlorofluoroenamine 76 
The initial approach to prepare the chlorofluoroenamine 76 involved the use of 
phosgene. This has been reported46 to be successful in the preparation of non-
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fluorinated chloroenamines and involves the production of an immmmm chloride 
intermediate as shown in Scheme 4.12. 
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Scheme 4.12: Preparation of chlorofluoroenamine 76 
Phosgene was generated from triphosgene, which is a white solid and is easy to 
handle. Triphosgene generates three equivalents of phosgene in situ eliminating the 
need to handle highly toxic phosgene gas. Initially the reaction was attempted in two 
stages with the phosgene reaction being carried out initially. However 19F NMR and 
TLC did not indicate that the reaction was taking place. A review47 on the use of 
phosgene pointed to increased reactivity if triethylamine was present. At this stage a 
new component was evident in the 19F NMR spectrum with a chemical shift of -109.6 
ppm however it was a minor component alongside the starting material 75, and no 
further attempts to improve the phosgene reaction were made. 
An alternative approach using oxalyl chloride as the chlorinating agent was tried with 
the addition of oxalyl chloride being carried out at -70°C. The reaction mixture was 
warmed to ambient temperature for 60 minutes, cooled to -70°C and the triethylamine 
was added. Again the reaction mixture was warmed to ambient temperature at which 
point TLC confirmed that four components were present and that the starting material 
was the minor component. The reaction was left overnight at ambient temperature but 
no further change was observed by TLC analysis. The crude product was purified by 
column chromatography over silica gel to give a red I orange oil. A possible 
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explanation for the vivid colour m the product could be the charge transfer 
equilibrium shown below. 
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Figure 4.11: Chlorofluoroenamine equilibrium 
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The 19F NMR spectrum showed a quartet (16Hz) at -102.lppm, which is consistent 
with the desired product. 
I _......., I T\ -101 
"' Figure 4.12: 19F NMR of chlorofluoroenamine 76 
4.3.1.1.3 Cyclisation reaction 
Cyclisation of non-fluorinated chloroenamines can be achieved via a two-stage 
reaction with a diazonium intermediate46'48 to give exclusively the 2H-azirines as 
shown in Scheme 4.13. 
Cl YN/ Fo 
76 
_______ .,.. 
Scheme 4.13: Strategy to azirine formation 
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For chlorofluoroenamine the reaction was initially carried out in diethyl ether, with 1 
equivalent of sodium azide but after 2 days at ambient temperature no conversion 
could be detected by TLC and NMR analysis. In an attempt to improve the solubility 
of the sodium azide, DMF was added to the reaction mixture but after a further two 
days at ambient no reaction could be detected. Finally the reaction was heated under 
reflux for 8 hours but once again no reaction products could be detected. 
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4.4 Conclusions 
~ Of the two routes assessed towards a-fluoropeptide synthesis, the oxazolone 
method would appear to have the greatest prospects. 
~ Oxazolone 27 was prepared and although unstable it was possible to attempt 
an a-fluoropeptide synthesis, by trapping with alanine methyl ester. However 
this led to a very unstable product and elimination of fluoride as determined by 
I9FNMR. 
~ Alternative methods for isolating the a-fluoropeptide, such as increasing the 
reactivity of the trapping species and deactivating the nitrogen, are worthy of 
further investigation. 
~ Attempts to improve the stability of the oxazolone by incorporating electron-
withdrawing groups have proved unsuccessful and in our case this has 
promoted dimerisation to pyrrolidone 70. 
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~ An interesting phenomenon has been investigated for pyrrolidone 70 
concerning the barriers to rotation ofthe difluorophenyl substituents. Variable 
temperature 19F NMR has been used to monitor the changes to the two fluorine 
signals as the temperature is reduced. This has shown that this is not a simple 
barrier to rotation and that interaction with other substituents (e.g. aryl) on the 
pyrrolidone, are changing the environment and hence the chemical shift of one 
of the fluorine atoms. 
~ A method for preparing chlorofluoroenamines 76 has been developed. 
97 
76 
~ Investigations into the use of azirines to prepare a-fluoropeptides have proved 
unsuccessful due to the difficulty in preparing fluoroazirines from 
chlorofluoroenamines. 
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Chapter 5 - Experimental and References 
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5.1 General Section 
All practical work was carried out m the laboratories of Pfizer, Whalton Road, 
Morpeth. Unless otherwise stated reactions were carried under a nitrogen atmosphere 
at room temperature with stirring. All reactions involving the use of hydrofluoric acid 
were carried out in Teflon equipment due to its incompatibility with glass. All 
solvents used were high purity grade supplied by Romil Chemical Company. All 
starting materials and reagents were purchased from Aldrich Chemical Company 
unless otherwise stated. 
TLC analysis for following reaction progress was carried out on Merck, Kieselgel 60 
coated glass plates and visualisation by UV, phosphomolybdic acid or sulphuric acid 
was used. 
Melting points were determined using a differential scanning calorimeter, with the 
melting range being the start and end of the endotherm. 
NMR spectra were recorded on a Jeol EX 270 MHz spectrometer on a 
deuterochloroform solution unless otherwise stated. 1H NMR were ran at 270 MHz, 
13C NMR were ran at 67.9 MHz and 19F NMR were ran at 254.2 MHz. 
IR spectra were recorded using a Nicolet magna IR, which is fitted with a microscope 
to enable spectra of an individual crystal to be determined. 
MS analysis was performed on a VG TRIO 1000 spectrometer. 
X-ray crystal structures were determined at the University of Durham by Dr Andres 
Go eta. 
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5.2 Experimental for Chapter 2 
5.2.1 (RS)-2-Fiuoropropionic acid, 38 
0 YoH 
F 
A 250 mL Teflon bottle, containing a magnetic follower, was charged with 
pyridinium polyhydrogen fluoride (100 mL, 70% w/w) and then (RS)-alanine, (8.6 g, 
96 mmol) was added. The solution was cooled to 0°C and sodium nitrite (22.6 g, 
232mmol) was added in five equal portions over I hour. The reaction mixture was 
stirred at 0°C for 1 hour and then warmed to room temperature and then stirred 
overnight. The reaction was quenched by addition to ice water (200 mL), extracted 
into diethyl ether (3 x 200 mL), washed with sodium chloride solution (3 x 200 mL, 
5% w/v) and dried over anhydrous sodium sulphate, filtered, evaporated and distilled 
in vacuo (68°C at 20 mbar) to afford a colourless liquid as the pure product. 
Yield: 1.4g, 15.2 mmol, 14%. 
1H NMR (d, Acetone): 5.12(1H, dq, J 48.5, 6.9, CFH), 1.61(3H, dd, J 23.5, 6.9, Me). 
13C NMR (d6 Acetone): 85.1(d, J 182.7, CFH), 18.2(d, J 22.3, CH3), No carbonyl 
signal detected. 
19F NMR (d6 Acetone): -184.76(dq, J 48.3, 23.5, CFH). 
5.2.2 (RS)-2-Fiuoropropionyl chloride, 39 
0 Ycl 
F 
Thionyl chloride was added dropwise to (RS)-2-fluoropropionic acid, (1.00 g, 10.9 
mmol) at room temperature until effervescence ceased. This signalled the absence of 
free water in the (RS)-2-fluoropropionic acid. A further 1 equivalent of thionyl 
chloride was added and the reaction was heated to reflux for 60 min. A sample was 
removed for 1H and 19F NMR analysis to confirm the absence of starting material. The 
product was distilled from the reaction mixture at atmospheric pressure to give a 
colourless liquid. 
Yield: 1.0 g, 9.1 mmol, 83%. 
1H NM.R: 5.14(1H, dq, J 48.6, 7.0, CFH), 1.66(3H, dd, J 22.8, 6.8, Me). 
13C NMR: 172.5(d, J27.9, C=O), 90.3(d, J 194.5, CFH), 17.6(d, J21.9, CH3). 
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19F NMR: -171.4(dq, J 49.1, 23.0, CFH). 
5.2.3 N- (R,S)-2-Fiuoropropionyi-(S)-phenylalanine, 36 
0 
~H 
F 
(S)-Phenylalanine (2.63g, 16 mmol) was dissolved in 4M NaOH (12 mL, 48 m mol). 
The reaction was cooled to ooc and (RS)-2-fluoropropionyl chloride (1.6g, 14 m mol) 
was added dropwise. The reaction was warmed to room temperature and stirred for 30 
minutes, acidified to pH = 3 with concentrated HCl and the product extracted into 
ethyl acetate (100 mL), washed with sodium chloride solution (3 x 100 mL, 5% w/v) 
and dried over anhydrous sodium sulphate, filtered and evaporated in vacuo to afford 
the crude product as a colourless oil as a mixture of diastereoisomers. 
Yield: 0.6g, 2.5 mmol, 16%. 
1H NMR: 7.23(5H, m, ArH), 6.92(1H, m, NH), 5.03(1H, dq, J 39.1, 6.8, CFH), 
4.90(1H, overlapping dd, J6.8, 6.8, CH), 3.19(2H, m, CH2), 1.48(3H, 2 overlapping 
dd, J 24.5, 6.8, CH3). 
13C NMR: 174.2(C=O), 174.1(C=O), 171.2(d, J 19.0, C=O), 171.1(d, J 20.0, C=O), 
135.3(Ar-C), 135.3(Ar-C), 129.3(Ar-C), 129.2(Ar-C), 128.6(Ar-C), 128.5(Ar-C), 
127.2(Ar-C), 127.2(Ar-C), 88.3(d, J 183.6, CFH), 88.2(d, J 183.5, CFH), 52.6(CH), 
52.4(CH), 37.4(CH2), 37.2(CH2), 18.2(d, J21.9, CH3), 18.12(d, J20.9, CH3). 
19F NMR: -182.8(ddq, J 49.2, 24.7, 4.2, CFH), -182.9(ddq, J 49.8, 25.2, 4.3, CFH). 
5.2.4 N- (R, S)-2-Fiuoropropionyi-(S)-phenylalanine sodium salt 
N-(R, S)-2-Fluoropropionyl-(S)-phenylalanine, 36, (0.60g, 2.5 mmol) was dissolved in 
the minimum quantity of 4M NaOH (5 mL). The pH of the solution was adjusted to 
pH = 7 using concentrated HCl and then diluted to a final volume of 10 mL using 
distilled water to give a 0.25 M solution of36 sodium salt. 
5.2.5 Acylase hydrolysis reaction 
Various acylase solutions (hog kidney acylase (HKA), Aspergillus melleus acylase 
(AMA), Bacillus icheniformis protease (BIP) and the Streptomyces cae.5pitrum 
protease (SCP)) were prepared at varying concentrations (HKA 11.5 mgmL-1, AMA 
219 mgmL-1, BIP 6.4 mgmL-1 and SCP 159.7 mgmL-1) in pH= 7 phosphate buffer, 
depending on their quoted activity for hydrolysing N-acetyl-L-methionine. An NMR 
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tube was then filled with 0.5 mL of36 sodium salt and 0.5 mL of the buffered enzyme 
solution. The NMR tubes were warmed to 37°C and the NMR spectra were recorded 
to monitor the progress of the hydrolysis. 
5.2.6 (R)-2-Fiuoropropionic Acid, (R) 38 
0 
0-oH 
F 
A 250 mL Teflon bottle, containing a magnetic follower, was charged with 
pyridinium polyhydrogen fluoride (100 mL, 70% w/w) and then (R)-alanine, (8.6 g, 
96 mmol) was added. The solution was cooled to ooc and sodium nitrite (22.6 g, 232 
mmol) was added in five equal portions over 1 hour. The reaction mixture was stirred 
at ooc for 1 hour and then warmed to room temperature and then stirred overnight. 
The reaction was quenched by addition to ice water (200 mL ), extracted into diethyl 
ether (3 x 200 mL), washed with sodium chloride solution (3 x 200 mL, 5% w/v) and 
dried over anhydrous sodium sulphate, filtered, evaporated and distilled in vacuo at 23 
mbar to afford a yellow liquid of mixed acid and anhydride products. 
Yield: 1.6g, 17.4 mmol, 18%. 
1H NMR (dt;-Acetone): 5.12(1H, dq, J 48.5, 6.9, CFH), 1.61(3H, dd, J 23.5, 6.9, Me). 
13C NMR (d6-Acetone): 85.1(d, J 182.7, CFH), 18.2(d, J 22.3, CH3), No carbonyl 
signal was observed. 
19F NMR (dt;-Acetone): -184.8(dq, J 48.3, 23.5, CFH). 
5.2.7 (R)-2-Fiuoropropionyl chloride, (R) 39 
0 
0-cl 
F 
Thionyl chloride, (4.56g, 38.3 mmol) was added dropwise to (R)-2-fluoropropionic 
acid, (1.00 g, 10.9 mmol) at room temperature. The reaction was heated under reflux 
for 30 min and a sample was removed for 1H and 19F NMR analysis to confirm the 
absence of starting material. A mixture of the desired product and thionyl chloride 
was distilled from the reaction mixture at atmospheric pressure to give the product as 
a yellow liquid. 
Yield: 1.26 g, 11.3 mmol, 104% (desired product plus thionyl chloride). 
1H NMR: 5.14(1H, dq, J 48.6, 7.0, CFH), 1.66(3H, dd, J 22.8, 6.8, Me). 
13C NMR: 172.5(d, J27.9, C=O), 90.3(d, J 194.5, CFH), 17.6(d, J21.9, CHJ). 
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19F NMR: -171.4(dq, J 49.1, 23.0, CFH). 
5.2.8 N-(R)-2-Fiuoropropionyl-( S)-phenylalani ne, (R,S)36 
0 
~H 
(S)-Phenylalanine (1.81g, 11 mmol) was dissolved in 4M NaOH (11 mL, 44 mmol). 
The reaction was cooled to ooc and (R)-2-tluoropropionyl chloride (1.26g, 11.3 
mmol) was added dropwise. The reaction was warmed to room temperature and 
stirred for 30 minutes, acidified to pH = 3 with concentrated HCl and the product 
extracted into ethyl acetate (1 00 mL ), washed with sodium chloride solution (3 x 100 
mL, 5% w/v) and dried over anhydrous sodium sulphate, filtered and evaporated in 
vacuo to afford the crude product as a colourless oil (0.23 g). NMR showed that the 
product was a mixture of (R, S) 36 and (S, S) 36 in a ratio 9:1. Further purification was 
afforded by treating the mixture with 4M NaOH (1 mL), acidifying to pH= 7 with 
HCl and reacting with a buffered solution (pH = 7) of A~pergillus melleus acylase 
until no (S, S) 36 diastereoisomer remained. The pH of the reaction mixture was then 
adjusted to 2 using HCl, extracted into ethyl acetate, dried over anhydrous sodium 
sulphate, filtered and evaporated in vacuo to afford the pure product, as judged by 19F 
NMR, as colourless oil. 
Yield: 93.6 mg, 0.8 mmol, 9%. 
1H NMR: 7.23(5H, m, ArH), 6.92(1H, m, NH), 5.03(1H, dq, J 39.1, 6.8, CFH), 
4.90(1H, overlapping dd, J 6.8, 6.8, CH), 3.28(1H, dd, J 14.0, 7.0, CH2a), 3.11(1H, 
dd, J 14.0, 7.0, CH2b), 1.55(3H, dd, J24.5, 6.8, CHJ). 
13C NMR: 174.2(C=O), 171.2(d, J 19.o, c=o), 135.3(Ar-C), 129.3(Ar-C), 128.6(Ar-
C), 127.2(Ar-C), 88.3(d, J 183.6, CFH), 52.6(CH), 37.2(CH2), 18.0(d, J20.9, CH3). 
19F NMR: -182.9(ddq, J 49.8, 25.2, 4.3, CFH). 
5.2.9 N- (R)-2-Fiuoropropionyi-(S)-phenylalanine sodium salt 
N-(R)-2-Fluoropropionyl-(S)-phenylalanine, (R, S)36, (0.20g, 0.8 mmol) was 
dissolved in the minimum quantity of 4M NaOH (1 mL). The pH of the solution was 
adjusted to pH = 7 using concentrated HCl and then diluted to a final volume of 10 
mL using distilled water to give a 83.6 mM solution of(R, S)36 sodium salt. 
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5.2.10 (S)Q2QFiuoropropionic acid, (S) 38 
0 ¥oH 
F 
A 125 mL Teflon bottle, containing a magnetic follower, was charged with 
pyridinium hydrogen fluoride (100 mL, 70% w/w) and then (R)-alanine, (8.6 g, 96 
mmol) was added. The solution was cooled to ooc and sodium nitrite (22.6 g, 232 
mmol) was added in five equal portions over 1 hour. The reaction mixture was stirred 
at ooc for I hour and then warmed to room temperature and then stirred overnight. 
The reaction was quenched by addition to ice water (100 mL), extracted into diethyl 
ether (3 x lOO mL), washed with sodium chloride solution (3 x 100 mL, 5% w/v) and 
dried over anhydrous sodium sulphate, filtered, evaporated and distilled in vacuo at 23 
m bar to afford a yellow liquid of mixed acid and anhydride products. 
Yield: 1.31g, 14.2 mmol, 15%. 
1H NMR (~-Acetone): 5.12(1H, dq, J 48.5, 6.9, CFH), 1.61(3H, dd, J 23.5, 6.9, Me). 
13C NMR (~-Acetone): 85.l(d, J 182.7, CFH), 18.2(d, J 22.3, CH3), no carbonyl 
signal evident. 
19F NMR (d6-Acetone): -184.76(dq, J 48.3, 23.5, CFH). 
5.2.11 (S)Q2~Fiuoropropionyl chloride, (S) 39 
0 ¥cl 
F 
Thionyl chloride, (1.42 g, 11.9 mmol) was added dropwise to (R)-2-fluoropropionic 
acid, (1.00 g, 10.9 mmol) at room temperature. The reaction was heated under reflux 
for 30 min and a sample was removed for 1H and 19F NMR analysis to confirm the 
absence of starting material. Further portions (0.2 mL) ofthionyl chloride were added 
until NMR analysis confirmed the disappearance of the starting material. The desired 
product was distilled from the reaction mixture at atmospheric pressure to give a 
colourless liquid. 
Yield: 0.17 g, 1.5 mmol, 14%. 
1H NMR: 5.03(1H, dq, J 48.7, 6.9, CFH), 1.61(3H, dd, J 23.5, 6.9, Me). 
13C NMR: I72.5(d, J27.9), 90.3(d, J 194.5), I7.6(d, J21.9). 
19F NMR: -184.3(dq, J 48.0, 23.7, CFH). 
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5.2.12 N-(S)-2-Fiuoropropionyi-(S)-phenylalanine, (S, S)36 
0 
u:c~H 
Fx: 
(S)-Phenylalanine (0.25g, 1.5 mmol) was dissolved in 4M NaOH (1.2 mL, 4.8 mmol). 
The reaction was cooled to 0°C and (S)-2-fluoropropionyl chloride (0.17g, 1.5 mmol) 
was added dropwise. The reaction was warmed to room temperature and stirred for 30 
minutes, acidified to pH = 3 with concentrated HCl and the product extracted into 
ethyl acetate (100 mL), washed with sodium chloride solution (3 x 100 mL, 5% w/v) 
and dried over anhydrous sodium sulphate, filtered and evaporated in vacuo to afford 
the crude product as a colourless oil. Recrystallisation from hexane and chloroform 
yielded the product as a white crystalline solid, which contained a 9:1 mixture (in 
favour of S, S 36) of the diastereoisomers. 
Yield: 0.23 g, 0.8 mmol, 28%. 
M. Pt.: 87.0- 87.5°C. 
FTIR Microscopy: 3388(s), 3335(s), 2979(s), 2800(br), 1729(s), 1624(s), 1545(s), 
1227(s) 
El (m/z): 239(5), 194(10), 148(100), 131(13), 120(30), 103(22), 91(95), 77(27), 
65(27), 47(33). 
1H NMR: 7.23(5H, m, ArH), 6.92(1H, m, NH), 5.03(1H, dq, J 39.1, 6.8, CFH), 
3.28(1H, dd, J 14.0, 7.0, CH2a), 3.11(1H, dd, J 14.0, 7.0, CH2b), 1.55(minor 
diastereoisomer, dd, J24.5, 6.8, CH3), 1.43(3H, 2 dd, J24.5, 6.8, CH3). 
13C NMR: 173.8(C=O), 171.2(d, J 19.0, C=O), 135.4(Ar-C), 129.3(Ar-C), 128.6(Ar-
C), 127.2(Ar-C), 88.3(d, J 183.6, CFH), 52.4(CH), 37.4(CH2), 18.1(d, J21.9, CH3). 
19F NMR: -182.8(ddq, J 49.2, 24.7, 4.2, CFH), -182.9(minor diastereoisomer, ddq, J 
49.8, 25.2, 4.3, CFH). 
5.2.13 Acylase kinetic study 
The typical procedure for an acylase hydrolysis reaction was to charge to an NMR 
tube with the required quantity of a sodium salt solution of the substrate. This was 
adjusted to give final solutions typically in the range 5 to 70 mM. To this a solution of 
AMA enzyme in phosphate buffer (pH= 7, 0.2 mL), with concentration adjusted for 
the activity was added. The total volume in the NMR tube was made up to 1 mL with 
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the addition of more phosphate buffer. The initial rate of hydrolysis was followed by 
NMR. 
5.3 Experimental for Chapter 3 
5.3.1 N-Propionyl-( S)-phenylalanine, 42 
0 u:yH 
(S)-Phenylalanine (5.0 g, 30 mmol) was dissolved in 4M NaOH (23 mL, 90 mmol). 
The reaction was cooled to ooc and propionyl chloride (2.8 g, 30 mmol) was added 
dropwise. The reaction was warmed to room temperature and stirred for 30 minutes, 
acidified to pH = 3 with concentrated HCl and the product extracted into ethyl acetate 
(I 00 mL ), washed with water until pH = 6 and dried over anhydrous sodium sulphate, 
filtered and evaporated in vacuo to afford the product as a white solid. The product 
was recrystallised from ethyl acetate I hexane. 
Yield: 2.0g, 9.0 mmol, 30.1% 
M. Pt.: 132.5- 133.5°C (Lit M. Pt. l32°C49) 
FTIR Microscopy: 3342(s), 2979(s), 2800(br), 1709(s), 1617(s), 1545(s). 
El (m/z): 221(8), 203(5), 177(6), 148(100), 131(12), 120(40), 104(23), 91(71), 
74(45), 65(22), 57(81) 
1H NMR: 7.25(5H, m, ArH), 5.89(1H, d, J 7.7, NH), 4.84(1H, dt, J 7.4, 5.9, CH), 
3.24(1H, dd, J 14.0, 5.8, Non equivalent CH2), 3.12(1H, dd, J 14.1, 6.2, Non 
equivalent CH2), 2.21(2H, q, J7.7, CH2), 1.10(3H, t, J7.7, CH3) 
13C NMR: 174.2(C=O), 174.1(C=O), 135.7(Ar-C), 129.4(Ar-C), 128.8(Ar-C), 
127.4(Ar-C) 53.2(CH), 37.2(CH2), 29.5(CH2), 9.6(CH3). 
5.3.2 2-Fiuoroacetyl chloride, 48 
Sodium fluoroacetate (4.4g, 44 mmol) was added to pthaloyl dichloride (6.97 mL, 48 
mmol) and heated under reflux for 1 hour. The product was distilled from the mixture 
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at atmospheric pressure keeping the temperature below 95°C to give a colourless 
liquid. 
Yield: 1.3g, 13.5 mmol, 31% 
1H NMR: 5.05(2H, d, CH2F) 
13C NMR: 82.16(CH2F, d, J 198.3), no carbonyl signal evident. 
19F NMR: -209.74(t, J 46.7, CH2F) 
0 
~~H 
F 
(S)-Phenylalanine (2.23g, 13.5 mmol) was dissolved in 4M NaOH (13.5 mL, 53.9 
mmol). The reaction was cooled to ooc and fluoroacetyl chloride (1.3 g, 13.5 mmol) 
was added dropwise. The reaction was warmed to room temperature and stirred for 30 
min, acidified to pH = 3 with concentrated HCl and the product extracted into ethyl 
acetate (100 mL), washed with water until pH= 6 and dried over anhydrous sodium 
sulphate, filtered and evaporated in vacuo to afford the crude product as a colourless 
oil. The product was recrystallised from dichloromethane I hexane. 
Yield: 0.87g, 3.9 mmol, 28.6% 
M. Pt.: 144- 145°C 
Elemental Analysis: Found,% C 58.60, %H 5.37, %N 6.10 
Calculated,% C 58.66, %H 5.37, %N 6.22 
FTIR Microscopy: 3387(s), 2960(s), 2800(br), 1742(s), 1650(s), 1564(s) 
El (m/z): 148(100), 131(5), 120(20), 103(10), 91(95)65(15). 
1H NMR: 7.25(5H, m, ArH), 6.68(1H, d, J 7.2, NH), 4.97(1H, ddd, J 7.2, 6.6, 5.8, 
CH), 4.78(2H, d, J 47.0, CH2F), 3.26(1H, dd, J 14.0, 5.8, Non equivalent CH2), 
3.15(1H, dd, J 14.0, 6.6, Non equivalent CH2) 
13C NMR: 175.0(C=O), 168.1(C=O, d, J 18.2), 135.1(Ar C), 129.3(Ar C), 128.9(Ar 
C), 127.6(Ar C), 80.2(CH2-F, d, J 186), 52.5(CH), 37.5(CH2). 
19F NMR: -225.58(dt, J 47.2, 2.5, CFH2). 
X-ray Analysis: See appendix Il 
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0 
~H 
(S)-Phenylalanine (5.0 g, 30 mmol) was dissolved in 4M NaOH (23 mL, 90 mmol). 
The reaction was cooled to ooc and 2-methylpropionyl chloride (3.23 g, 30 mmol) 
was added dropwise. The reaction was warmed to room temperature and stirred for 30 
min, acidified to pH = 3 with concentrated HCl and the product extracted into ethyl 
acetate ( 100 mL ), washed with water until pH = 6 and dried over anhydrous sodium 
sulphate, filtered and evaporated in vacuo to afford the crude product as a white solid. 
The product was recrystallised from ethyl acetate I hexane. 
Yield: 2.40 g, 10.2 mmol, 34.0% 
M. Pt.: 110.5- 112.0°C (Lit. M. Pt. 110- 112°C50) 
Elemental Analysis: Found,% C 65.38, %H 7.25, %N 5.83 
Calculated,% C 66.36, %H 7.28, %N 5.95 
JFTIR Mncroscopy: 3388(s), 3335(s), 1729(s), 1624(s), 1551(s). 
E.U: (m/z): 235(21), 191(190), 148(100), 120(67), 104(33), 90(65), 85(65), 71(75), 
65(38). 
1H NMR: 9.37(111, s, COOH), 7.25(5H, m, ArH), 6.05(111, d, J 7.4, NH), 4.87(1H, 
dt, J 7.4, 5.9, CH), 3.25(1H, dd, J 14.0, 5.5, Non equivalent CH2), 3.12(IH, dd, J 14.1, 
5.9, Non equivalent CH2), 2.36(111, septet, J 6.9, CH), 1.09(3H, d, J 6.9, CH3), 
1.07(3H, d, J 6.9, CH3). 
13C NMR: 177.7(C=O), 174.7(C=O), 135.7(Ar C), 129.5(Ar C), 128.6(Ar C), 
127.3(Ar C), 53.0(CH), 37.3(CH2), 35.5(CH), 19.5(CH3), 19.2(CHJ). 
X-ray Analysis: See appendix Ill 
5.3.5 Na(R)a2aChloropropanoyla(S)aphenylalanine, (R, S)50 
Thionyl chloride, (I .12 g, 9.43 mmol) was added dropwise to (R)-2-chloropropanoic 
acid, (0.93 g, 8.57 mmol) at room temperature. The reaction was heated under reflux 
for 60 min. 1H NMR showed that some starting material was still present so a further 
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aliquot (0.10g, 0.84 mmol) was added and the reaction was heated for a further 20 
min. After this time 1H NMR confirmed the absence of starting material and the 
reaction mixture was cooled to ambient temperature. 
The reaction mixture was added dropwise to a solution of (S)-phenylalanine (1.65g, 
10 mmol) in 4M NaOH (7.5 mL) while maintaining the temperature at 0°C. The 
reaction mixture was stirred at ambient temperature for a further 30 minutes after 
which time the pH was adjusted to 3 by the addition of concentrated HCI. The product 
was extracted into ethyl acetate, washed with water, dried over anhydrous sodium 
sulphate, filtered and evaporated in vacuo to afford the crude product as a colourless 
oil. 
Yield: 0.47g, 1.8 mmol, 21.0% 
1H NMR: 7.28(5H, m, ArH), 6.92(1H, d, J 7.2, NH), 4.85(1H, ddd, J 7.9, 6.2, 5.7, 
CH), 4.38(1H, q, J 7.1, CHCl), 3.24(1H, dd, J 14.0, 5.5, Non equivalent CH2), 
3.15(1H, dd, J 14.0, 6.3, Non equivalent CH2), 1.70(3H, d, J 6.9, CHJ). 
13C NMR: 174.87(C=O), 169.76(C=O), 135.17 (ArC), 129.36 (ArC), 128.87(Ar C), 
127.55 (ArC), 55.59(CH2-Cl), 53.37(CH), 37.31(CH2), 22.62(CHJ). 
5.3.6 N-(S)-2-Chloropropanoyi-(S)-phenylalanine, (S, S)50 
0 
~~H Clx 
Thionyl chloride, (1.12 g, 9.43 mmol) was added dropwise to (S)-2-chloropropanoic 
acid, (0.93 g, 8.57 mmol) at room temperature. The reaction was heated under reflux 
for 30 minutes. 1H NMR was used to confirm the absence of starting material and the 
reaction mixture was cooled to ambient temperature. 
The reaction mixture was added dropwise to a solution of (S)-phenylalanine (1.65g, 
10 mmol) in 4M NaOH (7.5 mL) while maintaining the temperature at 0°C. The 
reaction mixture was stirred at ambient temperature for a further 30 min after which 
time the pH was adjusted to 3 by the addition of concentrated HCI. The product was 
extracted into ethyl acetate, washed with water, dried over anhydrous sodium 
sulphate, filtered and evaporated in vacuo to afford the crude product as colourless oil. 
A white solid was obtained by trituration with hexane, which was recrystallised from 
hexane I chloroform to afford a crystalline solid suitable for X-ray analysis. 
Yield: 0.55g, 2.1 mmol, 24.6% 
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M. 1Pt.: 98 - 99°C (Lit. M. Pt. 88 - 89°C49) 
1FTIR Mkn-oscopy: 3374(s), 3322(s), 2980(s), 2800(br), 1743(s), 1663(s), 1558(s) 
]E.[ (m/z): 255(1), 219(6), 203(5), 176(6), 148(77), 120(28), 91(100), 65(26), 57(34). 
1H NMR: 7.28(5H, m, ArH), 6.92(1H, d, .! 7.4, NH), 4.87(1H, ddd,.! 7.8, 6.3, 5.7, 
CH), 4.36(1H, q, .! 7.2, CHCl), 3.26(1H, dd, .! 14.0, 5.7, Non equivalent CH2), 
3.13(1H, dd,.! 14.0, 6.3, Non equivalent CH2), 1.64(3H, d, .!7.2, CH3). 
13C NMR: 174.95(C=O), 169.64(C=O), 135.17 (ArC), 129.43 (ArC), 128.80(Ar C), 
127.52 (ArC), 55.41(CH2-Cl), 53.25(CH), 37.39(CH2), 22.62(CH3). 
X-ray Alllalysns: See appendix IV. 
(S)-2-Fluoropropionyl chloride, (S) 39, (0.20 g, 1.8 mmol) was added dropwise to a 
solution of aniline (0.34 g, 3.6 mmol) in diethyl ether (10 mL). The reaction was 
stirred for I 0 minutes, filtered and evaporated in vacuo to afford the crude product. 
The crude product was dissolved in chloroform (1 0 mL) and filtered to remove the 
aniline hydrochloride by product and evaporated in vacuo to produce an off white 
solid. This was recrystallised from chloroform I hexane to produce an off white 
crystalline product suitable for X-ray analysis. 
Yield: 0.05g, 0.3 mmol, 17.0%. 
M. Pt.: 58.6- 59.6°C. 
Elemental Analysis: Found,% C 64.27, %H 6.04, %N 8.32 
Calculated,% C 64.30, %H 5.95, %N 8.33 
1H NMR: 7.98(1H, s, NH), 7.1 - 7.6(5H, m, ArH), 5.11(1H, dq,.! 49.5, 6.9, CHF), 
1.67(3H, dd,.! 25.0, 6.9, CH3). 
13C NMR: 174.95(C=O), 129.20(Ar C), 125.02(Ar C), 120.03(Ar C), 89.00(d, .! 
184.8, CHF), 18.51(d, .!21.3, CH3). 
19F NMR -179.96(1F, ddq, J 49.6, 24.8, 6.7, CFH). 
X-ray Analysis: See appendix V. 
5.3.8 N-((S)m2aFiuoropropionyl)abenzylamine, 52 
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(S)-2-Fluoropropionyl chloride, (S) 39, (0.57 g, 5.2 mmol) was added dropwise to a 
solution ofbenzylamine (0.50 g, 4.7 mmol) in diethyl ether (10 m.L). The reaction was 
stirred for 10 min and quenched with water (5 m.L). The organic layer was separated, 
dried, filtered and evaporated in vacuo to afford the crude product. 19F NMR showed 
this to be a mixture of the desired product and 2-fluoropropanoic acid. Extraction of a 
chloroform solution with water removed the free acid. The chloroform solution was 
dried, filtered and evaporated in vacuo to afford a yellow solid. Recrystallisation from 
hexane gave the product as white needle like crystals. 
Yield: 0.18g, 1.0 mmol, 21.1%. 
1H NMR: 7.2- 7.5(5H, m, ArH), 6.60(1H, s, NH), 5.03(1H, dq, J 49.5, 6.9, CHF), 
4.48(2H, d, J 5.9, CH2), 1.60(3H, dd, J24.7, 6.7, CH3). 
ne NMR: 174.95(C=O), 137.0(Ar C), 128.89(Ar C), 127.87(Ar C), 127.82(Ar C), 
88.99(d, J 182.7, CHF), 43.09(CH2), 18.62(d, J21.3, CH3). 
19F NMR: -182.22(1F, ddq, J 49.4, 24.8, 4.5, CFH). 
5.3.9 2-Fiuoro-4-methylpentanoic acid, 55 
~OH 
0 
A 125 mL Teflon bottle, containing a magnetic follower, was charged with 
pyridinium hydrogen fluoride (100 m.L, 70% w/w) and (R, S)-leucine, (12.65 g, 96 
mmol) and the solution was cooled to 0°C. Sodium nitrite (22.60 g, 328 mmol) was 
added in five equal portions over 1 hour. The reaction mixture was stirred at ooc for 1 
hour and then warmed to room temperature and then stirred overnight. The reaction 
was quenched by addition to ice water (200 m.L), extracted into diethyl ether (3 x 100 
m.L), washed with sodium chloride solution (3 x 100 m.L, 5% w/v) and dried over 
anhydrous sodium sulphate, filtered, evaporated in vacuo to give the crude product. 
The crude product had high levels of water present and this was removed by 
azeotropic distillation with toluene under high vacuum to give a mixture ofthe desired 
product and anhydride as a yellow liquid. This was further purified by high vacuum 
distillation (84°C at 3 mbar) to afford the desired product as a colourless liquid. 
Yield: 4.64 g, 34.6 mmol, 36%. 
1H NMR: 5.00(1H, ddd, J 49.6, 9.3, 3.3, CFH), 1.6 - 2.0(3H, m, CH and CH2), 
0.98(6H, d, J 6.4, CH3). 
ne NMR: 175.52(d, J 23.8, C=O), 87.46(d, J 184.0, CHF), 40.92(d, J 20.4, CH2), 
24.58(CH), 23.07(CH3), 21.58(CH3). 
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1~ NMR: -191.37(ddd, J 49.9, 34.8, 18.0 CFH). 
5.3.1 0 2-Fiuoro-4-methylpentanoyl chloride, 56 
~Cl 
0 
Thionyl chloride (4.12 g, 34.6 mmol) was added to 2-fluoro-4-methylpentanoic acid, 
55 and the mixture was heated under reflux. The reaction was continued until the 
evolution of HCl gas had stopped. Atmospheric distillation produced a colourless 
liquid, which was found not to contain any desired product. Further distillation of the 
reaction mixture under reduced pressure ( ~ 100 mbar @ 45 - 58°C) produced the 
desired product as a yellow liquid. 
Yield: 1.50 g, 9.8 mmol, 28%. 
1H NMR: 5.05(1H, ddd, J 49.7, 9.1, 3.5, CFH), 1.6 - 2.0(3H, m, CH and CH2), 
0.98(6H, d, J 6.4, CH3). 
13C NMR: 175.52(d, J 23.8, C=O), 87.46(d, J 184.0, CHF), 40.92(d, J 20.4, CH2), 
24.58(CH), 23.07(CH3), 21.58(CH3). 
19F NMR: -177.23(ddd, J 49.8, 34.2, 18.0 CFH). 
5.3.11 N-(2-Fiuoro-4-methylpentanoyl)benzylamine, 53 
2-Fluoro-4-methylpentanoyl chloride, 56 (1.5 g, 9.8 mmol) was added dropwise to a 
mixture of ethyl acetate (10 mL), 4M sodium hydroxide (10mL) and benzylamine 
(1.05 g, 9.8 mmol).The reaction mixture was stirred for 30 minutes after which time 
the organic and aqueous layers were separated. The ethyl acetate solution was washed 
with sulphuric acid (5%, 10 mL), water (10 mL), dried, filtered and evaporated in 
vacuo to afford the crude product. Recrystallisation from hexane I diethyl ether (50 : 
50) gave the product as a white crystalline solid. 
Yield: 0.18 g, 0.8 mmol, 8%. 
M. Pt.: 73.5- 74.5°C. 
El (m/z): 223(15), 167(33), 118(25), 106(12), 91(100). 
1H NMR: 7.2 - 7.4(5H, m, ArH), 6.60(1H, s, NH), 4.96(1H, ddd, J 50.7, 9.1, 3.7, 
CFH), 4.48(2H, d, J 5.9), 1.6- 2.0(3H, m, CH and CH2), 0.96(6H, d, J 6.6, CH3). 
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ne NMR: 174.95(C=O), 137.67(Ar C), 132.63(Ar C), 128.87(Ar C), 127.79(Ar C), 
91.94(d, J 185.3, CHF), 43.09(CH2), 41.32(d, J 20.4, CH2), 24.73(CH), 23.24(CHJ), 
21.65(CH3). 
19F NMR: -188.90(m, CFH). 
5.3.12 2-Fiuoro-2-phenylacetic acid, 57 
F ulOH 
A 125 mL Tetlon bottle, containing a magnetic follower, was charged with 
pyridinium hydrogen fluoride (100 mL, 70% w/w) and (R, S)-phenylglycine, (14.52 g, 
96 mmol) and the solution was cooled to 0°C. Sodium nitrite (22.60 g, 328 mmol) was 
added in five equal portions over 1 hour. The reaction mixture was stirred at ooc for 1 
hour and then warmed to room temperature and then stirred overnight. The reaction 
was quenched by addition to ice water (200 mL), extracted into diethyl ether (3 x 100 
mL), washed with sodium chloride solution (3 x 100 mL, 5% w/v) and dried over 
anhydrous sodium sulphate, filtered, evaporated in vacuo to give the crude product. 
The crude product had high levels of water present and this was removed by 
azeotropic distillation with toluene under high vacuum to give a yellow solid. The 
solid was dried under vacuum at room temperature overnight to give the desired 
product. 
Yield: 13.00 g, 84.3 mmol, 88%. 
1B NMR: 11.0(1H, s, COOH), 7.3 -7.7(5H, m, ArH), 5.82(1H, d, J 47.5, CFH). 
ne NMR: 174.60(d, J 28.0, C=O), 133.34(d, 20.2, ArC), 130.05(Ar C), 129.03(Ar 
C), 126.77(Ar C), 88.84(d, J 186.8, CHF). 
19F NMR: -180.91(d, J 47.2, CFH). 
5.3.13 2-Fiuoro-2-phenylacetyl chloride, 58 ()\Cl 
A solution of 2-tluoro-2-phenylacetic acid, 54 (5.00 g, 32.4 mmol) in 
dichloromethane (50 mL) and dimethylformamide (1 mL) was prepared. To this 
oxalyl chloride (4.12 g, 32.4 mmol) was added slowly. During the addition vigorous 
evolution of HCl was seen. The reaction mixture was stirred for a further 60 min after 
which time HCl evolution had ceased. A further portion of oxalyl chloride (0.73 g, 5.7 
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mmol) and the reaction was stirred for a further 30 min. 19F NMR confirmed the 
absence of starting material an the reaction was stopped and the product was held for 
use in the amide synthesis. 
Yield: 7.60 g (mixture of desired product and oxalyl chloride). 
1H NMR: 7.3 -7.7(5H, m, ArH), 5.90(1H, d, J 47.7, CFH). 
13C NMR: 164.51(C=O), 136.8(Ar C), 130.80(Ar C), 129.31(Ar C), 127.54(Ar C), 
94.17(d, J 197.8, CHF). 
19F NMR: -163.96(d, J 47.8, CFH). 
5.3.14 N-(2-Fiuoro-2-phenylacetyl)benzylamine, 54 
2-Fluoro-2-phenylacetyl chloride, 55 (7.60 g, mixed with excess oxalyl chloride, 
assume 32.4 mmol) was added dropwise to a mixture of ethyl acetate (50 mL), 4M 
sodium hydroxide (50mL) and benzylamine (3.47 g, 32.4 mmol).The reaction mixture 
was stirred for 30 minutes after which time the organic and aqueous layers were 
separated. The ethyl acetate solution was washed with sulphuric acid (5%, 50 mL), 
water (50 mL), dried, filtered and evaporated in vacuo to afford the crude product. 
The crude product was recrystallised from hexane I diethyl ether (50 : 50) to obtain a 
pale yellow crystalline solid. 
Yield: 6.66 g, 27.4 mmol, 80%. 
M. Pt.: 96.5- 98.7°C. 
El (m/z): 243(20), 223(33), 118(8), 109(90), 91(100),. 
1H NMR: 7.2 - 7.6(10H, m, ArH), 6.80(1H, s, NH), 5.82(1H, d, J 48.2, CFH), 
4.52(2H, d, J 6.2). 
13C NMR: 199.00(C=O), 130.50(Ar C), 128.92(Ar C), 128.80(Ar C), 127.95(Ar C), 
91.97(d, J 187.9, CHF), 43.29(CH2). 
19F NMR: -177.73(dd, J 48.3, 3.9, CFH). 
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5.4 Experimental for Chapter 4 
5.4.1 (RS)-4-Benzyl-4-fluoro-2-phenyl-5-oxazolone, 27 
N 0 o>-0 
Sodium hydride was washed with heptane, the supematant decanted and blown dry 
with nitrogen several times to generated the active sodium hydride powder. A slurry 
of sodium hydride (0.12 g, 5 mmol) in THF (25 mL) was prepared and cooled to ooc. 
To this a solution of (RS)-4-benzyl-2-phenyl-5( 4H)-oxazolone, 26 (1.25 g, 5 mmol) in 
THF (25 mL) was added dropwise. The reaction mixture was stirred at 0°C for 30 
minutes and then at ambient temperature for a further 60 min, after which time a 
yellow solution was evident. To this solution DMF (10 mL) was added, followed by 
Selectfluor (I. 77 g, 5 mmol). The reaction mixture was stirred for 30 min, after which 
time 19F NMR indicated the presence of the desired product. The reaction mixture was 
poured into a mixture of diethyl ether (100 mL) and water (100 mL). The organic 
layer was washed with a further portion of water (100 mL) and the pH ofthe aqueous 
extract was 6.0. The organic layer was dried, filtered and evaporated in vacuo to 
afford the crude product as an unstable yellow oil. 
Yield: 1.18 g, 4.4 mmol, 88%. 
1H NMR: 7.1 - 8.0(10H, m, ArH), 3.55(1H, dd, J 13.1, 8.9, Non equivalent CH2), 
3.42(1H, dd, J 13.2, 11.3, Non equivalent CH2). 
19F NMR: -127.84(dd, J 11.3, 9.2, CF). 
5.4.2 (S)-Aianine methylester, 28 
~H2 
~0" 
0 
To a solution of (S)-alanine methylester hydrochloride (5g, 36 mmol) in DMF (150 
mL) add triethylamine (3.64 g, 5 mL, 36 mmol). The reaction mixture was stirred for 
10 minutes and a white precipitate was formed. The white solid (triethylammonium 
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chloride) was removed by filtration to give the desired product as a 0.24 M solution in 
DMF. 
5.4.3 N-2,6-Difluorobenzoyi-(S)-phenylalanine, 67 
,,H 
. 0 
F HN OCOOH 
To a solution of (S)-phenylalanine (28.1 g, 170 mmol) in 4M NaOH (170 mL) cooled 
to 0°C 2,6-ditluorobenzoyl chloride (31.5 g, 178 mmol) was added dropwise. The 
reaction mixture was warmed to ambient and stirred for a further 30 minutes. HCI was 
added to the reaction until a pH of3.0 had been attained and the product was extracted 
into ethyl acetate (200 mL) and washed with water (200 mL). The organic layer was 
dried, filtered and evaporated in vacuo to afford the crude product as colourless oil, 
which was triturated with pentane to produce a white solid. The product was further 
dried at 40°C under vacuum. 
Yield: 48.15 g, 157.7 mmol, 93%. 
1H NMR: 6.8- 7.6(8H, m, ArH), 6.50(1H, d, J 7.7, NH), 5.13(1H, ddd, J 7.7, 5.7, 
5.6, CH), 3.37(1H, dd, J 14.0, 5.6, Non equivalent CH2), 3.24(1H, dd, J 14.0, 5.7, Non 
equivalent CH2). 
19F NMR: -111.40(dd, J 5.9, 5.9, CF). 
5.4.4 Preparation of (S)-4-benzyl-2-(2,6-difluorophenyi)-5(4H)-
oxazolone, 68 
N-2,6-Ditluorobenzoyl-(S)-phenylalanine, 67 (10 g, 33 mmol), acetic anhydride (50 
mL) and 1,4-dioxan (50 mL) were stirred and the reaction was heated under reflux for 
60 min. TLC confirmed the absence of the starting material. The solvents were 
removed initially by high vacuum distillation and the final traces were removed by 
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azeotropic high vacuum distillation with toluene to give a pale yellow oil as the crude 
product. The desired product was obtained by chromatographic purification on silica 
gel using ethyl acetate (10%) I hexane (90%) as the mobile phase. The fractions 
containing the desired product were selected by TLC and after combination and 
removal of solvent in vacuo the product was recovered as colourless oil. 
Yield: 7.57 g, 26.4 mmol, 80%. 
1H NMR: 6.8- 7.6(8H, m, ArH), 4.72(1H, dd, J 6.2, 4.9 CH), 3.41(1H, dd, J 14.0, 
4.9, Non equivalent CH2), 3.24(1H, dd, J 14.0, 6.2, Non equivalent CH2). 
19F NMR: -107.75(dd, J 8.0, 5.9, CF). 
5.4.5 3,5~Dibenzyl~1 ~(2,6~difluorobenzoyl)~3~(2,6adifluorobenzoyl~ 
amino)pyrrolidine~2,4-dione, 70 
Sodium hydride was washed with heptane and the supernatant decanted and blown 
dry with nitrogen several times to generated the active sodium hydride powder. A 
slurry of sodium hydride (0.63 g, 26.4 mmol) in THF (100 mL) was prepared and 
cooled to 0°C. To this a solution of (S)-4-benzyl-2-(2,6-difluorophenyl)-5(4H)-
oxazolone, 61 (7.57 g, 26.4 mmol) in THF (100 mL) was added dropwise. The 
reaction mixture was stirred at 0°C for 30 minutes and then at ambient temperature for 
a further 50 minutes, after which time a yellow slurry was evident. The reaction 
mixture was poured into diethyl ether (300 mL) and water (300 mL) and separated. 
The organic layer was washed with water, dried, filtered and evaporated in vacuo to 
afford the crude product as a white solid. The crude product was recrystallised from 
ethyl acetate I hexane (20:80) to give the product as a white crystalline solid, which 
was suitable for X-ray structure analysis. 
Yield: 1.29 g, 2.2 mmol, 9 %. 
M. Pt.: 212.0- 213.0°C. 
El (mlz): 574(15), 399(23), 301(37), 287(88), 273(66), 256(59), 174(56), 157(100), 
105(73). 
1H NMR: 6.8- 7.5(16H, m, ArH), 6.73(1H, t, J 3.5, NH), 5.37(1H, dd, J 5.7, 3.5, 
CH), 3.44(1H, dd, J 14.2, 5.8, Non equivalent CH2), 3.?.9(1H, dd, J 14.2, 3.6, Non 
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equivalent CH2), 2.28(1H, d, J 14.1, Non equivalent CH2), 2.00(1H, d, J 14.1, Non 
equivalent CH2). 
13C NMR: 202.97(C=O), 170.94(C=O), 161.11(dd, J 257.2, 5.3, CF), 160.84(C=O), 
160.25(C=O), 159.70(dd, J253.6, 6.8, CF), 135.65(Ar Cquat), 133.56(t, J 11.4, ArCH), 
132.36(t, J, 9.9, ArCH), 131.62(Ar Cquat), 130.76(ArCH), 130.46(ArCH), 
129.11(ArCH), 128. 77(ArCH), 128.46(ArCH), 127.69(ArCH), 112.54(dd, J, 23.4, 
3.1, ArCH), 111.8(m, ArCH) 67.04(CH), 62.22(Cquat), 36.06(CH2), 34.10(CH2). 
19F NMR: -109.07(2F, ddd, J 10.2, 6.0, 3.5, CFH), -112.2(2F, br s, CFH). 
X-ray Analysis: See appendix VI. 
5.4.6 N-(2-Fiuoropropionyi)-N-methyl aniline 75 
2-Fluoropropionyl chloride (4.00 g, 36.2 mmol) was added dropwise to a solution of 
N-methyl aniline (4.63 g, 43.2 mmol) in ethyl acetate (20 mL) and 4M NaOH (20 
mL). The reaction was stirred for 30 min and the two layers were separated. The 
organic layer was washed with 5% sulphuric acid, followed by water, dried, filtered 
and evaporated in vacuo to afford the crude product as a yellow oil. 
Yield: 3.00 g, 16.6 mmol, 46 %. 
1H NMR: 7.2- 7.5(5H, m, ArH), 4.93(1H, dq, J 48.4, 6.4, CFH), 3.31(3H, s, CH3), 
1.39(3H, dd, J24.5, 6.4, CH3). 
13C NMR: 130.04(ArCH), 128.45(ArCH), 127.36(ArCH), 84.50(d, J 252, CFH), 
18.19(d, J 87.4, CH3), 14.27(CH3). 
19F NMR: -178.80(dq, J 48.4, 24.2, CHF). 
5.4. 7 N-(1-Chloro-2-fluoropropenyi)-N-methyl aniline 76 
To a solution of N-(2-fluoropropionyl)-N-methyl aniline 75 (1.00 g, 5.52 mmol) in 
DCM (10 mL) cooled to -70°C was added oxalyl chloride (0.77 g, 6.07 mmol). The 
reaction was warmed to ambient temperature and stirred for 60 min, after which time 
it was again cooled to -70°C and triethylamine (0.61 g, 6.07 mmol) was added. The 
reaction mixture was warmed to ambient temperature over 10 minutes and stirred 
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overnight. TLC analysis (ethyl acetate I hexane 50:50) determined that the starting 
material was a minor component and the reaction was stopped. The crude mixture was 
purified using column chromatography with ethyl acetate I hexane (50:50) as the 
eluent, which afforded the product as a red I orange oil. 
Yield: 0.21 g, 1.1 mmol, 19%. 
1H NMR: 6.8 -7.4(5H, m, ArH), 3.06(3H, d, J 1.0, CH3), 2.02(3H, d, J 15.8 CH3). 
19F NMR: -102.16(q, J 15.8, CF). 
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Appendix I 
Raw data from acylase kinetic studies 
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Reaction of (S, R) 36 with AMA (Run 1) 
Substrate Reaction time % conversion Initial rate Rsquared 
concentration (s) (mmol min-1) 
(mM) 
60 7.2 
463 10.7 
10 807 12.8 0.038 0.991 
1383 15.6 
2087 20.1 
60 3.73 
20 518 6.99 0.066 0.968 
898 8.35 
60 3.18 
30 482 5.89 0.078 0.946 
1047 7.47 
60 3.16 
40 435 4.73 0.104 0.999 
761 6.19 
60 3.79 
52.3 443 5.03 0.097 0.999 
817 6.12 
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Reaction of (S, R) 36 with AMA (Run 2) 
Substrate Reaction time (s) % conversion Initial rate (mmol 
concentration min-1) 
(mM) 
4.9 2220 16.9 0.022 
9.8 1860 12.8 0.040 
14.6 1800 10.7 0.052 
19.5 2160 11.2 0.061 
24.4 2340 12.0 0.077 
29.3 1800 10.4 0.102 
34.2 2280 11.4 0.105 
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Reactioll'il of (S, S} 36 with AMA (RlUin il} 
Substrate Reaction time (s) % conversion Initial rate (mmol 
concentration min-1) 
(mM) 
8.1 109 8.05 0.36 
15.3 98 5.26 0.49 
22.5 103 4.51 0.59 
30.6 108 4.14 0.70 
Reaction of (S, S) 36 with AMA (Run 2) 
Substrate Reaction time (s) % conversion Initial rate (mmol 
concentration min-1) 
(mM) 
8.36 470 26.5 0.25 
16.72 295 13.3 0.40 
25.08 298 10.9 0.49 
33.44 279 7.3 0.46 
41.80 340 8.5 0.55 
50.16 304 6.1 0.54 
58.52 300 7.8 0.81 
66.88 300 6.1 0.82 
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Reaction of 42 with AMA 
Substrate Reaction time (s) % conversion Initial rate (mmol 
concentration min-1) 
(mM) 
10.0 102 7.52 0.42 
20.0 138 7.84 0.68 
30.0 174 9.06 0.94 
40.0 198 8.94 1.08 
Reaction of 45 with AMA 
Substrate Reaction time (s) % conversion Initial rate (mmol 
concentration min-1) 
(mM) 
10.0 660 17.6 0.16 
20.0 1200 18.8 0.19 
30.0 1080 13.6 0.23 
40.0 1140 12.8 0.27 
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Reaction of 49 with AMA 
Substrate Reaction time % conversion Initial rate (J.lmol 
concentration (min) min-1) 
(mM) 
10.0 2220 2.96 0.134 
20.0 2212 2.24 0.203 
30.0 2706 2.01 0.222 
40.0 2700 1.73 0.257 
Reaction of (S, S)50 with AMA 
Substrate Reaction time % conversion Initial rate (~J.mol 
concentration (min) min-1) 
(mM) 
9.4 230 6.32 2.58 
18.8 252 3.99 2.98 
28.2 272 2.69 3.62 
37.5 290 3.27 4.23 
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Reaction of ( S, S)SO with AMA 
Substrate Reaction time % conversion Initial rate (J.Lmol 
concentration (min) min-1) 
(mM) 
4.7 1390 5.94 0.20 
9.4 1322 5.99 0.43 
14.1 1350 3.31 0.35 
18.8 1378 3.95 0.54 
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N-Fiuoroacetyi-(S)-phenylalanine 45 
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Table 1. Crystal data and structure refmement for N-fluoroacetyl-(S)-phenylalanine 45. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
8 range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Reflections with I>2cr(l) 
Absorption correction 
Refmement method 
Data I restraints I parameters 
Largest fmal shift/e.s.d. ratio 
Goodness-of-fit on F2 
Final R indices [I>2cr(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
Cll Hl2FN03 
225.22 
120(2) K 
0.71073 A 
Orthorhombic 
P21212 (No. ) 
a= 9.3659(6) A 
b = 16.0026(10)A 
c = 7 .5982(4) A 
1138.81(12)A3 
4 
1.314 g/cm3 
0.106mm·1 
472 
0.40 x 0.34 x 0.34 mm3 
2.52 to 27.48°. 
-12:::; h::; 12,-18:::; k::; 20,-8:::; /:::; 9 
8013 
2597 [R(int) = 0.0248] 
2497 
None 
Full-matrix least-squares on F2 
2596/57/192 
-0.001 
1.097 
RI =0.03I7,wR2=0.0784 
RI = 0.0335, wR2 = 0.0803 
0.96(69) 
O.I87 and -0.242 e.A-3 
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Table 2. Atomic coordinates ( x 1 04) and equivalent isotropic displacement parameters (A 2 x 1 04) 
for N-fluoroacetyl-(S)-phenylalanine 45. U(eq) is defmed as one third of the trace of the orthogonalized 
Uij tensor. 
X y z U(eq) 
0(1) 6537(1) 2543(1) 6807(1) 273(2) 
0(2) 4471(1) 1904(1) 6118(1) 274(2) 
0(3) 6115(1) 2240(1) 167(1) 288(2) 
F 3021(1) 1067(1) 1171(1) 384(2) 
N(l) 4867(1) 2085(1) 2693(1) 196(2) 
C(l) 5547(1) 2276(1) 5699(2) 202(2) 
C(2) 5905(1) 2509(1) 3811(2) 176(2) 
C(3) 5925(1) 3467(1) 3556(2) 236(3) 
C(4) 5063(1) 1969(1) 979(2) 202(2) 
C(5) 3911(1) 1494(1) 8(2) 264(3) 
C(l1A) 4575(4) 3883(4) 4240(5) 249(9) 
C(l2A) 4304(4) 4057(2) 6017(5) 314(6) 
C(l3A) 3051(4) 4462(2) 6545(6) 442(7) 
C(14A) 2028(4) 4707(2) 5324(7) 504(9) 
C(l5A) 2268(4) 4527(3) 3542(8) 487(8) 
C(16A) 3498(4) 4129(2) 3024(5) 336(6) 
C(11B) 4483(4) 3900(4) 3641(5) 249(9) 
C(12B) 3939(4) 4103(2) 5244(5) 314(6) 
C(l3B) 2611(4) 4523(2) 5349(6) 442(7) 
C(l4B) 1924(4) 4713(2) 3808(8) 504(9) 
C(l5B) 2469(4) 4524(2) 2194(6) 487(8) 
C(16B) 3770(4) 4113(2) 2099(5) 336(6) 
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Table3. Bond lengths [A] and angles [0 ] forN-fluoroacetyl-(S)-phenylalanine 45. 
0(1)-H(OJ) 0.91(2) C(4)-C(5) 1.513(2) 
0(1 )-C(l) 1.3233(14) C(llA)-C(J2A) 1.402(5) 
0(2)-C(1) 1.2127(15) C(1 JA)-C(l6A) 1.423(4) 
0(2)-H(IN) 2.29(2) C(I2A)-C(J3A) 1.400(5) 
0(3)-C(4) 1.240 I (I 5) C(J3A)-C(l4A) I .390(6) 
F-C(5) 1.3934(15) C(I4A)-C(15A) 1.403(8) 
F-H(IN) 2.27(2) C(l5A)-C(16A) 1.374(5) 
N(l)-H(IN) 0.81(2) C(llB)-C(J2B) 1.359(5) 
N(J )-C(4) 1.328(2) C(11B)-C(l6B) 1.391 (5) 
N(l)-C(2) 1.4584(15) C(l2B)-C(l3B) 1.416(5) 
C(l )-C(2) 1.520(2) C(l3B)-C(J 4B) 1.371(8) 
C(2)-C(3) 1.545(2) C(l4B)-C(l5B) 1.363(7) 
C(3)-C(l!B) 1.520(2) C(15B)-C(J 6B) 1.386(5) 
C(3)-C(11A) 1.521 (2) 
H(O 1 )-0(1 )-C( I) 107.8(14) C(16A)-C(IIA)-C(3) 119.3(3) 
C(1 )-0(2)-H(l N) 81.4(5) C(13A)-C(J2A)-C(11A) 121.4(3) 
C(5)-F-H(IN) 81.4(5) C(l4A)-C(l3A)-C(l2A) 121.1(4) 
H(1N)-N(l)-C(4) I 18.3(12) C(l3A)-C(l4A)-C(l5A) 118.4(4) 
H(IN)-N(l)-C(2) 118.8(12) C(16A)-C(l5A)-C(l4A) 120.4(4) 
C(4 )-N(l )-C(2) 122.91(10) C(15A)-C(l6A)-C(11A) 122.5(4) 
0(2)-C(l)-0(1) 125.00(1 I) C(12B)-C(l!B)-C(16B) 121.1(2) 
0(2 )-C(l )-C(2) 123.46(10) C(12B)-C(l!B)-C(3) 118.7(3) 
O(l)-C(1)-C(2) 111.53(10) C(l6B)-C(J IB)-C(3) 120.1 (3) 
N(1 )-C(2)-C(l) 106.77(9) C(l!B)-C(l2B)-C(J3B) 119.5(3) 
N (1 )-C(2 )-C(3) 113.35(10) C(14B)-C(13B)-C(J2B) 118.0(4) 
C(l)-C(2)-C(3) 11 1.36(10) C(15B)-C(14B)-C(l3B) 122.9(3) 
C(11B)-C(3)-C(2) I 15.9(3) C(l4B)-C(J 5B)-C(l6B) 118.8(4) 
C(11A)-C(3)-C(2) 112.4(3) C(15B)-C(l6B)-C(l 1B) 119.6(4) 
0(3 )-C( 4 )-N(l) 123.31(11) 
0(3)-C(4)-C(5) 119.96(11) 
N(J)-C(4)-C(5) 116.72(11) 
F-C(5)-C(4) 111.33(10) 
C(12A)-C(11A)-C(l6A) 116.2(2) 
C(l2A)-C(l1A)-C(3) 124.5(3) 
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Table 4. Anisotropic displacement parameters (A 2 x 1 04) for N-fluoroacety1-(S)-phenylalanine 45. The 
anisotropic displacement factor exponent takes the form: -21t2[ h2 a*ZU 11 + ... + 2 h k a* b* U 12 ] 
Un U22 u33 u23 ul3 U1z 
0(1) 224(4) 445(6) 150(4) 16(4) -23(3) -75(4) 
0(2) 216(4) 430(5) 175(4) 37(4) 8(3) -68(4) 
0(3) 223(4) 488(6) 153(4) -21(4) 9(3) -82(4) 
F 413(5) 469(5) 271(4) -39(4) 57(4) -228(4) 
N(1) 180(5) 248(5) 160(5) -4(4) 14(4) -23(4) 
C(l) 178(5) 272(6) 157(5) -4(4) I (4) 6(4) 
C(2) 155(5) 232(5) 142(5) -7(4) 6(4) -4(4) 
C(3) 212(6) 243(6) 253(6) 8(5) 4(5) -31 (5) 
C(4) 180(5) 248(5) 177(5) 2(4) -16(4) 18(4) 
C(5) 244(6) 353(7) 193(6) -31(5) 14(5) -65(5) 
C(11A) 201(7) 177(6) 370(30) 0(20) -99(14) -21(6) 
C(l2A) 320(20) 243(8) 380(20) -33(14) 69(12) 11 (I 0) 
C(13A) 390(20) 261(10) 680(20) -71(14) 180(14) 16(10) 
C(14A) 233(12) 241(11) 1040(20) -50(20) 100(20) 30(9) 
C(15A) 301(13) 307(12) 850(20) 30(20) -90(20) 34(10) 
C(16A) 337(13) 258(8) 410(20) 54(13) -89(13) -30(8) 
C(IIB) 201 (7) 177(6) 370(30) 0(20) -99(14) -21(6) 
C(12B) 320(20) 243(8) 380(20) -33(14) 69(12) 11 (I 0) 
C(13B) 390(20) 261(10) 680(20) -71(14) 180(14) 16(10) 
C(14B) 233(12) 241(11) 1040(20) -50(20) 100(20) 30(9) 
C(15B) 301(13) 307(12) 850(20) 30(20) -90(20) 34(10) 
C(16B) 337(13) 258(8) 410(20) 54(13) -89(13) -30(8) 
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Table 5. Hydrogen coordinates ( x103) and isotropic displacement parameters (A2 x10 3) forN-
fluoroacetyl-(S)-phenyla1anine 45. 
X y z U(iso) 
H(01) 630(2) 236(1) 791(3) 61 (6) 
H(IN) 415(2) 190(1) 314(2) 29(4) 
H(2) 689(2) 230(1) 357(2) 17(3) 
H(31) 621(2) 356(1) 231 (3) 33(4) 
H(32) 664(2) 369(1) 428(2) 29(4) 
H(51) 334(2) 192(1) -65(2) 37(5) 
H(52) 437(2) 110(1) -80(3) 37(4) 
H(l2A) 498(1) 390(1) 688(1) 38 
H(l3A) 290(1) 457(1) 776(1) 53 
H(14A) 119(1) 499(1) 569(1) 60 
H(15A) 158(1) 468(1) 269(1) 58 
H(l6A) 364(1) 401(1) 181(1) 40 
H(l2B) 445(1) 396(1) 629(1) 38 
H(l3B) 221(1) 467(1) 645(1) 53 
H(14B) 1 03(1) 499(1) 387(1) 60 
H(ISB) 197(1) 467(1) 115(1) 58 
H(16B) 417(1) 398(1) 99(1) 40 
Table 6. Hydrogen bonds for N-fluoroacetyl-(S)-phenylalanine 45 [A and 0 ]. 
D-H. .. A d(D-H) d(H ... A) d(D .. .A) <(DHA) 
0(1 )-H(01) ... 0(3)#1 0.91(2) 1.74(2) 2.628(1) 165(2) 
Symmetry transformations used to generate equivalent atoms: # 1 x,y ,z+ 1 
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Appendix Ill 
0(38) 
N(18) 
C(158) 
N-(2-Methylpropionyi)-(S)-phenylalanine, 49 
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C(148) 
Table 1. Crystal data and structure refmement for N-(2-methylpropionyl)-(S)-phenylalanine, 49. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
8 range for data collection 
Index ranges 
Ref1ections collected 
Independent reflections 
Reflections with 1>2cr(I) 
Absorption com:ction 
Max. and min. transmission 
Refmement method 
Data I restraints I parameters 
Largest final shiftle.s.d. ratio 
Goodness-of-fit on F2 
Final R indices [1>2cr(l)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
Cl3 Hl7 N 03 
235.28 
150(2) K 
1.54178 A 
Tetragonal 
P43212 (No. 96) 
a= 12.7734(14)A 
b = 12.7734(14)A 
c = 32.356(3) A 
5279.2(9) A3 
16 
1.184 glcm3 
0.686mm-1 
2016 
0.40 x 0.36 x 0.12 mm3 
3.72 to 75.0°. 
-6 ::::; h ::::; 16, -6 :S k::::; 16, -17 :S I::::; 40 
4952 
4091 [R(int) = 0.0213] 
3477 
None 
1.0000 and 0.8594 
Full-matrix least-squares on F2 
409010 I 444 
-0.031 
1.079 
Rl = 0.0442, wR2 = 0.1018 
Rl = 0.0562, wR2 = 0.1093 
-0.16(26) 
0.00074(10) 
0.182 and -0.145 e.A-3 
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Table 2. Atomic coordinates (xI 04) and equivalent isotropic displacement parameters (A 2 xI 04) 
for N-(2-methylpropionyl)-(S)-phenylalanine, 49. U(eq) is defmed as one third of the trace of the 
orthogonalized Uij tensor. 
X y z U(eq) 
O(IA) 3614(2) 5635(2) 712(1) 387(5) 
0(2A) 2278(2) 5787(2) 1154(1) 379(5) 
0(3A) 3328(2) 2440(2) 1534(1) 435(5) 
N(IA) 2252(2) 3705(2) 1316(1) 308(5) 
C(IA) 2912(2) 5258(2) 973(1) 303(6) 
C(2A) 3023(2) 4089(2) 1023(1) 299(6) 
C(3A) 3009(2) 3485(2) 608(1) 332(6) 
C(4A) 2457(2) 2873(2) 1549(1) 321(6) 
C(5A) 1594(2) 2478(3) 1830(1) 418(7) 
C(6A) 2049(4) 2138(5) 2243(1) 757(14) 
C(7A) 1021(4) 1582(4) 1610(2) 750(12) 
C(l1A) 1977(2) 3532(2) 379(1) 316(6) 
C(12A) 1215(3) 2776(3) 444(1) 497(8) 
C(l3A) 267(3) 2816(3) 235(1) 582(10) 
C(14A) 80(3) 3583(3) -49(1) 444(7) 
C(l5A) 831(3) 4341(3) -120(1) 441(7) 
C(16A) 1769(2) 4315(2) 95(1) 364(6) 
0(18) 3654(2) 459(2) 1623(1) 492(6) 
0(28) 5022(1) 679(1) 1200(1) 375(5) 
0(38) 3913(2) -2376(2) 773(1) 381(5) 
N(l8) 5180(2) -1433(2) 1078(1) 290(5) 
C(18) 4439(2) 124(2) 1395(1) 324(6) 
C(28) 4527(2) -1061(2) 1410(1) 317(6) 
C(38) 4963(3) -1413(2) 1833(1) 420(7) 
C(48) 4846(2) -2098(2) 791(1) 301(6) 
C(58) 5657(2) -2504(3) 491(1) 441(7) 
C(68) 6301(4) -3362(3) 689(2) 771(15) 
C(78) 6323(3) -1628(3) 321(1) 636(11) 
C(ll8) 5096(2) -2585(2) 1860(1) 393(7) 
C(l28) 6067(3) -3059(3) 1834(1) 569(10) 
C(l38) 6162(4) -4138(3) 1850(1) 766(13) 
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C(l4B) 
C(l5B) 
C(16B) 
5300(4) 
4316(3) 
4226(3) 
-4758(3) 
-4305(3) 
-3230(3) 
1890(1) 
1917(1) 
1897(1) 
685(11) 
576(9) 
467(8) 
Table 3. Bond lengths [A] and angles [0 ] for N-(2-methylpropionyl)-(S)-phenylalanine, 49. 
O(lA)-H(OA) 0.87(4) 
O(lA)-C(lA) 1.323(3) 
0(2A)-C( 1 A) 1.206(3) 
0(3A)-C(4A) 1.243(3) 
N(lA)-H(1A) 0.80(3) 
N(IA)-C(4A) 1.330(3) 
N(lA)-C(2A) 1.452(3) 
C(1 A)-C(2A) 1.509(4) 
C(2A)-C(3A) 1.549(4) 
C(3A)-C(11A) 1.512(4) 
C(4A)-C(5A) 1.516(4) 
C(5A)-C(6A) 1.518(5) 
C(5A)-C(7 A) 1.535(6) 
C(11A)-C(16A) 1.384(4) 
C(llA)-C(l2A) 1.387(4) 
C(12A)-C(13A) 1.389(5) 
C(l3A)-C(14A) 1.363(5) 
C(14A)-C(15A) 1.383(4) 
C(15A)-C(16A) 1.385(4) 
0(1 B)-H(OB) 0.94(4) 
0(1 B)-C(l B) 1.317(3) 
0(2B)-C(l B) 1.207(3) 
0(3B)-C(4B) 1.246(3) 
N (1 B)-H( 1 B) 0.89(4) 
N(lB)-C(4B) 1.327(3) 
N (1 B)-C(2B) 1.442(3) 
C(l B)-C(2B) 1.518(4) 
C(2B)-C(3B) 1.543(4) 
C(3B)-C(11B) 1.510(4) 
C(4B)-C(5B) 1.512(4) 
C(5B)-C(7B) 1.510(5) 
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C(5B)-C(6B) 1.513(5) 
C(11B)-C(12B) 1.382(5) 
C(l1B)-C(l6B) 1.388(4) 
C(l2B)-C(l3B) 1.385(6) 
C(l3B)-C(14B) 1.362(6) 
C(14B)-C(15B) 1.386(6) 
C(15B)-C(16B) 1.379(5) 
H(OA)-0(1A)-C( 1 A) 112.9(22) 
H(1A)-N(IA)-C(4A) 121.2(22) 
H(1 A)-N(1A)-C(2A) 118.3(22) 
C(4A)-N(1A)-C(2A) 120.5(2) 
0(2A)-C(1A)-0(1A) 124.1 (3) 
0(2A)-C(l A)-C(2A) 124.4(2) 
0(1 A)-C(l A)-C(2A) 111.4(2) 
N (1 A)-C(2A)-C( 1 A) 109.9(2) 
N(l A)-C(2A)-C(3A) 112.9(2) 
C(l A)-C(2A)-C(3A) 113.5(2) 
C(IIA)-C(3A)-C(2A) 114.5(2) 
0(3A)-C(4A)-N(1A) 120.5(2) 
0(3A)-C( 4A)-C(5A) 121.8(2) 
N(l A)-C( 4A)-C(5A) 117.7(2) 
C(4A)-C(5A)-C(6A) 110.1(3) 
C(4A)-C(5A)-C(7 A) 108.4(3) 
C(6A)-C(5A)-C(7 A) 112.2(4) 
C(16A)-C(11A)-C(12A) 117.9(3) 
C(16A)-C(11A)-C(3A) 121.4(2) 
C(12A)-C(11A)-C(3A) 120.7(3) 
C(l1A)-C(12A)-C(13A) 120.9(3) 
C(14A)-C(13A)-C(12A) 120.5(3) 
C(l3A)-C(14A)-C(15A) 119.5(3) 
C(l4A)-C( 15A)-C( 16A) 120.0(3) 
C(l5A)-C(l6A)-C(11A) 121.1(3) 
H(OB)-O(IB)-C(IB) 109.6(24) 
H(IB)-N(IB)-C(4B) 121.9(22) 
H(l B)-N(l B)-C(2B) 114.7(22) 
C(4B)-N(l B)-C(2B) 123 .2(2) 
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0(2B)-C(IB)-0(1B) 124.9(2) 
0(2B)-C(l B)-C(2B) 123.9(2) 
0(1 B)-C(l B)-C(2B) 111.3(2) 
N(l B)-C(2B)-C(IB) 110.3(2) 
N(l B)-C(2B)-C(3B) 110.9(2) 
C(1 B)-C(2B)-C(3B) 110.3(2) 
C(l1B)-C(3B)-C(2B) 112.4(2) 
0(3B)-C(4B)-N(lB) 121.5(2) 
0(3 B)-C( 4 B)-C(5B) 121.8(2) 
N(l B)-C(4B)-C(5B) 116.6(2) 
C(7B)-C(5B)-C( 4B) 111.5(3) 
C(7B)-C(5B)-C(6B) 112.7(3) 
C(4B)-C(5B)-C(6B) 110.4(3) 
C(12B)-C(11B)-C(16B) 117 .6(3) 
C(l2B)-C(11B)-C(3B) 122.1(3) 
C(l6B)-C(11B)-C(3B) 120.2(3) 
C(l1B)-C(12B)-C(l3B) 120.8(4) 
C(l4B)-C(l3B)-C( 12B) 120.8(4) 
C(l3B)-C(14B)-C(15B) 119.7(4) 
C(16B)-C(l5B)-C(14B) 119.2(4) 
C(l5B)-C(l6B)-C(11B) 121.9(4) 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (A 2 x 1 03) for N -(2-methylpropionyl)-(S)-phenylalanine, 
49. The anisotropic displacement factor exponent takes the form: -2n2[ h2 a*2U 11 + ... + 2 h k a* b* U 12 ] 
Un Dzz u33 Uz3 ul3 u12 
O(IA) 41(1) 30(1) 46(1) -6(1) 11 (1) -6(1) 
0(2A) 30(1) 34(1) 51 (1) -6(1) 5(1) 1(1) 
0(3A) 30(1) 42(1) 59(1) 9(1) 8(1) 13(1) 
N(lA) 23(1) 33(1) 36(1) 2(1) 2(1) 5(1) 
C(IA) 25(1) 34(1) 32(1) -8(1) -3(1) -1 (1) 
C(2A) 22(1) 32(2) 35(1) -2(1) 1 (1) I (1) 
C(3A) 35(2) 27(2) 37(1) -5(1) 7(1) 3(1) 
C(4A) 26(1) 35(2) 35(1) -4(1) 2(1) 3(1) 
C(SA) 31 (2) 49(2) 46(2) 9(1) 5(1) 13(2) 
C(6A) 56(2) 125(4) 47(2) 30(3) 14(2) 19(3) 
C(7A) 51 (2) 79(3) 95(3) 4(3) 17(2) -22(2) 
C(llA) 36(2) 30(1) 29(1) -8(1) 8(1) -1 (1) 
C(l2A) 60(2) 44(2) 45(2) 10(2) -1 1(2) -17(2) 
C(l3A) 52(2) 62(2) 61 (2) 12(2) -11(2) -26(2) 
C(l4A) 44(2) 45(2) 44(1) -3(1) -6(1) -6(2) 
C(ISA) 51(2) 40(2) 41 (1) 3(1) I (1) -2(2) 
C(l6A) 37(2) 34(2) 38(1) 0(1) 8(1) -4(1) 
O(IB) 45(1) 35(1) 68(1) -3(1) 29(1) 2(1) 
0(2B) 31 (I) 32(1) 49(1) 3(1) 7(1) -2(1) 
0(3B) 32(1) 34(1) 49(1) -9(1) -7(1) -5(1) 
N(IB) 23(1) 34(1) 30(1) -5(1) 2(1) -3(1) 
C(IB) 30(1) 34(2) 34(1) -1(1) 5(1) -1 (1) 
C(2B) 28(2) 33(2) 34(1) -5(1) 5(1) -8(1) 
C(3B) 55(2) 40(2) 31 (1) -4(1) 6(1) -10(2) 
C(4B) 36(2) 24(1) 30(1) -3(1) -3(1) 3(1) 
C(SB) 43(2) 48(2) 42(1) -15(1) 6(1) 3(2) 
C(6B) 74(3) 45(2) 112(4) 20(2) 49(3) 30(2) 
C(7B) 71 (3) 69(3) 51(2) 10(2) 30(2) 24(2) 
C(llB) 49(2) 39(2) 30(1) 2(1) -4(1) -4(2) 
C(l2B) 43(2) 61(2) 66(2) 17(2) -13(2) -3(2) 
C(l3B) 61(3) 70(3) 98(3) 32(2) -10(2) 26(2) 
C(l4B) 89(3) 45(2) 72(2) 18(2) -3(2) 14(2) 
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C(lSB) 69(3) 37(2) 67(2) 5(2) 2(2) -4(2) 
C(l6B) 48(2) 39(2) 53(2) 0(1) 6(2) -2(2) 
Table 5. Hydrogen coordinates ( x 1 03) and isotropic displacement parameters (A 2 x 1 03) for N -(2-
methylpropionyl)-(S)-phenylalanine, 49. 
X y z U(iso) 
H(OA) 363(3) 632(3) 71 (1) 51 (1 0) 
H(lA) 170(3) 400(2) 133(1) 37(9) 
H(2A) 367(2) 396(2) 116(1) 25(6) 
H(3Al) 359(3) 380(2) 44(1) 45(8) 
H(3A2) 319(2) 274(2) 67(1) 38(8) 
H(SA) 116(3) 304(3) 186(1) 48(9) 
H(6Al) 157(4) 200(4) 246(2) 101(15) 
H(6A2) 228(3) 287(4) 236(1) 83(15) 
H(6A3) 263(5) 161(4) 222(2) 123(18) 
H(7Al) 59(4) 132(4) 183(1) 94(14) 
H(7A2) 152(5) 105(5) 154(2) 137(23) 
H(7A3) 69(4) 181(4) 128(2) 127(18) 
H(l2A) 132(2) 222(3) 66(1) 43(8) 
H(l3A) -28(4) 228(4) 28(1) 100(15) 
H(l4A) -63(3) 365(3) -18(1) 58(10) 
H(lSA) 77(3) 488(3) -33(1) 80(12) 
H(l6A) 236(3) 483(3) 2(1) 53(9) 
H(OB) 359(3) 119(3) 160(1) 74(12) 
H(IB) 584(3) -124(3) 109(1) 57(10) 
H(2B) 388(2) -136(2) 136(1) 19(6) 
H(3Bl) 571(3) -109(3) 189(1) 60(10) 
H(3B2) 453(2) -115(2) 205(1) 41 (8) 
H(SB) 530(2) -274(2) 19(1) 47(8) 
H(6BI) 670(4) -367(4) 48(1) 99(15) 
H(6B2) 584(4) -387(4) 83(1) 101(16) 
H(6B3) 668(4) -304(4) 95(2) 1 05(19) 
H(7Bl) 676(3) -193(3) 10(1) 81 (12) 
H(7B2) 671(4) -133(5) 58(2) 140(21) 
H(7B3) 582(5) -106(5) 17(2) 141(20) 
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H(l2B) 665(4) -266(4) 183(1) 98(16) 
H(l3B) 682(4) -452(4) 186(1) 108(16) 
H(l4B) 539(3) -555(4) 191(1) 91 (13) 
H(l5B) 370(3) -475(3) 196(1) 70(11) 
H(l6B) 357(3) -292(3) 191 (1) 70(12) 
Table 6. Torsion angles [0 ] for N-(2-methylpropionyl)-(S)-phenylalanine, 49. 
0(2A)-C(l A)-C(2A)-N(l A) 0.6(4) 
C(l A)-C(2A)-N(lA)-C( 4A) -149.4(2) 
C(2A)-N(l A)-C( 4A)-C(5A) -176.6(2) 
N(l A)-C( 4A)-C(5A)-C(7 A) 96.2(3) 
N(lA)-C(2A)-C(3A)-C(llA) 59.9(3) 
C(2A)-C(3A)-C(ll A)-C(l2A) -90.9(3) 
0(2B)-C(lB)-C(2B)-N(lB) -16.5(4) 
C(lB)-C(2B)-N(lB)-C(4B) -120.7(3) 
C(2B)-N(l B)-C( 4B)-C(5B) -173.6(2) 
N(IB)-C(4B)-C(5B)-C(7B) -47 .3(4) 
N(lB)-C(2B)-C(3B)-C(llB) -55.8(3) 
C(2B)-C(3B)-C(llB)-C(l2B) 1 04.4(3) 
Table 7. Hydrogen bonds for N-(2-methylpropionyl)-(S)-phenylalanine, 49 [A and o]. 
D-H ... A d(D-H) d(H .. .A) d(D .. .A) <(DHA) 
0(1 A)-H(OA) ... 0(3B)#l 0.87(4) 1.72(4) 2.576(3) 167(3) 
0(1B)-H(OB) ... 0(3A) 0.94(4) 1.65(4) 2.580(3) 172(4) 
N(lA)-H(lA) ... 0(2B)#2 0.80(3) 2.19(3) 2.956(3) 162(3) 
N(lB)-H(lB) ... 0(2A)#3 0.89(4) 2.09(4) 2.936(3) 160(3) 
Symmetry transformations used to generate equivalent atoms: 
#1 x,y+l,z #2 x-1/2,-y+l/2,-z+l/4 #3 x+l/2,-y+l/2,-z+l/4 
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Appendix IV 
N-(S)-2-Chloropropanoyi-(S)-phenylalanine, (S, S)50 
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Table I. Crystal data and structure refmement for N-(S)-2-chloropropanoyl-(S)-phenylalanine, (S, S)SO. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
e range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Reflections with I> 2cr(l) 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data I restraints I parameters 
Largest fmal shiftle.s.d. ratio 
Goodness-of-fit on F2 
Final R indices [I>2cr(l)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
Cl2 H14 Cl N 03 
255.69 
150(2) K 
1.54178 A 
Tetragonal 
P432 12 (No. 96) 
a= 12.772(2) A 
b = 12.772(2) A 
c = 32.044(2) A 
5227.1(12) A3 
16 
1.300 glcm3 
2.575 mm-1 
2144 
0.28 x 0.24 x 0.12 mm3 
3.73 to 75.09°. 
y= 90° 
-7 7S h 7S 16,-7 7S k7S 16,-17 7S 17S 40 
5349 
4274 [R(int) = 0.0269] 
3465 
Psi-scans 
1.0000 and 0.7830 
Full-matrix least-squares on f2 
4274101416 
0.102 
1.040 
RI = 0.0489, wR2 = 0.1176 
RI =0.0666, wR2 = 0.1298 
0.00(2) 
0.00057(10) 
0.199 and -0.360 e.A-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 x 104) 
for N-(S)-2-chloropropanoyl-(S)-phenylalanine, (S, S)50. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
X y z U(eq) 
O(lA) 3691(2) 5598(2) 720(1) 402(6) 
0(2A) 2311(2) 5760(2) 1145(1) 361(6) 
0(3A) 3322(2) 2410(2) 1562(1) 462(7) 
N(lA) 2278(2) 3683(2) 1319(1) 308(7) 
C(1A) 2969(3) 5221(3) 978(1) 302(8) 
C(2A) 3074(3) 4056(3) 1029(1) 325(8) 
C(3A) 3052(3) 3451(3) 609(1) 362(9) 
C(4A) 2464(3) 2868(3) 1564(1) 318(8) 
C(5A) 1595(3) 2539(4) 1850(1) 455(10) 
C(6A) 2038(14) 2807(14) 2323(5) 470(20) 
CIA 1218(5) 1327(5) 1837(2) 734(8) 
C(6A') 2001(6) 2182(7) 2279(2) 470(20) 
CIA' 1063(2) 1324(2) 1598(1) 734(8) 
C(11A) 2013(3) 3490(3) 386(1) 342(8) 
C(l2A) 1265(4) 2717(4) 442(2) 555(13) 
C(13A) 322(5) 2755(4) 236(2) 650(20) 
C(14A) 98(4) 3551(4) -38(1) 517(11) 
C(15A) 820(4) 4328(4) -95(1) 455(10) 
C(16A) 1769(4) 4292(3) 114(1) 436(10) 
O(lB) 3694(3) 408(3) 1632(1) 480(8) 
0(2B) 5055(2) 706(2) 1203(1) 375(6) 
0(3B) 3979(2) -2384(2) 747(1) 400(7) 
N(IB) 5237(3) -1396(2) 1050(1) 287(6) 
C(lB) 4487(3) 116(3) 1394(1) 341(8) 
C(2B) 4600(3) -1068(3) 1399(1) 287(8) 
C(3B) 5073(3) -1441(3) 1815(1) 350(8) 
C(4B) 4881(3) -2047(3) 761(1) 294(8) 
C(5B) 5673(3) -2454(3) 443(1) 411(9) 
C(6B) 6285(5) -3395(4) 617(2) 620(20) 
ClB 6573(1) -1459(1) 288(1) 480(3) 
C(llB) 5188(3) -2614(3) 1831(1) 331(8) 
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C(l2B) 6142(4) -3102(4) 1776(2) 496(11) 
C(l3B) 6227(5) 
-4176(4) 1784(2) 600(14) 
C(l4B) 5351(5) 
-4785(4) 1844(2) 606(14) 
C(l5B) 4389(4) 
-4321(4) 1903(2) 520(12) 
C(l6B) 4306(4) 
-3241(3) 1892(1) 426(10) 
Table3. Bond lengths [A] and angles [0 ] for N-(S)-2-chloropropanoyi-(S)-phenylalanine, (S, S)SO. 
0(1 A)-H(OA) 0.91 (7) C(l5A)-C(l6A) 1.386(6) 
0(1A)-C(1A) 1.328(4) 0(1 B)-H(OB) 0.68(4) 
0(2A)-C(lA) 1.212(4) O(lB)-C(lB) 1.321 (5) 
0(3A)-C(4A) 1.243(4) 0(2B)-C(lB) 1.212(4) 
N(l A)-H(lA) 0.94(5) 0(3B)-C(4B) 1.230(4) 
N(IA)-C(4A) 1.325(5) N(lB)-H(lB) 0.84(5) 
N(lA)-C(2A) 1.458(5) N(lB)-C(4B) 1.325(4) 
C(IA)-C(2A) 1.503(5) N(lB)-C(2B) 1.446(4) 
C(2A)-C(3A) 1.551 (5) C(lB)-C(2B) 1520(5) 
C(3A)-C(llA) 1.508(6) C(2B)-C(3B) 1.538(5) 
C(4A)-C(5A) 1.499(5) C(3B)-C(llB) 1506(6) 
C(5A)-C(6A') 1.539(8) C(4B)-C(5B) 1.528(5) 
C(5A)-ClA 1.622(8) C(5B)-C(6B) 1.538(7) 
C(5A)-C(6A) 1.65(2) C(5B)-ClB 1.784(4) 
C(5A)-ClA' 1.876(5) C(IIB)-C(l2B) 1.380(6) 
C(llA)-C(l6A) 1.379(6) C(llB)-C(l6B) 1.396(6) 
C(l1A)-C(l2A) 1.386(6) C(l2B)-C(l3B) 1.376(7) 
C(l2A)-C(l3A) 1.376(7) C(l3B)-C(l4B) 1.376(8) 
C(l3A)-C(l4A) 1.374(7) C(l4 B)-C( 15B) 1.377(7) 
C(14A)-C(l5A) 1.367(6) C(15B)-C(16B) 1.385(6) 
H(OA)-0(1A)-C(1A) 100.1(44) N(1A)-C(2A)-C(lA) 109.3(3) 
H(l A)-N(IA)-C( 4A) 120.1(29) N(l A)-C(2A)-C(3A) 112.1(3) 
H(1 A)-N(lA)-C(2A) 119.1(29) C(l A)-C(2A)-C(3A) 113.4(3) 
C(4A)-N(lA)-C(2A) 120.6(3) C(llA)-C(3A)-C(2A) 114.3(3) 
0(2A)-C(1A)-0(1A) 123.4(3) 0(3A)-C( 4A)-N(l A) 121.6(3) 
0(2A)-C( 1 A)-C(2A) 125.2(3) 0(3A)-C( 4A)-C(5A) 121.6(3) 
0(1 A)-C(l A)-C(2A) 111.4(3) N(l A)-C( 4A)-C(5A) 116.7(3) 
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C(4A)-C(5A)-C(6A') 112.3(4) C( 14B)-C(l5B)-C(l6B) 119.6(5) 
C(4A)-C(5A)-ClA 118.2(4) C( 15B)-C(16B)-C(11 B) 120.9(4) 
C(4A)-C(5A)-C(6A) 104.4(7) 
ClA-C(5A)-C(6A) 108.8(7) 
C(4A)-C(5A)-C1A' 103.7(3) 
C(6A')-C(5A)-ClA' 105.2(4) 
C(16A)-C(11A)-C(l2A) 117.1(4) 
C(16A)-C(11A)-C(3A) 121.5(4) 
C(l2A)-C(l1A)-C(3A) 121.3(4) 
C(13A)-C(l2A)-C(l1 A) 121.1 (5) 
C(l4A)-C(13A)-C(l2A) 121.0(5) 
C(15A)-C(14A)-C(l3A) 118.9(5) 
C(14A)-C(15A)-C(16A) 120.1(4) 
C(11A)-C(l6A)-C(15A) 121.8(4) 
H(OB)-0(1 B)-C(l B) 112.7(39) 
H(lB)-N(lB)-C(4B) 122.8(32) 
I-1(1 B)-N(l B)-C(2B) 115.3(32) 
C(4B)-N(lB)-C(2B) 121.9(3) 
0(2B)-C(1 B)-0( 1 B) 125.1(4) 
0(2B)-C(1 B)-C(2B) 124.6(3) 
0(1 B)-C(l B)-C(2B) 110.3(3) 
N (1B)-C(2B)-C(l B) 109.5(3) 
N (l B)-C(2B)-C(3B) 111.1(3) 
C(1 B)-C(2B)-C(3B) 110.8(3) 
C(11B)-C(3B)-C(2B) 112.0(3) 
0(3B)-C(4B)-N(IB) 124.5(3) 
0(3B)-C(4B)-C(5B) 118.5(3) 
N(IB)-C(4B)-C(5B) 116.9(3) 
C(4B)-C(5B)-C(6B) 111.1(3) 
C(4B)-C(5B)-ClB 111.7(3) 
C(6B)-C(5B)-ClB 109.3(3) 
C(l2B)-C(11B)-C(16B) 118.1(4) 
C(12B)-C(11B)-C(3B) 122.1 (4) 
C(l6B)-C(11B)-C(3B) 119.8(4) 
C(l3B)-C(12B)-C(11B) 121.2(5) 
C(14B)-C(l3B)-C(12B) 120.1(5) 
C(13B)-C(14B)-C(15B) 120.1(5) 
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Table 4. Anisotropic displacement parameters (A2 x 103) for N-(S)-2-chloropropanoyl-(S)-
phenylalanine, (S, 8)50. The anisotropic displacement factor exponent takes the form: -2n2[ h2 a*2V 11 
+ ... + 2 h k a* b* u12] 
ull U22 u33 u23 u13 u12 
0(1A) 42(2) 33(2) 45(1) 2(1) 10(1) -{)(1) 
0(2A) 33(1) 33(1) 42(1) -2(1) 3(1) 3(1) 
0(3A) 39(2) 38(2) 61(2) 9(1) 8(1) 11(1) 
N(1A) 31(2) 29(2) 33(1) 3(1) 3(1) 1(2) 
C(1A) 28(2) 27(2) 36(2) -3(1) -2(1) -6(2) 
C(2A) 27(2) 37(2) 33(2) -2(2) -1(2) 2(2) 
C(3A) 43(2) 27(2) 39(2) -3(2) 8(2) 3(2) 
C(4A) 28(2) 27(2) 39(2) -2(2) 2(2) 3(2) 
C(5A) 42(2) 49(3) 46(2) 16(2) 7(2) 13(2) 
C(6A) 32(3) 79(6) 30(2) 10(4) 11(2) 16(5) 
CIA 56(1) 55(1) 110(2) 12(2) 7(2) -12(1) 
C(6A') 32(3) 79(6) 30(2) 10(4) 11(2) 16(5) 
CIA' 56(1) 55(1) 110(2) 12(2) 7(2) -12(1) 
C(l1A) 39(2) 31(2) 33(2) -8(2) 5(1) -3(2) 
C(l2A) 70(4) 40(3) 56(3) 12(2) -14(2) -18(3) 
C(13A) 67(4) 58(3) 71(3) 13(3) -22(3) -30(3) 
C(14A) 50(3) 58(3) 48(2) -1(2) -9(2) -2(3) 
C(15A) 50(3) 46(3) 41(2) 2(2) -2(2) -3(2) 
C(16A) 54(3) 33(2) 44(2) 1(2) 2(2) -7(2) 
0(18) 48(2) 31(2) 65(2) 4(2) 24(2) 11(2) 
0(28) 34(2) 30(1) 48(1) 4(1) 6(1) 0(1) 
0(38) 32(2) 39(2) 48(2) -8(1) -3(1) -7(1) 
N(18) 25(2) 29(2) 32(1) -4(1) 5(1) -4(1) 
C(l8) 29(2) 36(2) 37(2) 0(2) 2(2) 4(2) 
C(28) 27(2) 29(2) 31(2) -3(1) 7(1) 0(2) 
C(38) 37(2) 36(2) 31(2) -1(2) 5(2) -1(2) 
C(48) 32(2) 27(2) 29(2) 0(1) -1(1) 3(2) 
C(58) 42(2) 45(2) 36(2) -8(2) 7(2) 3(2) 
C(68) 69(4) 44(3) 73(3) 9(3) 33(3) 24(3) 
ClB 46(1) 60(1) 39(1) 11(1) 12(1) 4(1) 
C(118) 34(2) 37(2) 28(2) 5(2) 0(1) 2(2) 
C(l28) 42(3) 53(3) 54(2) 9(2) -5(2) 0(2) 
C(138) 53(3) 53(3) 74(3) 7(2) -2(3) rl(3) 
C(148) 83(4) 36(3) 63(3) 11(2) 3(3) 13(3) 
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C(15B) 60(3) 37(3) 58(3) 6(2) 4(2) -5(3) 
C(16B) 39(2) 41(3) 48(2) -3(2) 4(2) 0(2) 
Table 5. Hydrogen coordinates ( x 103) and isotropic displacement parameters (A2 x 103) for N-(S)-2-
chloropropanoyl-(S )-phenylalanine, (S, S )50. 
X y z U(iso) 
H(OA) 351(6) 628(6) 72(2) 121(25) 
H(1A) 161(4) 400(4) 132(1) 62(15) 
H(2A) 374(3) 398(3) 114(1) 27(9) 
H(3Al) 363(3) 377(3) 43(1) 27(9) 
H(3A2) 322(3) 282(3) 67(1) 22(10) 
H(5A) 94(3) 301(3) 182(1) 30(10) 
H(6A1) 152(1) 262(1) 253(1) 64(12) 
H(6A2) 218(1) 354(1) 234(1) 64(12) 
H(6A3) 267(1) 242(1) 237(1) 64(12) 
H(6A4) 142(1) 198(1) 245(1) 64(12) 
H(6A5) 237(1) 275(1) 241(1) 64(12) 
H(6A6) 247(1) 160(1) 224(1) 64(12) 
H(12A) 139(4) 219(4) 58(1) 49(13) 
H(13A) -16(4) 227(5) 29(2) 87(19) 
H(14A) -59(4) 356(3) -18(1) 50(12) 
H(15A) 68(4) 490(4) -29(2) 65(14) 
H(16A) 219(4) 478(4) 9(2) 59(15) 
H(OB) 361(4) 93(3) 163(1) 35(14) 
H(lB) 584(4) -115(4) 104(1) 55(14) 
H(2B) 388(3) -136(3) 135(1) 19(8) 
H(3Bl) 575(3) -114(3) 186(1) 35(11) 
H(3B2) 467(4) -109(3) 204(1) 51(12) 
H(5B) 534(4) -263(4) 18(2) 72(15) 
H(6B1) 680(5) -361(5) 47(2) 99(22) 
H(6B2) 575(4) -401(5) 71(2) 81(17) 
H(6B3) 673(5) -320(5) 87(2) 92(21) 
H(12B) 665(4) -269(4) 176(1) 47(14) 
H(l3B) 686(5) -442(5) 175(2) 95(21) 
H(l4B) 537(4) -551(4) 182(1) 56(14) 
H(15B) 381(4) -472(4) 194(1) 52(14) 
H(16B) 363(3) -291(3) 191(1) 35(10) 
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Table 6. Torsion angles [0 ] for N-(S)-2-chloropropanoyl-(S)-phenylalanine, (S, S)50. 
0(2A)-C(lA)-C(2A)-N(lA) -1.5(5) 
C(1A)-C(2A)-N(lA)-C(4A) -148.1(3) 
C(2A)-N(1A)-C(4A)-C(5A) -179.6(3) 
N(lA)-C(4A)-C(5A)-ClA 126.6(4) 
N(lA)-C(4A)-C(5A)-ClA' 104.9(3) 
N(1A)-C(2A)-C(3A)-C(llA) 57.4(4) 
C(2A)-C(3A)-C(l1A)-C(12A) -93.0(5) 
0(2B)-C(1B)-C(2B)-N(lB) -18.2(5) 
C(1B)-C(2B)-N(1B)-C(4B) -120.6(4) 
C(2B)-N(1B)-C(4B)-C(5B) -171.7(3) 
N(lB)-C(4B)-C(5B)-ClB -39.3(4) 
N(lB)-C(2B)-C(3B)-C(l1B) -58.5(4) 
C(2B)-C(3B)-C(11B)-C(12B) 103.1(4) 
Table 7. Hydrogen bonds for N-(S)-2-chloropropanoyl-(S)-phenylalanine, (S, S)50 [A and 0 ]. 
D-H ... A d(D-H) d(H ... A) d(D ... A) <(DHA) 
0(1 A)-H(OA) ... 0(3B)# 1 0.91(7) 1.81(7) 2.606(4) 145(6) 
0(1B)-H(OB) .. .0(3A) 0.68(3) 1.94(4) 2.611(4) 174(5) 
N(1A)-H(1A) ... 0(2B)#2 0.94(5) 2.02(5) 2.945(4) 166(4) 
N(lB)-H(lB) ... 0(2A)#3 0.84(5) 2.18(5) 2.938(4) 150(4) 
Symmetry transfonnations used to generate equivalent atoms: 
#1 x,y+1,z #2 x-1/2,-y+l/2,-z+l/4 #3 x+l/2,-y+l/2,-z+l/4 
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Appendix V 
N-((S)-2-Fiuoropropionyl)-aniline, 51 
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Table I. Crystal data and structure refinement for N-((S)-2-fluoropropionyl)-aniline, 51. 
Identification code 99snr205 
Empirical formula C9 HIO F N 0 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Absorption correction 
Refmement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(l)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
I67.I8 
150(2) K 
1.54I84 A 
Triclinic 
PI 
a= 5.367(I) A 
b = 8.82I(4) A 
c = 9.893(3) A 
4I2.8(2) A3 
2 
I.345 Mg/m3 
0.867 mm-1 
I76 
0.40 xO.I7 x0.07 mm3 
4.90 to 74.96°. 
a= I06.65(2)0 . 
f3= 101.84(2)0 . 
y = I05.13(2)0 . 
-6<=h<=6, O<=k<= II, -II <=l<= Il 
I593 
I592 [R(int) = O.OI55] 
None 
Full-matrix least-squares on F2 
1582 I 3 I 236 
1.092 
RI =0.043I, wR2 =0.1122 
RI = 0.0492, wR2 = 0.1536 
0.0(2) 
0.2I7 and -0.290 e.A-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103) 
for N -((S )-2-fluoropropionyl)-aniline, 51. U ( eq) is defined as one third of the trace of the 
orthogonalized Uii tensor. 
X y z U(eq) 
F(1) 5391(4) 6587(3) 7242(2) 53(1) 
N(l) 2309(5) 4023(3) 4863(3) 26(1) 
0(1) -1529(5) 4391(3) 5333(3) 40(1) 
C(l1) 1118(6) 2612(3) 3513(3) 25(1) 
C(l2) -1265(7) 2391(4) 2488(3) 28(1) 
C(13) -2323(7) 982(4) 1193(3) 31(1) 
C(14) -1046(7) -203(4) 912(4) 33(1) 
C(l5) 1351(7) 40(4) 1942(4) 35(1) 
C(16) 2443(6) 1453(4) 3232(4) 30(1) 
C(l7) 928(6) 4738(4) 5691(3) 33(1) 
C(18) 2658(8) 5968(5) 7264(4) 28(1) 
C(19) 1829(9) 7454(6) 7781(5) 42(2) 
C(l8') 2519(39) 6656(24) 6813(21) 37(5) 
C(19') 1997(38) 6580(22) 8203(19) 36(5) 
F(2) 9911(4) 7956(3) 4431(2) 39(1) 
N(2) 6869(6) 5729(3) 1864(3) 28(1) 
0(2) 3041(5) 6178(3) 2268(3) 43(1) 
C(21) 5717(6) 4475(4) 426(3) 28(1) 
C(22) 3156(6) 3259(4) 11(4) 31(1) 
C(23) 2154(7) 2015(4) -1382(4) 35(1) 
C(24) 3662(7) 1959(5) -2373(4) 37(1) 
C(25) 6194(7) 3155(5) -1955(4) 36(1) 
C(26) 7236(6) 4408(4) -551(3) 31(1) 
C(27) 5475(6) 6458(4) 2681(3) 30(1) 
C(28) 7116(7) 7654(4) 4254(3) 32(1) 
C(29) 6647(8) 9301(4) 4606(4) 42(1) 
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Table 3. Bond lengths [A] and angles [0 ] for N-((S)-2-fluoropropionyl)-aniline, 51. 
F(l)-C(18) 1.433(4) 
F(1)-C(18') 1.54(2) 
N(l)-H(l) 0.84(4) 
N(l)-C(l7) 1.348(4) 
N(1)-C(ll) 1.422(4) 
0(1)-C(l7) 1.222(4) 
C(ll)-C(16) 1.387(4) 
C(l1)-C(l2) 1.388(5) 
C(12)-C(l3) 1.389(4) 
C(13)-C(14) 1.388(5) 
C(14 )-C(15) 1.390(5) 
C(15)-C(16) 1.388(4) 
C(17)-C(18) 1.541(5) 
C(17)-C(18') 1.61(2) 
C(18)-C(19) 1.480(6) 
C(18')-C(19') 1.47(3) 
F(2)-C(28) 1.418(4) 
N(2)-H(2) 0.78(4) 
N(2)-C(27) 1.352(4) 
N(2)-C(21) 1.418(4) 
0(2)-C(27) 1.220(4) 
C(21 )-C(26) 1.385(4) 
C(21 )-C(22) 1.398(5) 
C(22)-C(23) 1.383(4) 
C(23 )-C(24) 1.392(5) 
C(24 )-C(25) 1.379(5) 
C(25)-C(26) 1.394(4) 
C(27)-C(28) 1.524(4) 
C(28)-C(29) 1.494(5) 
H(1)-N(1)-C(l7) 114.7(26) 
H(1)-N(1)-C(ll) 118.7(26) 
C(17)-N(1)-C(ll) 125.1(3) 
C(16)-C(11)-C(l2) 120.3(3) 
C(l6)-C(11)-N(l) 117.7(3) 
C(12)-C(ll)-N(l) 122.0(3) 
C(11)-C(l2)-C(13) 119.1(3) 
C(14 )-C(13)-C(12) 121.2(3) 
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C(l3)-C(14)-C(15) 119.1(3) 
C(16)-C(15)-C(14) 120.2(3) 
C(l1 )-C(16)-C(15) 120.1(3) 
0(1 )-C(17)-N(1) 125.5(3) 
0(1)-C(17)-C(18) 119.4(3) 
N(1)-C(17)-C(18) 114.8(3) 
0(1)-C(17)-C(18') 112.5(7) 
N(1)-C(17)-C(18') 116.1(7) 
F(l)-C(18)-C(19) 106.9(3) 
F(1)-C(18)-C(17) 107.7(3) 
C(19)-C(18)-C(17) 113.6(4) 
C(19')-C(l8')-F(1) 95.0(14) 
C(19')-C(18')-C(17) 101.9(13) 
F(1)-C(18')-C(17) 99.4(11) 
H(2)-N(2)-C(27) 119.9(30) 
H(2)-N(2)-C(21) 114.6(30) 
C(27)-N (2 )-C(21) 125.3(3) 
C(26)-C(21 )-C(22) 119.7(3) 
C(26)-C(21)-N(2) 118.8(3) 
C(22 )-C(21 )-N (2) 121.3(3) 
C(23 )-C(22)-C(21) 119.5(3) 
C(22 )-C(23 )-C(24) 120.9(3) 
C(25)-C(24 )-C(23) 119.5(3) 
C(24 )-C(25)-C(26) 120.3(3) 
C(21 )-C(26)-C(25) 120.2(3) 
0(2)-C(27)-N(2) 125.0(3) 
0(2 )-C(27)-C(28) 119.1(3) 
N(2)-C(27)-C(28) 115.8(3) 
F(2)-C(28)-C(29) 108.7(3) 
F(2)-C(28)-C(27) 109.4(2) 
C(29)-C(28)-C(27) 112.0(3) 
Symmetry transfonnations used to generate equivalent atoms: 
Table 4. Anisotropic displacement parameters (A2x 103) for N-((S)-2-fluoropropionyl)-aniline, 51. 
The anisotropic displacement factor exponent takes the form: -2n2[ h2 a*2U 11 + .. . + 2 h k a* b* U 12 ] 
Ull uzz U33 uz3 un u12 
F(1) 16(1) 65(2) 48(1) -15(1) 4(1) 6(1) 
N(l) 15(2) 33(1) 26(1) 6(1) 3(1) 8(1) 
0(1) 19(1) 50(1) 38(1) 0(1) 8(1) 9(1) 
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C(ll) 18(2) 27(1) 28(1) 8(1) 7(1) 9(1) 
C(12) 23(2) 30(1) 30(1) 10(1) 7(1) 12(1) 
C(13) 25(2) 34(2) 29(2) 7(1) 3(1) 10(1) 
C(14) 27(2) 31(1) 32(1) 0(1) 6(1) 7(1) 
C(15) 25(2) 33(2) 44(2) 6(1) 11(2) 14(1) 
C(16) 16(2) 34(1) 35(2) 8(1) 3(1) 11(1) 
C(17) 21(2) 37(2) 29(2) -1(1) 6(1) 7(1) 
C(18) 13(2) 35(2) 25(2) 2(2) 1(1) 5(2) 
C(19) 23(3) 39(2) 46(3) -8(2) 3(2) 15(2) 
F(2) 20(1) 49(1) 38(1) 3(1) 1(1) 15(1) 
N(2) 14(2) 32(1) 32(1) 7(1) 3(1) 10(1) 
0(2) 21(1) 46(1) 47(1) -2(1) 3(1) 14(1) 
C(21) 23(2) 31(1) 28(1) 11(1) 4(1) 12(1) 
C(22) 22(2) 35(2) 35(2) 12(1) 9(1) 9(1) 
C(23) 25(2) 36(2) 35(2) 9(1) 5(1) 6(1) 
C(24) 31(2) 41(2) 30(2) 5(1) 4(1) 12(1) 
C(25) 28(2) 49(2) 32(2) 12(1) 10(1) 15(1) 
C(26) 22(2) 39(2) 33(2) 12(1) 7(1) 11(1) 
C(27) 22(2) 33(2) 33(2) 7(1) 6(1) 13(1) 
C(28) 21(2) 34(2) 36(2) 8(1) 6(1) 9(1) 
C(29) 30(2) 36(2) 47(2) 0(2) 7(2) 13(1) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) 
for N-((S)-2-fluoropropionyl)-aniline, 51. 
X y z U(eq) 
H(1) 3982(87) 4317(48) 5293(42) 24(9) 
H(12) -2160(7) 3193(4) 2656(3) 33 
H(l3) -3954(7) 824(4) 487(3) 37 
H(14) -1807(7) -1170(4) 28(4) 40 
H(l5) 2258(7) -755(4) 1765(4) 42 
H(16) 4103(6) 1638(4) 3928(4) 35 
H(18) 2595(8) 5349(5) 7966(4) 36 
H(l91) -54(9) 7069(6) 7786(5) 33(7) 
H(192) 1989(9) 8121(6) 7144(5) 33(7) 
H(l93) 3004(9) 8148(6) 8791(5) 33(7) 
H(18') 2246(39) 7590(24) 6486(21) 48 
H(194) 2880(38) 7695(22) 8984(19) 53 
H(l95) 2723(38) 5771(22) 8493(19) 53 
H(196) 41(38) 6223(22) 8055(19) 53 
H(2) 8445(90) 6052(50) 2148(43) 27(10) 
H(22) 2125(6) 3284(4) 686(4) 37 
H(23) 407(7) 1197(4) -1664(4) 42 
H(24) 2951(7) 1100(5) -3327(4) 44 
H(25) 7229(7) 3132(5) -2628(4) 44 
H(26) 9003(6) 5210(4) -256(3) 38 
H(28) 6576(7) 7120(4) 4963(3) 42 
H(291) 7648(8) 10005(4) 5642(4) 43(6) 
H(292) 4712(8) 9121(4) 4442(4) 43(6) 
H(293) 7299(8) 9865(4) 3960(4) 43(6) 
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Table 6. Torsion angles [0 ] forN-((S)-2-fluoropropionyl)-aniline, 51. 
C(16)-C(l1)-N(l)-C(17) -143.3(3) 
C(ll )-N(l )-C(17)-C(18) 166.3(3) 
N(l)-C(17)-C(l8)-F(l) 24.5(5) 
C(26 )-C(2l )-N (2 )-C(27) 149.0(3) 
C(21)-N(2)-C(27)-C(28) 174.4(3) 
N(2)-C(27)-C(28)-F(2) 9.9(4) 
Symmetry transformations used to generate equivalent atoms: 
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3,5-Dibenzyl-1-(2,6-difluorobenzoyl)-3-(2,6-
difluorobenzoylamino )pyrrolidine-2,4-dione, 70 
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Table 1. Crystal data and structure refinement for 3 ,5-dibenzyl-1-(2,6-difluorobenzoyl)-3-(2,6-
difluorobenzoylamino )pyrrolidine-2,4-dione, 70. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
No. of reflections for cell determination 
Theta range for cell determination 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal shape 
Crystal colour 
Diffractometer 
Data collection method 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta= 28.28° 
Absorption correction 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
00srv264 
C64 H44 F8 N4 08 
1149.03 
100(2) K 
0.71073 A 
Monoclinic 
C21c 
5176 
2.72'- 28.2r 
a= 19.713(1) A 
b = 14.119(1) A 
c= 19.154(1)A 
5319 .3(6) A3 
4 
1.435 Mg/m3 
0.114 mm-' 
2368 
0.26 X 0.26 X 0.08 mm3 
rectangular plate 
colourless 
Bruker SMART-CCD 
w scans 
1.78 to 28.28°. 
P= 93.807(1)0 • 
y = 90°. 
-26<=h<=26, -18<=k<=l8, -25<=1<=25 
29740 
6595 [R(int) = 0.0470] 
99.8% 
None 
Full-matrix least-squares on F2 
659510 I 467 
1.064 
Rl = 0.0543, wR2 = 0.1236 
RI = 0.0762, wR2 = 0.1345 
0.387 and -0.402 e.A-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103) 
for 3 ,5-dibenzyl-1-(2,6-difluorobenzoyl)-3 -(2,6-difluorobenzoylamino )pyrrolidine-2,4-dione, 70. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
0(1) 6176(1) 1399(1) -653(1) 28(1) 
0(2) 4206(1) 2430(1) -150(1) 26(1) 
0(3) 5583(1) 4150(1) -299(1) 25(1) 
0(4) 4717(1) 2162(1) 1411(1) 25(1) 
N(1) 5738(1) 2566(1) -5(1) 19(1) 
N(2) 4343(1) 3785(1) 457(1) 21(1) 
F(1) 7310(1) 3179(1) -475(1) 69(1) 
F(2) 5211(1) 2855(1) -1715(1) 42(1) 
F(3) 2958(1) 3818(2) 902(1) 63(1) 
F(4) 3526(1) 3217(1) -1390(1) 52(1) 
C(2) 5479(1) 3474(1) 68(1) 18(1) 
C(3) 5029(1) 3499(1) 690(1) 19(1) 
C(4) 5032(1) 2456(1) 942(1) 19(1) 
C(5) 5525(1) 1884(1) 528(1) 19(1) 
C(lO) 6065(1) 2234(1) -583(1) 21(1) 
C(l1) 6272(1) 2961(1) -1105(1) 22(1) 
C(l2) 5845(1) 3230(1) -1669(1) 24(1) 
C(13) 6027(1) 3868(2) -2166(1) 29(1) 
C(14) 6667(1) 4269(2) -2092(1) 30(1) 
C(l5) 7112(1) 4041(2) -1527(1) 40(1) 
C(16) 6900(1) 3394(2) -1047(1) 36(1) 
C(20) 3976(1) 3197(1) 20(1) 20(1) 
C(21) 3277(1) 3516(1) -233(1) 22(1) 
C(22) 2785(1) 3787(2) 209(1) 38(1) 
C(23) 2125(1) 4001(2) -22(2) 55(1) 
C(24) 1949(1) 3960(2) -726(2) 46(1) 
C(25) 2415(1) 3698(2) -1194(1) 36(1) 
C(26) 3065(1) 3469(1) -937(1) 28(1) 
C(30) 5313(1) 4193(1) 1259(1) 21(1) 
C(31) 6004(1) 3915(1) 1590(1) 20(1) 
C(32) 6600(1) 4097(1) 1256(1) 24(1) 
C(33) 7230(1) 3817(2) 1565(1) 31(1) 
C(34) 7270(1) 3366(2) 2209(1) 33(1) 
C(35) 6681(1) 3190(2) 2546(1) 29(1) 
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C(36) 6052(1) 3456(1) 2238(1) 23(1) 
C(40) 6142(1) 1514(1) 982(1) 21(1) 
C(41) 5982(1) 667(1) 1429(1) 19(1) 
C(42) 6030(1) 722(2) 2153(1) 30(1) 
C(43) 5934(1) -83(2) 2558(1) 39(1) 
C(44) 5796(1) -944(2) 2241(1) 34(1) 
C(45) 5734(1) -1003(2) 1517(1) 32(1) 
C(46) 5822(1) -202(1) 1118(1) 25(1) 
Table 3. Bond lengths [A] and angles [0 ] for 3,5-dibenzy1-1-(2,6-difluorobenzoyl)-3-(2,6-
difluorobenzoy1amino )pyrro1idine-2,4-dione, 70. 
0(1)-C(lO) 1.208(2) C(15)-C(16) 1.380(3) 
0(2)-C(20) 1.226(2) C(15)-H(15) 0.92(3) 
0(3)-C(2) 1.210(2) C(20)-C(21) 1.499(3) 
0(4)-C(4) 1.199(2) C(21)-C(22) 1.383(3) 
N(l)-C(2) 1.391(2) C(21)-C(26) 1.387(3) 
N(1)-C(10) 1.399(2) C(22)-C(23) 1.379(3) 
N(l)-C(5) 1.483(2) C(23 )-C(24) 1.371(4) 
N(2)-C(20) 1.353(2) C(23 )-H(23) 0.96(4) 
N(2)-C(3) 1.452(2) C(24 )-C(25) 1.374(4) 
N(2)-H(2N) 0.84(2) C(24 )-H(24) 0.97(3) 
F(1)-C(l6) 1.353(3) C(25)-C(26) 1.380(3) 
F(2)-C(l2) 1.355(2) C(25)-H(25) 0.95(3) 
F(3)-C(22) 1.349(3) C(30)-C(31) 1.517(3) 
F(4)-C(26) 1.346(3) C(30)-H(302) 0.99(2) 
C(2)-C(3) 1.533(3) C(30)-H(30 I) 0.98(2) 
C(3)-C(30) 1.542(3) C(31 )-C(3 2) 1.397(3) 
C(3)-C(4) 1.550(2) C(31 )-C(36) 1.398(3) 
C(4)-C(5) 1.525(3) C(32)-C(33) 1.396(3) 
C(5)-C(40) 1.538(3) C(32)-H(32) 0.96(2) 
C(5)-H(5) 0.98(2) C(33)-C(34) 1.386(3) 
C(lO)-C(ll) 1.508(3) C(33)-H(33) 0.96(3) 
C(ll)-C(l2) 1.378(3) C(34 )-C(3 5) 1.387(3) 
C(11)-C(l6) 1.380(3) C(34 )-H(34) 0.93(3) 
C(l2)-C(l3) 1.375(3) C(35)-C(36) 1.390(3) 
C(l3 )-C(l4) 1.381(3) C(35)-H(35) 0.95(3) 
C(l3)-H(l3) 0.92(3) C(36)-H(36) 0.92(2) 
C(l4)-C(l5) 1.385(3} C(40)-C(41) 1.516(3) 
C(l4)-H(l4) 0.95(3) C(40)-H(402) 0.97(2) 
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C(40)-H(401) 0.96(2) C(43)-H(43) 0.98(3) 
C(41)-C(42) 1.387(3) C(44)-C(45) 1.387(3) 
C( 41 )-C( 46) 1.391(3) C(44)-H(44) 0.93(3) 
C(42)-C(43) 1.395(3) C(45)-C(46) 1.383(3) 
C(42)-H(42) 0.97(3) C(45)-H(45) 0.89(3) 
C(43)-C(44) 1.378(3) C(46)-H(46) 0.99(2) 
C(2)-N(1)-C(10) 125.39(15) C(12)-C(13)-C(14) 118.4(2) 
C(2)-N(1)-C(5) 114.05(15) C(12)-C(13)-H(13) 118.5(17) 
C(10)-N(1)-C(5) 119.58(15) C(14)-C(13)-H(l3) 123.0(17) 
C(20)-N(2)-C(3) 117.93(16) C(13)-C(14)-C(l5) 120.7(2) 
C(20)-N(2)-H(2N) 120.6(15) C(13)-C(14)-H(14) 122.2(15) 
C(3)-N(2)-H(2N) 119.8(15) C(15)-C(14)-H(14) 117.1(15) 
0(3 )-C(2 )-N (1) 126.28(17) C(l6)-C(15)-C(14) 118.1(2) 
0(3 )-C(2 )-C(3) 124.20(16) C(16)-C(15)-H(15) 120.1(18) 
N (1 )-C(2 )-C(3) 109.52(15) C(14 )-C(15)-H(15) 121.7(18) 
N (2 )-C(3 )-C(2) 110.02(15) F(1)-C(16)-C(11) 116.82(18) 
N(2)-C(3)-C(30) 109.17(15) F(1)-C(16)-C(15) 119.9(2) 
C(2 )-C(3 )-C(30) 111.21(15) C(11)-C(16)-C(15) 123.3(2) 
N (2 )-C(3 )-C( 4) 110.19(15) 0(2)-C(20)-N(2) 120.92(17) 
C(2 )-C(3 )-C( 4) 103.25(14) 0(2)-C(20)-C(21) 121.82(17) 
C(30)-C(3)-C(4) 112.88(15) N (2 )-C(20 )-C(21) 117.26(16) 
0(4 )-C(4 )-C(5) 125.87(16) C(22 )-C(21 )-C(26) 115.45(18) 
0( 4 )-C( 4 )-C(3) 124.74(17) C(22 )-C(21 )-C(20) 123.57(18) 
C(5)-C(4)-C(3) 109.33(15) C(26 )-C(21 )-C(20) 120.72(18) 
N(1)-C(5)-C(4) 103.49(14) F(3)-C(22)-C(23) 118.7(2) 
N(1)-C(5)-C(40) 111.08(15) F(3)-C(22)-C(21) 117.93(19) 
C( 4 )-C( 5 )-C( 40) 113.10(16) C(23 )-C(22 )-C(21) 123.3(2) 
N(1)-C(5)-H(5) 111.2(13) C(24 )-C(23 )-C(22) 118.5(3) 
C(4 )-C(5)-H(5) 108.1(13) C(24 )-C(23 )-H(23) 125(2) 
C(40)-C(5)-H(5) 109.7(13) C(22 )-C(23 )-H(23) 116(2) 
0(1)-C(10)-N(1) 120.79(17) C(23 )-C(24 )-C(2 5) 121.0(2) 
0(1)-C(10)-C(11) 122.03(17) C(23 )-C(24 )-H(24) 117.3(17) 
N(1)-C(10)-C(11) 117.18(16) C(25)-C(24 )-H(24) 121.6(17) 
C(12)-C(11)-C(16) 116.06(18) C(24 )-C(25)-C(26) 118.4(2) 
C(12)-C(11)-C(10) 122.04(18) C(24 )-C(25)-H(25) 122.3(15) 
C(16)-C(11)-C(l0) 121.90(18) C(26 )-C(25)-H(25) 119.2(15) 
F(2)-C(12)-C(13) 119.56(18) F(4)-C(26)-C(25) 118.9(2) 
F(2)-C(12)-C(ll) 117.08(17) F ( 4 )-C(26 )-C(21) 117.89(18) 
C(13)-C(12)-C(l1) 123.34(19) C(25)-C(26)-C(21) 123.2(2) 
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C(31 )-C(3 0 )-C(3) 113.96(15) C(41)-C(40)-C(5) 113.68(15) 
C(31 )-C(30)-H(302) 111.8(12) C(41)-C(40)-H(402) 109.6(12) 
C(3 )-C(30)-H(302) 104.7(12) C(5)-C(40)-H(402) 108.9(12) 
C(31 )-C(30)-H(30 1) 109 .5(12) C( 41 )-C( 40)-H( 401) 107.6(14) 
C(3 )-C(30)-H(30 1) 108.3(13) C( 5 )-C( 40 )-H( 40 1) 107.6(13) 
H(302)-C(30)-H(30 1) 108.3(18) H( 402 )-C( 40 )-H( 40 1) 109.3(18) 
C(32)-C(31)-C(36) 118.90(18) C(42)-C(41)-C(46) 118.51(17) 
C(32)-C(31)-C(30) 121.30(17) C(42)-C(41)-C(40) 121.23(17) 
C(36)-C(31)-C(30) 119.79(17) C(46)-C(41)-C(40) 120.16(17) 
C(33)-C(32)-C(31) 120.27(19) C(41)-C(42)-C(43) 120.4(2) 
C(33)-C(32)-H(32) 118.1(15) C(41)-C(42)-H(42) 119.9(16) 
C(31 )-C(3 2 )-H(3 2) 121.6(15) C(43 )-C(42)-H(42) 119.7(16) 
C(34 )-C(33)-C(32) 120.3(2) C(44)-C(43)-C(42) 120.3(2) 
C(34 )-C(33)-H(33) 120.5(15) C(44)-C(43)-H(43) 119.5(17) 
C(3 2 )-C(3 3 )-H(3 3) 119.2(15) C(42)-C(43)-H(43) 120.2(17) 
C(3 3 )-C(34 )-C(3 5) 119.8(2) C(43)-C(44)-C(45) 119.7(2) 
C(3 3 )-C(34 )-H(34) 121.7(18) C(43)-C(44)-H(44) 119.9(17) 
C(3 5 )-C(34 )-H(34) 118.5(18) C( 45 )-C( 44 )-H( 44) 120.3(16) 
C(34 )-C(35)-C(36) 120.3(2) C( 46 )-C( 45)-C( 44) 119.8(2) 
C(34)-C(35)-H(35) 121.4(15) C(46)-C(45)-H(45) 119.8(17) 
C(36)-C(35)-H(35) 118.3(15) C(44 )-C(45)-H(45) 120.4(17) 
C(3 5 )-C(36)-C(31) 120.48(19) C(45)-C(46)-C(41) 121.17(19) 
C(35 )-C(36)-H(36) 119.1(14) C(45)-C(46)-H(46) 119.2(14) 
C(31 )-C(36)-H(36) 120.3(14) C(41)-C(46)-H(46) 119.6(14) 
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Table 4. Anisotropic displacement parameters (A2x 103) for 3,5-dtbenzyl-1-(2,6-difluorobenzoyl)-3-
(2,6-difluorobenzoylamino)pyrrolidine-2,4-dione, 70. The anisotropic displacement factor exponent 
takes the form: -21t2[ h2 a*2U11 + ... + 2 h k a* b* U12 ] 
uu uzz U33 u23 uu utz 
0(1) 36(1) 20(1) 30(1) 2(1) 11 (l) 5(1) 
0(2) 26(1) 24(1) 29(1) -4(1) -1(1) 5(1) 
0(3) 37(1) 17(1) 22(1) 4(1) 5(1) 2(1) 
0(4) 24(1) 26(1) 24(1) 5(1) 7(1) 1(1) 
N(1) 19(1) 16(1) 21(1) 3(1) 3(1) 2(1) 
N(2) 20(1) 18(1) 25(1) 0(1) -1(1) 5(1) 
F(1) 25(1) 102(1) 77(1) 67(1) -18(1) -15(1) 
F(2) 41(1) 48(1) 34(1) 12(1) -13(1) -22(1) 
F(3) 53(1) 110(2) 26(1) -2(1) 6(1) 44(1) 
F(4) 58(1) 76(1) 21(1) -2(1) 2(1) 24(1) 
C(2) 20(1) 18(1) 17(1) 0(1) -2(1) 0(1) 
C(3) 19(1) 18(1) 18(1) 1(1) 0(1) 3(1) 
C(4) 19(1) 19(1) 19(1) 2(1) -1(1) 1(1) 
C(5) 19(1) 17(1) 20(1) 4(1) 3(1) 0(1) 
C(lO) 19(1) 21(1) 21(1) 3(1) 3(1) 1(1) 
C(11) 24(1) 20(1) 22(1) 2(1) 8(1) 5(1) 
C(l2) 28(1) 24(1) 21(1) -2(1) 2(1) -5(1) 
C(13) 38(1) 29(1) 20(1) 3(1) -2(1) 0(1) 
C(14) 33(1) 29(1) 30(1) 13(1) 11(1) 4(1) 
C(15) 21(1) 45(1) 54(2) 26(1) 4(1) -1(1) 
C(16) 22(1) 43(1) 43(1) 23(1) 1(1) 2(1) 
C(20) 22(1) 21(1) 17(1) 2(1) 2(1) 3(1) 
C(21) 20(1) 21(1) 25(1) 2(1) -1(1) 2(1) 
C(22) 31(1) 56(2) 27(1) 5(1) 4(1) 14(1) 
C(23) 30(1) 82(2) 53(2) 15(2) 10(1) 25(1) 
C(24) 25(1) 53(2) 59(2) 20(1) -7(1) 5(1) 
C(25) 37(1) 34(1) 35(1) 7(1) -16(1) -5(1) 
C(26) 32(1) 24(1) 27(1) 0(1) -1(1) 2(1) 
C(30) 23(1) 20(1) 21(1) -3(1) 3(1) 2(1) 
C(31) 24(1) 16(1) 21(1) -4(1) 0(1) -1(1) 
C(32) 28(1) 19(1) 25(1) -3(1) 4(1) -3(1) 
C(33) 24(1) 26(1) 41(1) -6(1) 3(1) -3(1) 
C(34) 28(1) 27(1) 42(1) -7(1) -12(1) 3(1) 
C(35) 37(1) 23(1) 26(1) -1(1) -8(1) 1(1) 
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C(36) 28(1) 20(1) 21(1) -4(1) 1(1) -2(1) 
C(40) 18(1) 19(1) 25(1) 4(1) 1(1) 1(1) 
C(41) 15(1) 17(1) 25(1) 5(1) 3(1) 1(1) 
C(42) 40(1) 25(1) 26(1) 1(1) -4(1) -9(1) 
C(43) 51(1) 40(1) 24(1) 9(1) -4(1) -14(1) 
C(44) 37(1) 25(1) 41(1) 14(1) 5(1) -3(1) 
C(45) 34(1) 18(1) 43(1) -1(1) 10(1) -1(1) 
C(46) 27(1) 23(1) 26(1) -1(1) 8(1) 4(1) 
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) 
for 3 ,5-dibenzyl-1-(2,6-difluorobenzoyl)-3-(2,6-difluorobenzoylamino )pyrrolidine-2,4-dione, 70. 
X y z U(eq) 
H(2N) 4220(12) 4349(18) 509(12) 26(6) 
H(5) 5274(11} 1348(16) 308(11) 24(6) 
H(l3) 5714(13) 4014(19) -2530(14) 42(7) 
H(14) 6819(12) 4714(18) -2416(13) 35(6) 
H(15) 7524(16) 4330(20) -1453(15) 55(8) 
H(23) 1820(19) 4160(30) 333(19) 86(12) 
H(24) 1488(15) 4150(20) -882(15) 55(8) 
H(25) 2309(13} 3693(17) -1686(14) 36(7) 
H(302) 5327(11) 4811(16) 1019(11) 22(5) 
H(301) 4987(11) 4236(15) 1620(11) 22(5) 
H(32) 6592(12) 4427(17) 816(13) 34(6) 
H(33) 7635(13) 3947(17) 1327(13) 36(7) 
H(34) 7684(15) 3170(20) 2423(15) 50(8) 
H(35) 6694(12) 2872(18) 2986(13) 36(7) 
H(36) 5664(12) 3296(16) 2455(12) 27(6) 
H(402) 6322(11) 2023(15) 1278(11) 18(5) 
H(401) 6480(12) 1319(16) 671(12) 27(6) 
H(42) 6126(14) 1320(20) 2381(14) 48(8) 
H(43) 5963(15) -40(20) 3071(15) 52(8) 
H(44) 5732(13) -1477(19) 2512(14) 43(7) 
H(45) 5630(13) -1554(19) 1307(14) 40(7) 
H(46) 5793(12) -257(16) 600(12) 30(6) 
170 
Table 6. Torsion angles [0 ] for 3,5-dlbenzyl-1-(2,6-difluorobenzoyl)-3-(2,6-
difluorobenzoy1amino )pyrrolidine-2,4-dione, 70. 
C(l 0 )-N (1 )-C(2 )-0(3) -11.9(3) C(16)-C(11)-C(12)-C(13) 2.0(3) 
C(5)-N(1 )-C(2)-0(3) 179.56(17) C(10)-C(ll)-C(12)-C(13) -177 .88(19) 
C(10)-N(1 )-C(2)-C(3) 167.84(16) F(2)~(12)~(13)-C(14) 177.40(19) 
C(5)-N(l)-C(2)-C(3) -0.7(2) C(11)-C(12)-C(13)-C(14) -0.9(3) 
C(20 )-N (2 )~(3 )-C(2) 65.7(2) C( 12 )-C( 13 )-C( 14 )-C(l5) -0.6(3) 
C(20 )-N (2 )-C(3 )-C(30) -171.99(16) C(13 )-C(14 )-C(15)-C(l6) 0.8(4) 
C(20 )-N (2 )-C(3 )-C( 4) -47.5(2) C(12)-C(11)-C(16)-F(1) 176.3(2) 
0(3 )-C(2 )-C(3 )-N (2) 59.1(2) C(10)-C(11)-C(16)-F(l) -3 .8(3) 
N ( 1 )-C(2 )-C(3 )-N (2) -120.64(16) C(12)-C(11)-C(16)-C(15) -1.7(4) 
0(3 )-C(2 )-C(3 )-C(30) -62.0(2) C(l0)-C(11)-C(16)-C(15) 178.1(2) 
N(1)-C(2)-C(3)-C(30) 118.28(16) C(14 )-C(15)-C(16)-F(1) -177.6(2) 
0(3 )~(2 )-C(3 )-C( 4) 176.66(17) C(14 )-C(15)-C(16)-C(11) 0.4(4) 
N ( 1 )-C(2 )-C(3 )-C( 4) -3 .05(18) C(3)-N(2)-C(20)-0(2) 2.9(3) 
N (2 )-C(3 )-C( 4 )-0( 4) -59.7(2) C(3 )-N (2 )-C(20 )-C(21) -178.23(16) 
C(2 )-C(3 )-C( 4 )-0( 4) -177.16(17) 0(2 )-C(20)~(21 )~(22) 124.6(2) 
C(30 )-C(3 )-C( 4 )-0( 4) 62.7(2) N(2 )-C(20)~(21 )~(22) -54.2(3) 
N (2 )-C(3 )-C( 4 )-C( 5) 123 .12(16) 0(2 )-C(20 )-C(21 )-C(26) -49.3(3) 
C(2)-C(3)-C(4)-C(5) 5.65(18) N (2 )-C(20)-C(21 )-C(26) 131.8(2) 
C(30)-C(3)-C(4 )-C(5) -114.54(17) C(26 )-C(21 )-C(22)-F(3) 178.2(2) 
C(2)-N(1)-C(5)-C(4) 4.2(2) C(20)-C(21 )-C(22)-F(3) 4.0(4) 
C(10)-N(1)~(5)-C(4) -165.06(15) C(26)-C(21)-C(22)-C(23) -0.1(4) 
C(2)-N(1)-C(5)-C(40) -117.41(17) C(20 )-C(21 )-C(22 )-C(23) -174.3(3) 
C(10)-N(1)~(5)-C(40) 73.3(2) F(3 )~(22 )~(23 )-C(24) -179.4(3) 
0(4)-C(4)-C(5)-N(1) 176.82(18) C(21 )-C(22 )-C(23 )-C(24) -1.1(5) 
C(3)-C(4)-C(5)-N(1) -6.03(18) C(22 )-C(23 )-C(24 )-C(25) 0.9(5) 
0(4 )-C(4 )-C(5)-C(40) -62.9(2) C(23 )-C(24 )-C(25)-C(26) 0.5(4) 
C(3 )-C( 4 )-C( 5 )~( 40) 114.26(16) C(24 )-C(25)-C(26)-F( 4) -179.7(2) 
C(2)-N(1)-C(l0)-0(l) -167.99(18) C(24 )-C(25 )-C(26 )-C(21) -1.8(3) 
C(5)-N(l )-C(l0)-0(1) 0.0(3) C(22 )-C(21 )-C(26)-F( 4) 179.4(2) 
C(2)-N(1)-C(10)-C(11) 12.2(3) C(20)-C(21)-C(26)-F(4) -6.2(3) 
C(5)-N(1)-C(l0)-C(11) -179.81(16) C(22 )-C(21 )-C(26)-C(25) 1.6(3) 
0(1)~(10)-C(11)-C(l2) 90.5(2) C(20 )-C(21 )-C(26 )-C(25) 175.9(2) 
N(1)~(10)~(11)-C(l2) -89.7(2) N (2 )~(3 )-C(30 )-C(31) 174.76(16) 
0(1)~(10)-C(11)-C(16) -89.4(3) C(2 )-C(3 )-C(30)-C(31) -63.7(2) 
N(1)~(10)-C(11)-C(16) 90.4(2) C( 4 )-C(3 )-C(3 0 )-C(31) 51.9(2) 
C(16)-C(1l)-C(l2)-F(2) -1 '/6.32(19) C(3 )-C(30)-C(3l )-C(32) 79.6(2) 
C(10)-C(11)-C(12)-F(2) 3.8(3) C(3 )-C(30)-C(31 )-C(36) -99.5(2) 
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C(3 6 )-C(31 )-C(3 2 )-C(3 3) 0.4(3) 
C(30)-C(31)-C(32)-C(33) -178.68(18) 
C(3 1 )-C(3 2 )-C(3 3 )-C(3 4) -0.7(3) 
C(32)-C(33)-C(34)-C(35) 0.2(3) 
C(3 3 )-C(34 )-C(3 5)-C(36) 0.6(3) 
C(34 )-C(35)-C(36)-C(31) -1.0(3) 
C(3 2 )-C(31 )-C(36)-C(3 5) 0.4(3) 
C(30)-C(31 )-C(36)-C(35) 179.53(18) 
N(1)-C(5)-C(40)-C(41) -167.68(15) 
C(4 )-C(5)-C(40)-C(41) 76.5(2) 
C(5)-C(40)-C(41)-C(42) -115.4(2) 
C(5)-C(40)-C(41)-C(46) 68.3(2) 
C(46)-C(41)-C(42)-C(43) 1.5(3) 
C(40)-C(41)-C(42)-C(43) -174.9(2) 
C(41)-C(42)-C(43)-C(44) 0.5(4) 
C(42)-C(43)-C(44)-C(45) -1.8(4) 
C(43)-C(44)-C(45)-C(46) 1.0(3) 
C(44)-C(45)-C(46)-C(41) 1.0(3) 
C(42)-C(41)-C(46)-C(45) -2.3(3) 
C(40)-C(41)-C(46)-C(45) 174.18(18) 
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X-Ray structures of two a-ftuoroamide derivatives show 
the O=C-C-F moiety tending towards a trans planar 
conformation, for which ab initio calculations suggest a 
deep (up to 8 kcal mol-1) potential minimum. 
Fluorine substituents can have profound stereoelectronic and 
polar effects 1 on the conformation of organic molecules, 
e.g. the gauche effect in 1,2-difluoroethane 2 or the fluorine 
anomeric effect in a-fluoroethers. 3 With one fluorine substituent 
in the a-position to a carbonyl group, as in a-fluoroaldehydes,4 
a-fluoroketones 5 and a-fluoroesters,6 the preferred conform-
ation of the O=C-C-F moiety is trans-planar, but the energy 
difference between cis and trans-conformations is rather small 
(0.8-2.0 kcal mol- 1). For fluoroacetamide FCH2CONH2, MO 
calculations 7 suggest a much bigger difference, 7.5 kcal mol- 1 
in favour of the trans-disposition of the F and 0 atoms, which 
was actually found by X-ray 8 and neutron 7 diffraction studies 
(it is noteworthy that the parent acetamide adopts an entirely 
different conformation~- It could be expected therefore that 
introduction of an a-fluorine substituent into a substituted 
amide will stabilise the N-C(O)-C-F moiety in the conform-
ation with the F atoms trans to the carbonyl and cis to 
the NH group. To verify this, we undertook the synthesis and 
X-ray structural and theoretical studies of mono-fluorinated 
compounds la and 2, and of non-fluorinated lb for com-
parison.t 
n aYOH a 
Fig. 1 Molecular structure of la (50% thermal ellipsoids) showing 
disorder in the phenyl group. 
~NJl 
H ~, 1 
1a R = F 
1b R =Me 
N-Fluoroacetyi-(S)-phenylalanine la, the first N-fluoro-
acylated amino acid derivative, was prepared by coupling (S)-
phenylalanine with the acid chloride of monofluoroacetic acid 
FCH2COCI, and lb respectively with ~H5COCI. The X-ray 
structure of la (Fig. I) shows the C-F bond oriented nearly cis 
to theN-Hand trans to the C=O bond, with the N(1)C(4)C(5)F 
torsion angle of -16.0(2t. The entire H02C-C-NH-C(=O}-
C-F moiety is roughly planar, with the torsion angles 0(2)-
C(I)C(2)N(1) -9.2(2t and C(I)C(2)N(I)C(4) -162.2(1t, 
compared to 151.6(2t and -58.9(3t, respectively, in lb. Thus, 
while in lb both the carboxy and the amide protons participate 
in intermolecular hydrogen bonds (Fig. 2), in la only the former 
does, while H(IN) forms a bifurcated intramolecular hydrogen 
bond with F and 0(2), at distances H · · · F 2.27(2) and H · · · 0 
2.29(2) A. 
a-Fiuoropropionamide 2 was then studied, to establish 
whether the trans conformation is affected when a substituent is Fig. 2 Molecular structure of lb. 
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012) 
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Fig. 3 An asy=etric unit in the structure of 2. containing S (solid) 
and R (dashed) isomers. 
attached to the fluoromethyl group. This amide 2 was prepared 
from (S)-alanine by a diazotisation reaction in the presence 
of hydrogen fluoride-pyridine 10•11 (see Scheme I), whereby the 
0 
~HoAf~3 
F 
3 
Q o .. ... AfCH3 
11,111 N -' H 
___... I 
H F 
2 
Scheme t i, NaN02, HF·pyridine (83%); ii, SOCI2 (61°/.,); iii, aniline 
(17%). 
amino group is substituted by fluorine with predominant 
retention of the absolute configuration. The resultant a-fluoro-
propionic acid 3 comprised 90% of the (S) and I 0% of the (R) 
enantiomer, as was assessed according to a previously described 
technique, 12 by 19F NMR of its complex with a chiral base. By 
treating 3 with thionyl chloride, it was converted to its acid 
chloride, which was then coupled to aniline to generate 2, which 
was characterised by its X-ray crystal structure. 
The asymmetric unit of 2 (Fig. 3) contains two molecular 
sites, one of which (A) is occupied by 79(1 )% of (S)-2 and 
21(1 )% of (R)-2 and the other (B) by the (S)-isomer only. 
Thus the overall (SIR) enantiomeric composition is ea. 9: 1, 
in accordance with the N MR data. Molecule B retains the anti 
planar orientation of the C-F and C=O bonds, with the N-
C(O)-C-F torsion angle of 9.9(4t. At site A, this angle is 
increased to 24.5(5t for the major (S) component and - 35( 1 t 
for the minor (R) one. This conformational distortion may be 
due to the peculiar crystal packing, required to accommodate 
both enantiomers at the same crystal site. Each molecule is 
linked with its own translational (along the x direction) equiv-
alents by N-H · · · 0 hydrogen bonds of equal strength. 
An ah initio analysis of N-methyl-2-(S)-fiuoropropionamide 
4 was carried out at the B3LYP/6-3IG*(d) level using the 
0 
H3C, ~,CH3 N ·' 
I H 
H F 
4 
GAUSSIAN98 program, 13 in order to quantify the dependence 
of the conformation on the F-C-C--0 torsion angle (r). The 
calculated energy profile (Fig. 4) shows a single distinct mini-
mum at r = 180° (C-F and N-H bonds eclipsed), the maximum 
at r = 300° and a plateau at about r = 60°. The maximum is due 
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Fig. 4 Rotational energy profile of N-methyl-2-fluoropropionamide 4 
monitoring rotation around the C-C(O) bond. Ab initio calculations 
were carried out at the B3LYP/6-31G*(d) level. Energies of conform-
ations la and 2 are indicated in the profile. 
to H · · · H steric repulsions when the methyl group approaches 
N-H, the preferred methyl group location being in the hemi-
sphere proximate to the carbonyl group. The plateau indicates 
some stabilisation of the gauche conformation, in which the 
C-H bond eclipses N-H. It is noteworthy that fiuoro-
acetamide 7 shows a distinct potential minimum for this con-
formation, second deepest after that at r = 180°. The energy 
difference of ea. 7 kcalmol- 1 between the cis (r = 0) and trans 
( r = 180°) conformers of 4 is similar to that in fluoroacetamide 
(7.5 kcal mol- 1) and at least four times greater in the other 
a-fluorocarbonyl systems studied earlier. 4-6 The stabilisation of 
the trans conformer is due mainly to the interaction between 
fluorine lone pairs and the N-H er* orbital, which contributes 
3.1 kcal mol-\ according to NBO analysis 14 of the interaction 
energies. The rest of the energy difference is due to minor 
effects, viz. a greater interaction in the trans conformation 
between the C-F er orbital and both the antiperiplanar C=O er* 
orbital (1 kcal mol- 1) and the antiperiplanar methyl C-H er* 
orbital (I kcal mol- 1). The transconformer also has the smaller 
dipole moment (2.1 D) since the C--0 and C-F bond dipoles are 
opposed, compared to 4.8 D in the cis conformer where they 
re-inforce the charge separation. 
It is important that the fluorine effect can not be explained 
simply by formation of an intramolecular hydrogen bond 
N-H · · · F, although the H(lN) · · · F distance observed in la 
is typical for such bonds. 15•16 A survey of structural data 15•16 
shows that a F atom bonded to carbon (in contrast with 
'inorganic' fluorine) forms weak hydrogen bonds, e.g. 2.4 kcal 
mol- 1 for H3CF · · · HOH vs. 5 to I 0 kcal mor1 for H · · · 0 
bonds. 15 
In general it has proven very difficult to prepare peptides 
containing a-fluorinated substituents within the amino acid 
residues, although there have been some limited successes 17•18 
but clearly if synthetic methods were developed the current 
observations suggest that the substitution of the C-F bond into 
peptides could perhaps offer a valuable tool for controlling 
peptide conformation. 
Notes and references 
t X-Ray diffraction experiments on a Rigaku AFC6S 4-circle dilfract-
ometer (Cu-Ka radiation) for I band 2, SMART IK CCD area detector 
diffractometer (Mo-Ka radiation) for la; structure solution (direct 
methods) and least squares refinement (against F 2 of all data) with 
SHELXTL software (G. M. Sheldrick, Bruker Analytical X-ray 
Systems, Madison, Wisconsin, USA, 1997). CCDC reference number 
188/188. 
la: CuH12FN03, M= 225.22, T = 120 K, orthorhombic, space group 
P21212 (No. 18), a= 9.366(1), b = 16.003(2), c = 7.598(1) A, U = 
1138.8(1) A', Z = 4, D, = 1.314 g cm- 3, i = 0.71073 A, JL = 0.11 mm-•, 
8013 reflections (2596 unique) with 28 ~ 55°, 192 variables refined to 
R = 0.032 [2497 data, 1 <> 2a(J)), wR(F2) = 0.080, flp......,- = 0.19, -0.24 
e A_,_ The phenyl ring disorder was mtionalised as two positions 
(differing by an 18° libmtion) with 50% occupancies, which were 
refined with restraints to regular hexagonal ring and equal anisotropic 
ADP for two positions of each atom. 
lb: CuH15N03, M= 221.25, T = 150 K, orthorhornbic, space group 
P212121 (No. 19), a= 5.754(2), b = 8.139(2), c = 24.873(2) A, U = 
1164.9(4) A', Z = 4, D, = 1.262 g cm-3, i = 1.54184 A, tt = 0.75 mm-•, 
1899 reflections (1597 unique) with 28 ~ 150°, 172 variables refined to 
R = 0.036 [1417 data, 1 <> 2a(J)], wR(F2 ) = 0.084, flp......,- = 0.15, -0.15 
eA_,_ The absolute configuration was confirmed by anomalous scatter-
ing: Flack pammeter -0.16(33). 
2: C~1ofNO, M = 167.18, T = 150 K, triclinic, space group PI (No. 
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firmed by anomalous scattering: Flack parameter 0.0(2). 
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Abstract 
The acylase from Aspergillus melleus was able to hydrolyse the amide bond of (S)-phenylalanine-N-2-(R,S)-fluoropropionamide and 
discriminate the diastereoisomers such that the (S,S)-diastereoisomer was hydrolysed by an order of magnitude faster than the (S,R)-
diasteroL~omer. The origin of the kinetic discrimination is attributed to both binding and kinetic effects. © 2000 Elsevier Science S.A. All 
rights reserved. 
Keywords: '9p-NMR; Acylase; Aspergillus melleus, :1.-fluoroamide; Enzyme resolution 
lt is part of the culture of bio-organic chemistry that the 
fluorine atom is considered to have a steric influence just 
slightly greater than that of a hydrogen atom [1]. However, 
electronically fluorine and hydrogen are clearly very differ-
ent. It is also part of the culture of bio-organic chemistry that 
lipase and acylase enzymes distinguish substrates through 
binding interactions which are largely steric in nature. Steric 
models for the common hydrolytic enzymes have been 
developed where 'small', 'medium' and 'large' pockets 
have been identified which define the chirality of the pre-
ferred enantiomer of a given substrate enantiomer [2,3]. In 
general, these models have served well as predictive tools. 
On the other hand, if an cx.-fluoroester or cx.-fluoroarnide is 
presented as a substrate to a hydrolytic enzyme, then the 
compound is chiral by virtue of the substitution of a hydro-
gen by a fluorine. It is now not so obvious, on the basis of 
established steric models, to predict the outcome of such a 
kinetic resolution, as the fluorine and hydrogen are both 
'small' and a distinction based on steric considerations 
cannot be made, which predicts how these groups will best 
fit the enzyme surface. 
Examples of successful kinetic resolutions with cx.-fluor-
oesters are rare [4,5], however, the following one [4] serves 
to illustrate that certain enzymes can distinguish fluorine and 
hydrogen at the stereogenic centre. 
Lipase P30 was able to selectively hydrolyse the (S)-
enantiomer of ethyl 2-fluorohexanoate over the (R)-enantio-
·corresponding author. Tel.: +44-191-374-2000. 
E-mnil address: david.o'hagan@durham.ac.uk (D. O'Hagan). 
mer and on work up the (R)-ester was isolated in 99% ee 
after 60% conversion, as illustrated in Fig. I. Such a dis-
crimination cannot easily be accounted for on the basis of a 
steric difference between hydrogen and fluorine, and we 
have previously suggested that a stereo-electronic effect is 
responsible for this discrimination [1,6]. The enzyme attacks 
the ester, via a serine alkoxide nucleophile and becomes 
acylated. The preferred transition state has the serine alk-
oxide attacking the carbonyl anti to the vicinal fluorine 
atom. The overlap of the C-F cr* orbital with the carbonyl 
LUMO stabilises this molecular orbital in transition state A 
relative to transition state B, and the electron density of the 
serine nucleophile can donate into the C-F cr* orbital only in 
transition state A, lowering the energy of anti approach to 
the fluorine atom. Also, the electrostatic repulsion between F 
and o- is minimised in transition state A. Calculations 
suggest up to a 2.5 kcal mol- 1 difference in the energy of 
these transition states, and there is a sufficient energy 
difference to account for the observed kinetic resolution. 
In this paper, we report the first study on the enzymatic 
resolution of an cx.-fluoroamide with an acylase. We were led 
to this investigation after a recent evaluation of the preferred 
conformation of N-alkyl cx.-fluoropropionarnides [7]. Anum-
ber of years ago, both electron [8] and neutron diffraction [9] 
analyses have demonstrated that the major conformer of 
monofluoroacetamide (FCH2C(O)NH2) has the C-F bond 
anti to the C=O bond and syn to the N-H bond of the amide 
in the solid state as illustrated in Fig. 2. The energy 
difference between this and the next favoured syn confor-
mation was calculated to be 7.5 kcal mol- 1• ln our recent 
0022-1139/00/$- see front matter© 2000 Elsevier Science S.A. All rights reserved. 
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Fig. I. Rationale for the stereoselectivity observed during the lipase mediated hydrolysis of a racemic :x-fluoroester. 
preferred conformation has 
C-F and C::O anti planar 
Fig. 2. Conformation of fluoroacetamide. 
study [7], we have investigated the preferred conformation 
of N-alkyl cr-fluoropropionamides by both X-ray crystal-
lography and ab initio calculations. It is found that the trans 
conformation is again favoured in the solid state for these 
amides where the C-F bond lies anti to the C=O bond as 
shown in Fig. 3. Calculations revealed that this was the only 
minimum on the rotational energy profile (around the FC-
C(O) bond) and that the barrier to rotation was large at 
8.0 kcal mol- 1• The fluorine atom and not the methyl group 
dictates the conformation of these arnides. 
It follows that with such a conformational preference, 
where the C-F and N-H bonds are syn and eo-planar, 
enantiomers of tx-fluoropropionamides will necessarily have 
to locate their methyl groups in opposite spacial locations 
around the stereogenic centre (Fig. 3). This is anticipated to 
impose significantly different diastereomeric interactions 
during the binding of such enantiomers to an enzyme. With 
this in mind, we have synthesised (S)-phenylalanine N-
(R,S)-2-fiuoropropionamide as a substrate for acylase 
hydrolysis as shown in Scheme I. 
0 
¥. R H • N' I 
F H 
enantlomers of a -fluoropropionamides have 
preferred conformations with G-F and C::O anti 
olanar which dictates the location of the Me 
Fig. 3. Conformation of :x-fluoropropionamides. 
This substrate was chosen as the diastereoisomers are 
distinguised only by the fluorine atom at the stereogenic 
centre. Incubation of this substrate with the acylase from 
Aspergillus melleus resulted in a slow hydrolysis. The 
relative rates of hydrolysis of the two diastereoisomers 
could be followed analytically, in a very straightforward 
manner by 19p-NMR., as each diastereoisomer had a unique 
and resolvable I9p_NMR resonance ((S,S) ~ 182.1 ppm and 
(S,R) ~181.67 ppm). The enzymatic reaction was moni-
tored through time in an NMR tube, and the rate slowed 
down considerably as the reaction approached 50% con-
version. The reaction was stopped at 57% conversion where 
the ratio of isomers was 98 : 2, representing a diastereo-
meric excess of the residual substrate of 96% de. The major 
diastereoisomer was (S,R), the diastereoisomer which is 
hydrolysed more slowly by the enzyme (Scheme 2). 
In order to gain some insight into the origin of the 
observed selectively, Km and V max data for each diaster-
eoisomer were obtained in separate experiments. This 
required the preparation of each diastereomer in an enan-
tiomerically enriched form. This was achieved by preparing 
(S)- and (R)-2-fluoropropionic acids directly from (S)- and 
(R)-alanines by diazotisation and in situ treatment with HF-
pyridine [10]. The diazotisation reaction is reported to 
proceed with predominant retention of configuration 
[11, 12]. In the event, it emerged that the product 2-fiuor-
opropionic acids were generated in an enantiomeric excess 
of 80% ee from the enantiomerically pure alanines. This 
enantioselectivity was established by recording 19F-NMR 
of (S)-2-(dipheny1methyl)pyrrolidine salts of the resultant 
( 
R=OH 
R=CI 
HI 
-
0 <(02' ~ 
... Jl ···VV T -~,. 
Scheme I. (i) NaN02, HF pyridine, 14%; (ii) SOC12, 83%; (iii) Aq. 
NaOH, 16%. 
J. W Banks, D. O'Hagan/ Journal of Fluorine Cl1£mistry 102 (2000) 235-238 237 
0 ~w-~~ 
....... Jl ,.· ~ I -~~~­
F H 
A. melleus 
lipase 
57% conversion 
0 cow-~1 
11 •• · ~ ~,., 
. N 
: H 
F 
(S, R) 96% de 
+ 
Scheme 2 
2-fluoropropionic acids in CDCh [13]. The enantiomeri-
cally enriched 2-fluoropropionic acids were converted to 
their acid chlorides after treatment with thionyl chloride and 
were then coupled directly to (S)-phenylalanine. This gen-
erated diastereomerically enriched compounds of 80% de, a 
value which was readily determined by integration of the 
two fluorine signals in the 19p-NMR spectrum, associated 
with each diastereoisomer. In the case of the (S,R) stereo-
isomer, the material was stereochemically purified by an 
initial short bio-transfommtion with the A. me Ileus acylase, 
to hydrolyse the 10% (S,S) isomer and the diastereomeri-
cally pure (S,R) substrate was recovered as its sodium salt. 
The (S,R) stereoisomer was enantiomerically pure within 
the limits of 19p-NMR detection. For the (S,R) stereoisomer, 
improvement of the 80% de was not so readily achievable 
and this material was used directly for the kinetic study 
(Table 1). 
Initial reaction rates (v) at different substrate concentra-
tions [S] were determined by 19p-NMR analysis, and then 
plotted as Lineweaver-Burke plots (1/v versus 1/[S]) to 
determine Vmax and Km for each substrate [14]. It emerged 
that the (S,S) substrate has a Km of 16.26 mM and a V max of 
0.92 mM min- 1, whereas the (S,R) substrate had a Km of 
40.34 mM and a Vmax of0.20 mM min- 1• Km is a measure 
of substrate binding and V max a measure of the rate of 
product formation (enzyme-substrate complex breakdown). 
The overall efficiency of the enzyme for each substrate can 
be estimated by comparing VIK values for each substrate. 
These values emerge as VIK = 0.0566 for the (S,S) sub-
strate, and V/K = 0.005 for the (S,R) substrate. The study 
predicts one order of magnitude difference in the rates of 
hydrolysis in favour of the (S,S) substrate and the experi-
mental value of 96% de for the residual (S,R) diastereoi-
somer in the previous study is consistent with this analysis. 
The Km values reveal that there is a differential binding 
affinity of the substrates by the A. me Ileus lipase. Also the 
Vmax values indicate a differential rate of product formation, 
Table I 
Kinetic parameters for tbe hydrolysis of (S)-phenylalanine-N-2-fluoropro-
pionarnides witb Arpergillus melleus. The data are an average of two 
separate studies in each case 
Substrate Km(mM) Vmax VIK 
diastereomer (mMmin- 1) 
(S,S)" 16.26 ± 1.84 0.92 ± 0.07 0.0566 
(S,R) 40.34 ± 3.21 0.20 ± 0.02 0.0050 
"80% de. 
which is perhaps related to the relative rates of enzyme 
acylation/deacylation. 
In summary, the A. me ileus lipase can mediate an efficient 
kinetic resolution between diastereoisomers of (S)-pheny-
lalanine-N-(R,S)-2-fluoropropionamide. Although, acylases 
have hardly been explored in such reactions, this initial 
study suggests that they offer an excellent method for 
preparing enantiomerically enriched 2-fluorocarboxylic 
acids and arnides. The preferred conformation of such 
amides, where the C-F and C=O bonds orientate anti to 
each other, predicts a discernable binding difference 
between the enzyme and each diastereomeric substrate. 
Although, the data reveal that both substrates have Km 
values in the high mM range, and are poor binders, a two 
fold difference in binding affinity emerges. Perhaps less 
obviously, the V max data revealed a four fold difference 
between the diastereoisomers, and reflects the difference in 
the rate of product formation (or enzyme-substrate break-
down). Perhaps this latter difference lies in off-loading the 
2-fluoroacyl ester-enzyme complex by nucleophilic attack 
by water, a process which should be susceptible to the 
stereoelectronic effect discussed above for the lipase hydro-
lysis of cx-fluoroesters [1,6]. 
The overall kinetic profile of such enzyme resolutions are 
complex and difficult to deconstruct as there are various 
factors operating at different stages along the enzyme 
reaction course, however, it emerges from this study that 
conformational and stereoelectronic effects can combine to 
result in highly stereoselective enzymatic resolutions with 
mono-fluorinated ester and amide substrates. 
1. Experimental 
FTIR spectra were recorded on a Nicolet Magna IR 550 
Spectrometer. NMR spectra were obtained on a Jeol EX 
270 MHz spectrometer in CDC13 or D20. Chemical shifts 
are quoted relative to TMS for 1H- and 13C-NMR spectra 
and 19F-NMR chemical shifts are quoted as negative relative 
to fluorotrichloromethane. Solvents were dried and distilled 
prior to use. Reactions requiring anhydrous conditions were 
carried out under an atmosphere of nitrogen. 
1.1. Preparation of (R,S)-2-fluoropropanoic acid 
(R,S)-Alanine, (8.6 g, % mmol) was added to a stirred 
solution of pyridinium hydrogen fluoride (100 ml, 70% w/ 
w) in a Teflon bottle. The solution was cooled to ooc and 
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sodium nitrite (22.6 g, 232 mmol) was added in five equal 
portions over 1 h. The reaction mixture was stirred at ooc 
for 1 h and was then warmed to room temperature and then 
stirred overnight. The reaction was quenched by addition to 
ice water ( 100 ml). The aqueous solution was extracted into 
diethy1ether (3 x 100 ml), washed with sodium chloride 
solution (3 x 100 ml, 5% w/v) and dried over anhydrous 
sodium sulphate. The organics were filtered and the solvent 
was evaporated. The residue was distilled (50°C, 23 mbar) 
to afford the product ( 1.4 g, 14%) as a colourless oil. 
c5H(270 MHz, CDC13) 5.12 (IH, dq, J 48.5, 6.9, CFH), 
1.61 (3H, dd, J 23.5, 6.9, Me); c5c(67.9 MHz, CDCh) 
85.1 (d, J 182.7), 18.2 (d, J 22.3); c5p(254.2 MHz, CDC13) 
~184.76 (dq, J 48.3, 23.5, CFH). 
1.2. Preparation of(R,S)-2-jluompropatwyl chloride 
Thionyl chloride, (2.8 g, 23.5 mmol) was added dropwise 
to heat (R,S)-2-fiuoropropanoic acid, ( 1.00 g, 10.9 mmol) at 
room temperature. The reaction was heated to reflux for 
60 ruin and a sample removed for 1H- and 19F-NMR ana-
lysis to confirm the absence of starting material. The product 
was distilled (bp. 56°C) directly from the reaction mixture at 
atmospheric pressure to give the product as a colourless oil 
(1.0 g, 83%). c5H(270 MHz, CDC13 ) 5.14 (1H, dq, J 48.6, 
7.0, CFH), 1.66 (3H, dd, J 22.8, 6.8, Me); c5c(67.9 MHz, 
CDC13) 172.5 (d, J 27.9), 90.3 (d, J 194.5), 17.6 (d, J 21.9); 
c5F{254.2 MHz, CDCh) ~171.4 (dq, J 49.1, 23.0, CFH). 
1.3. Preparation of(S)-phenylalanine-N-2-(R,S)-
fluoropmpionamide 
(S)-Phenylalanine (2.63 g, 16 mmol) was dissolved in 
4 M NaOH (12 ml, 48 mmol). The reaction was cooled to 
0°C and (R,S)-2-fiuoropropanoyl chloride (1.6 g, 14 mmol) 
was added dropwise. The reaction was warmed to room 
temperature and stirred for 30 ruin, acidified to pH = 3 with 
a HCl solution and the product was extracted into ethyl 
acetate (100 ml), washed with brine (3 x 100 ml, 5% w/v) 
and dried over anhydrous sodium sulphate, filtered and 
evaporated in vacuo to afford the product as an amorphous 
white solid (0.6 g, 2.5 mmol, 16%). M.p. 87.0-87SC; 
FTIR 3388 (s), 3335 (s), 2979 (s), 2800 (br), 1729 (s), 
1624 (s), 1545 (s), 1227 (s); El (m/z) 239 (5), 194 (10), 148 
(100), 131 (13), 120 (30), 103 (22), 91 (95), 77 (27), 65 (27), 
47 (33); c5H(270 MHz, CDCh), 7.23 (5H, m, ArH), 6.92 (lH, 
m, NH), 5.03 (lH, dq, J 39.1, 6.8, CFH), 4.90 (lH, over-
lapping dd, J 6.8, 6.8, CH), 3.19 (2H, m, CH2 ), 1.48 (3H, 2 
overlapping dd, J 24.5, 6.8, CH3); c5c(67.9 MHz, CDC13) 
174.2, 174.1, 171.2 (d, J 19.0), 171.1 (d, J 20.0), 135.3, 
135.3, 129.3, 129.2, 128.6, 128.5, 127.2, 127.2, 88.3 (d, J 
183.6, CFH), 88.3 (d, J 183.5, CFH), 52.6, 52.4, 37.4, 37.24, 
18.3 (d, J 21.9), 18.1 (d, J 20.9); c5F{254.2 MHz, CDCh) 
~182.79 (ddq, J 49.2, 24.7, 4.2, CFH), ~182.92 (ddq, J 
49.8, 25.2, 4.3, CFH). 
1.4. Acylase enzyme reaction 
( S)-Phenylalanine-N-2-(R,S)-fiuoropropionarnide was 
dissolved in 4 M NaOH (three equivalents) and the solution 
adjusted to pH = 7 with aq. HCl and then diluted to a known 
volume of phosphate buffer (pH = 7), to give a 50 mM 
concentration of substrate in solution. Each diastereoisomer 
was readily observable by 19p-NMR. c5F{254.2 MHz, 
CDCh) ~181.67 (dq, J 48.7, 25.2, CFH) (S,S)-diastereoi-
somer, ~182.10 (dq, J 48.5, 25.2, CFH), (S,R)-diastereoi-
somer. The above solution of sodium (S)-phenylalanine-N-
2-(R,S)-fiuoropropionarnide (0.2 ml) (for a 10 mM reaction) 
and phosphate buffer, (pH= 7, 0.6 ml) was placed in a 
5 mm NMR tube. A solution (0.2 ml of a 25 mg/ml, 
0.5 units/rug) of the A. melleus acylase (Sigma Chem.) in 
phosphate buffer (pH = 7) was added to initiate the reaction 
and the reaction maintained at 25°C and monitored by t9p_ 
NMR. 
For the kinetic analysis of the individual diastereoi-
somers, the same conditions were used. For the faster 
reacting (S,S)-diastereoisomer the initial reaction rate could 
be calculated after 5-10 ruin by monitoring the integration 
of the fluorine signals by 19p-NMR. For the slower reacting 
(S,R)-diastereoisomer this required several hours. 
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